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INTRODUCTION 
Life is life’s work 
 The battle against disease is perhaps as old as humanity itself. 
Year after year, lakhs of patients are diagnosed with serious 
ailments that don’t respond to existing therapies. These patients 
and their needs are a daily focus of work. 
 
 Life is our life’s work is a powerful statement to help 
humanity by discovering, developing and providing innovative 
products that lead to healthier and more productive lives. Helping 
people lead a long and healthy life that’s what we are all about. 
 
 Health is a positive states of well being that is to say every 
organ of the body functioning normally and perfect functional 
balance with every other organ. 
 
 The condition of the locomotor system is also one of the state 
of health. The locomotor system includes the muscles, bones, joints 
and soft tissue structure such as tendons, ligaments. 
 
 Medicine as everyone knows is not merely a science but an 
art as well. 
 
 Siddha system is based on Truth and Philosophy. According 
to this system of medicine, man and nature are inseparable and 
interdependent. 
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It is not only curative but also possess Preventive, 
Rehabilitation and Rejuvenation aspect of its own than other 
systems of medicine in the world. 
 
 This system has the unique features like removal of the root 
cause of the disease and perfect remedies for body, mind and soul. 
 
 There are many ways to attain the eternal world such as 
Gnana margam and Kanma margam. Human body is considered to 
be the media for that we must have disease less life. 
 
 Siddha system of medicine is dedicated bequest of siddhars 
cheerfully given to the human society to live long and free from 
disease.The medicines formulated by siddhars are clinically trialed 
drugs. 
“MAs; khkiw Nakiw ahnkt;th nwd;dpd; 
 MatPlil Nthh;fs;kh dplh;fNs ay;yhky; 
 Vw Ntwpiy atUly; tPe;jplh jpaw;wj; 
 J}a ed;kUe; Jiuj;jyh yhnkdr; nrhy;tha;” 
       - Njiuah; 
 If the natural harmony of the Threethathu becomes altered 
and  disequilibrium causes various diseases. 
 
 Dysharmony of Threethathu may be due to arusuvaigal, 
climatic changes and habits of the individual. 
 
 In the present circumstances with the high level of 
environmental degradation, westernized life style and scant regard 
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for social and moral values, it is impossible to maintain healthy life. 
Among the three dhosas vatham is placed first. 
 
 In Yugi munivar's "Vaidhya Chindamani" vatha diseases are 
classified into 80 types. Keelvayu comes under the 80 types of 
vatha diseses. In the text book of siddha maruthuvam keelvayu is 
further divided into 10 types. 
 
Vali azhal keel vayu comes under in this 10 subdivisions. 
 Author had selected Vali Azhal Keel vayu for the clinical study 
of the dissertation work which correlate with Rheumatoid Arthritis 
in modern aspect, on the basis of the siddha concept, the course of 
the disease, diagnosis and treatment.  
 
 The author had chosen the drug MegaSoolai Veekathukku 
choornam [Rishi choornam] as internal medicine and Arkaadthi 
thylum [Rishi thylam] as external. As it is a herbal formulation it is 
purely safe and free from adverse effects. 
 
 The author hopes that this dissertation work will help the 
sufferers of Vali azhal keel vayu in giving new modality of treatment.  
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AIM AND OBJECTIVES 
AIM 
 Rheumatoid Arthritis is not only a polyarthritis, and the name 
Rheumatoid disease is preferable since it directs attention to whole 
patient and not just the joints. 
 
 Vali azhal keel vayu is a disease which causes so much 
suffering because of the tendency of crippling without killing. Most 
of the patients are unable to do their day today activities 
independently. The mean age of onset of Rheumatoid Arthritis is 40 
years. Hence it affects the people in their active period of their life. 
 
 Since about majority of the clinical outcomes in today's 
medical world pertain to musculoskeletal disorders, lot of interest 
has been developed in this field. 
 
 Complete remedy for this disease has not yet been arrived at 
all. Here this study was carried out with an intention to formulate 
an ideal treatment for the Vali azhal keel Vayu. 
 
They are 
¾ To relive symptomps including fatigue, pain, swelling and 
stiffness. 
¾ To prevent joint destruction, loss of joint function, deformity 
and disability. 
¾ To preserve quality of life 
 
 This being a preliminary endeavor by the author, as if it 
would be a helping hand to the sufferers. With this view, the 
dissertation subject was under taken. 
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OBJECTIVES 
¾ To study the clinical cause of the disease Vali azhal keel vayu 
with observation on the Aetiology, Pathology, Diagnosis, 
Prognosis, complications and treatment by making use of 
Siddha aspect. 
 
¾ To expose the unique diagnostic method mentioned by 
siddhars, to know how the disease Vali azhal keel vayu alters 
the normal conditions of the body under the topic 
Mukkutram, Poripulangal, Ezhu Udal Kattukal and Envagai 
Thervugal. 
 
¾ To know the extend of correlation of Aetiology, classification, 
signs and symptoms of Vali azhal keel vayu in Siddha Aspect 
with Rheumatoid Arthritis in modern medicine. 
 
¾ To have detailed clinical investigaion.  
 
¾ To have a clinical trial on Vali azhal keel vayu with Mega 
Soolai veekathukku Chooranam as internal medicine and  
Arkaathi thylam as external medicine. 
 
¾ To evaluate the biochemical and pharmacological effects of 
trial medicine. 
 
¾ To use modern parameters to confirm and prognosis of the 
disease. 
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ABSTRACT 
 
 The author had chosen the disease Vali azhal keel vayu for 
the dissertation subject because it is one of the disorder which 
affects the individuals in higher incidence. It's increased occurrence 
in recent times is due to stress, strain and abnormal dietary habits. 
 
 The inscriptions mentioned in the siddha literature about this 
disease and therapeutics impressed the author very much. 
 
 The disease is correlated with rheumatoid Arthritis as 
mentioned in modern medicine. 
 
 The author diagnosed the disease by using siddha parameters 
like Envagai Thervugal, Kaalam, thinai, Mukkutra Verupadugal 
and modern parameters like laboratory investigations. 40 patients 
in either sex had been selected by the author both as in inpatients 
(20) and out patients (20) and they were administered with the trial 
medicines. 
 
1. Mega Soolai Veekathukku  Chooranam 1gm thrice a 
day (Internal).  
2. Arkaathi Thylam - External Application 
3. The   trial   medicines   are   subjected   to   biochemical   
and pharmacological analysis. 
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SIDDHA ASPECTS 
 
thjk; 
 clk;gpw;F ahnjhU jPq;Fk; Nehplhjgb mZj;Jt &gkha; cly; 
vq;Fk; gutp jhJf;fis vy;yhk; ghJfhf;Fk; Xh; tpj rf;jp. ,J ce;jpapd; 
fPo; gpwe;J clk;G KOtjpYk; gutp Rthrk;> grp> jhfk; KjypaitfSf;F 
Mjhukhf ,Ue;J nfhz;L gy tpfhuq;fis Vw;gLj;jpf; nfhz;bUf;Fk; 
Kg;gpzpfspy; xd;W. thjk; jd;dstpy; mjpfhpf;Fk; NghJ euk;G 
Jthuq;fspy; nfl;l ePh; jq;fp jirapy; Cwp rh;thq;fj;ijAk; gw;wp epw;Fk; 
Xh; NehahFk;. 
 
 ,J Kg;gpzpfspy; Kjd;ikahdjhFk;. thjk; cly; KOtJk; gutp 
tho;git vdpDk; ghj Kjy; ce;jp tiu gutp ,af;f nray;fisr; 
nra;Ak;. ,ij fPo;fhZk; ghly; %yk; mwpayhk;. 
“tsp Kjyh naz;zpaKf; Fw;w nky;yhk; 
tho;tnjdpDk; NjfKw;Wk; gk;gpg;gue;J 
njspTwr; rhw;Wk; ehgpf;Ff; fPo; thjk;” 
  - kUj;Jt jdpghly; 
 
thjj;jpd; jd;ik 
 kz;zPudy;fh nyd;D ehd;Fk; 
 epuNy ehw;we; jl;ge; jpl;gk; 
 cUtp Y}w;w Kila thfp 
 nka;nghUs opnghU nsdtpL tifa 
 mZf;fs; nka;nghUs; fhhPa kopnghUs; 
 
 vdg; Gfd;wpUg;gjhy; thjj;jpd; ,aw;iftbtk; Ez;ik 
(mZj;Jtk;)> neha;ikfshFk;. NkYk; ,af;fk;> jl;gk;> ntk;ik> 
xg;gutpd;ik Mfpait thjj;jpd; jd;ikfshFk;. 
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thjk; thOkplk; 
  “nespe;jpl;l thjkgh dj;ijg; gw;wp 
   epiwe;jpilar; Nrh;e;Je;jpf; fPNo epd;W 
  Fspe;jpl;l %ykJ} nlOe;J fhkf; 
   nfhbapilg; gw;wpnaOq; Fzj;ijg; ghNu 
  Fzkhd ntYk;igNkw; nwhw;if ehb 
   --------------------- 
  epzkhd nghUj;jplKk; Nuhkf; fhYk; 
   epiwthfp khq;fpr nky;yhk; gue;J 
   --------------------- 
   fhy;fhl;b thjnkq;Fq; fyf;Fe; jhNd” 
        - itj;jpa rjfk; 
NkYk; kUj;Jt jdpg;ghlypy; 
  “cz;b rikj;Jlw; $l;Lq; Flw;gFjp 
   jpz;bnyd;G nrtpFwq;F tpz;l 
   njhLzh;T Njhw;Wtpf;Fk; NjhypUg; gpt;thWk; 
   tLtpylhk; tspf;F” 
      vd;W $wg;gl;Ls;sJ. 
¾ mghdd; 
¾ ,lfiy 
¾ ce;jpapd; fPo; %yk; 
¾ vYk;G 
¾ fhJ 
¾ njhil 
¾ Njhy; 
¾ ,Lg;GgFjp 
¾ jir 
¾ euk;G 
¾ %l;Lfs;  
¾ kyk; 
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thjj;jpd; ,aw;ifg; gz;Gfs; 
thjk; jd; ,aw;if epiyapy; epd;W 
¾ Cf;fKz;lhf;fy; 
¾ %r;Rtply;> thq;fy; 
¾ kdnkhop nka;fSf;Fr; nraiyj; juy; 
¾ kyk; Kjypa gjpdhd;F Ntfq;fis ntspg;gLj;jy; 
¾ rhuk; Kjypa VO cw;fl;Lfl;Fk; xj;j epfo;r;rp juy; 
¾ Ik;nghwpfl;F td;ik nfhLj;jy; 
Mfpatw;wpy; clw;F Jiz GhpjNy tspapd; ,aw;if gz;ghFk;. 
 
thjk; khWgLk;NghJ clypy; GhpAk; njhopy; 
 thjkhdJ jd; ,aw;ifg; gz;gpypUe;J khWgLk; NghJ clypy; 
fPo;fz;l nray;fs; GhpAk; vd $wg;gl;Ls;sJ. 
¾ cly; Nehjy; 
¾ Fj;jy; 
¾ gpsj;jy; Nghd;w typ 
¾ euk;G Fd;wy; 
¾ eLf;fy; 
¾ kd ,Wf;fkhjy; 
¾ ePh;g;girapd;ik 
¾ mirj;jy; 
¾ ,isj;jy; 
¾ Filr;ry; 
¾ jb Kjypatw;why; mbgl;lJ Nghd;w Ntjid 
¾ %l;L eOty; 
¾ cWg;Gfs; jsh;r;rp 
¾ kaph;f; $r;nrwpjy; 
¾ if> fhy;fis ePl;lTk;> klf;fTk; Kbahik 
¾ ePh; Ntl;if 
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¾ nfz;ilf;fhy;> njhil Kjypad nehWq;fpg; NghtJ Nghy typ 
¾ if> fhy; nray; ,oj;jy; 
¾ kyk; rpWePh; Kjypad jilgLjy; 
¾ vr;RitAk; Jth;g;ghapUj;jy; 
¾ tha; ePUwy; 
¾ Njhy;> kyk;> ePh; Kjypad fWj;Jf; fhzy; 
 
fgj;jpd; njhopy;  - fPy;fs; njhopy;GhpahjpUj;jy;. 
 
Ritf;Fk;> thjj;jpw;Fk; cs;s njhlh;G 
  “Gspj;Jth; tpQ;Rq;fwp ahw; G+hpf;Fk; thjk;”   
- rpfpr;rhuj;djPgk; 
thjj;ij mjpfhpf;fr; nra;Ak; Ritfshtd Gspg;G> Jth;g;G. 
  “thj Nkypl;lhy; kJuk; GspAg;G 
   NrjKwr; nra;AQ; rpiwak; - Xjf;Nfs; 
   fhue; Jth;frg;Gf; fhl;LQ;Rit nay;yhk; 
   rhug; ghpfhuQ; rhw;W” 
- rpfpr;rhuj;djPgk; 
thjj;ij rkg;gLj;Jk; Ritfshtd ,dpg;G> Gspg;G> cth;g;G 
 
thj gpj;jj;Jf;Fk; - clw;jhJf;FKs;s nghUj;jk; 
tsp - vYk;gpYk; 
moy; - nre;ePhpYk; nghUe;jp epw;Fk; 
thj Nuhfq;fspd; ,Ug;gplk; 
  “vz;gJ thjkhF kpUtifg; gFj;Jf; fhzpy; 
   ez;GW miuf;FNkNy ehw;gJ thjkhFk; 
   gz;GNr uiuf;Ff;fPNo gj;Jehz; fhFnkd;W 
   tz;L Nrh; FoypdhNs thjj;jpd; $WjhNd” 
       - mfj;jpah; 2000 
 thj NuhfkhdJ ,Lg;Gf;F Nky; ehw;gJ> ,Lg;Gf;Ff; fPo; ehw;gJ 
vd;W ,Utifahfg; gFf;fg;gLfpwJ. 
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thj Neha;f;fhd ,ay; 
 “re;jputhj Klk;G Fsph;e; njOe;Nj eLf;FQ; rPjtha; thk; 
 Ke;jpa Fj;jprpte;J re;Jfs; NjhWq; File;J nkhspfs; tPq;Fk; 
 te;jpa njhe;j thjk; euk;Gfnsy;yh kprp e;J tyk; tplhJ 
 me;J mt;thF thjk; tPf;fKz;lh Klypw;wp KUz;lhNk” 
        - Njiuah; thflk; 
 cly; eLf;fk;> euk;Gjsh;r;rp> %l;Lfspy; typ> cly; Fsph;jy; kw;Wk; 
tPf;fk; fhZk;. 
 
  “mwpajpk; %d;wpd jhz;ik nrhd;dhh;ee;jp 
   vwpa ey;thj nkwpf;Fk; Fzq;NfS 
   Fwpnadf; iffhy; Fisr;R tpyhr;re;J 
   gwpnad nehe;Jkw; gr;irg;Gz;zhFNk” 
        - jpU%y ehadhh; 
 
  if> fhy; kw;Wk; tpyhr;re;J ,tw;wpy; typ cz;lhFk;. 
  “thjk; te;Jw;w NghJ tapwJ nghUkp nfhs;Sk; 
   jhJtpo;e;jpog;G iffhy; re;Jfs; fLg;Gj; Njhd;Wk; 
   rPnjhU kyKk; ePUQ; rpWj;Jld; fLj;J tpO 
   khjtkiu Nky;te;j thjj;jpd; FzkpjhNk” 
- A+fp Kdpth; ngUE}y; itj;jpa fhtpak; 1000 
 
 tapW nghUky;> ,Lg;G> if> fhy; re;Jfspy; typ> kyk;> ePh; rpWj;J 
fLj;J ,wq;Fk;. 
 
thj Neha;f;fhd fhuzq;fs; 
  “thjNkgpwg;gjw;F tul;rpahUlykhF 
   khjyhy; Fsph;r;rpahY kjpYWk; thjNuhfk; 
   ePjpNrujdpYs;s epwq;Fzkpjw;F Kz;L 
   Ntjpauwp ththjg; gpwtpaP njd;dhyNk” 
 thjk; gpwg;gjw;F fhuzk; cly; twl;rpailtjhFk;. cly; kpfTk; 
Fsph;e;J fhzg;gl;lhYk; thj Nuhfk; cz;lhFk;. 
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 “Fsph;r;rpAk; neha;ikA Kilad Tz;zy; 
   Gzh;r;rp kpFj;jy; cwf;fk; ePj;jy; 
  khRk; ePUk; MR gLjy; 
  jhq;fh Kaw;rpfs; jifawr; nra;jy; 
  FUjp Fiwjy; epidT kpFjy; 
  Jah;rpdk; Kjypad kpFjpgly; 
  tba Kjy nkype;J Nghjy; 
  fLk; gpzpAWjy; mfl nkypjy; 
  cs;sWg;gpw; rpy ePq;fy; tPo;jy; 
  fUthapw; Gz;gly; cly; EWq;fpLjy; 
  caph;epiy jhf;fy; cz;zhjpUj;jy; 
  clk;gpy; ghy;fs; kpff; Fiwe;jpLjy; 
  czhr;rp epiyfs; cwj;jhf;fpLjy; 
  vd;G rpijjy; eQ;R kUe;Jzy; 
  vd;gTk; gpwTk; tspa Neha;fl; 
  fbg;gilahf mwpjy; eyNk” 
      - khd;KUfpak; 
 
 “jhndd;w frg;NghL Jth;g; Giwg;G  
   rhjfkha; kpQ;RfpYk; rikj;j tz;zk; 
  Mndd;w thwpde;J Grpj;j yhYk; 
  Mfhaj; J}wyJ Fbj;jyhYk; 
  ghndd;w gfYwf;f kpuhtpopg;G 
  gl;bdpNa kpfTWjy; ghu nka;jy; 
  Njndd;w nkhopahh; Nkw;rpe;ij ahjy; 
  rPf;fpukha; thjkJ nrdpf;Fe; jhNd” 
      - A+fp itj;jpa rpe;jhkzp 
 
 frg;G> Jth;g;G> fhuk; Nrh;e;j czit mUe;Jjy; Mwpd czit 
cz;zy;> Njq;fpa ePiu mUe;Jjy;> gfypy; J}q;fp ,uT tpopj;jpUj;jy;> 
gl;bdp fplj;jy;> kpFe;j Rikiaj; J}f;Fjy;> ngz;zpd; Nky; kpFe;j 
tpUg;gk; nfhs;sy;. 
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thjk; mjpfhpf;Fk; fhyk; 
 “Mbahjpaha; Ig;grp <wha; 
   mzpykjw; Nfhuhrpapy; fhyk; 
  flfKjy; Jyhk;tiuapy; thjkhFq; 
  fz;zhbiag; grpAkJNt ahFk;” 
      - rjfehb 
Mb> Ig;grp khjq;fspy; thjkhdJ mjpfhpf;Fk;. 
 
thj khWg;ghl;bw;fhd fhuzq;fs; 
 “thAtpd; Fzj;Jld; #lZfpy; 
  thatpdp lq;fspy; Neha;fSz;L 
  thAtpy; Fsph;r;rp jhd; $bbNyh 
  te;jpLk; eypfSk; Ntwplj;Nj 
  thAtpy; mdy;jUk; nea;g;gike;jhy; 
  thATk; mlq;fpLk; tha;ikapJ 
  thAtpd; gpzpfisg; Nghf;fplNt 
  tFj;jpLk; Kdpnkhop fz;bLNk” 
     - rpj;j kUj;Jthq;fr; RUf;fk; 
thjj;Jld; gpj;jKk;> fgKk; Nrh;e;jpbd; thjk; khWghL milAk;. 
 
thj khWg;ghl;bd; tiffs; 
jd;dpiy tsh;r;rp 
 Kf;Fw;wq;fSk; jj;jk; ,lq;fspy; tsh;r;rpailtNj jd;dpiy 
tsh;r;rpahFk;. 
fhyk; 
 KJNtdpy; fhyk; (Mdp Kjy; Mb tiu) 
 
Ntw;Wepiy tsh;r;rp 
 tsh;r;rp mile;j Kf;Fw;wq;fs; jk; ,lj;ij tpl;L kPwp 
Ntw;W ,lj;jpw;Fg; guTkhapd; mJ Ntw;W epiy tsh;r;rp vdg;gLk;. 
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fhyk; 
 fhh;fhyk; (Mtzp Kjy; Gul;lhrp tiu) 
 
jd;dpiy miljy; 
 Kf;Fw;wq;fSk; jj;jk; ,lq;fspy; ,aw;ifaha; epiyg;gLtjhFk;.  
fhyk; 
 $jph; fhyk; (Ig;grp Kjy; fhh;j;jpif tiu) 
 
thjNeha; - nghJ FwpFzq;fs; 
 
“nfhy;yNt thjkJ kPwpw;why; 
Nrhh;tile;j thAtpdhy; Njfnkq;Fk; 
nky;y iffhy; mrjpaz;lhFk; 
nka;Klq;Fk; epkpu nthz;zhj; jpkph; cz;lhFk;” 
      - mfj;jpah; ehb 
 
 “thjtPW md;dkpwq;fhJ fLg;Gz;lhk; tz;zKz;lhk; 
 NkhJ fl;LNuhfk; ruKz;lh kpUkYkyh Kwq;fhnjd;W 
 XJ #hpa thjkdyhF eLf;fKz;lhk; nghUs;fsha;e; 
 jPnjdNt euk;gprpj;J re;Jfs; NjhWq; fpLf;Fe; jhNd” 
      - Njiuah; thflk; 
 
 grpapd;ik> cly;fLg;G> Ruk;> ,Uky;> cwf;fkpd;ik> cly; eLf;fk;> 
euk;Gj;jsh;r;rp> re;Jfs; Nehjy;> cly;Fsph;jy;> tPf;fKz;lhjy; Nghd;w 
FwpFzq;fs; cz;lhFk;. 
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fPy; thA 
,ay; 
  “tspA ikAe; jd;dpiy nfl;L 
  typAld; tPf;fr; RuKk; fha;e;J 
  %l;Lf NlhWk; KLf;fpNa nehe;J 
  %l;Lf ld;dpd; ePUk; Rue;J 
  jhq;nfhzh typAld; nehe;jpL kk;Nk” 
     - rghgjp ifNaL 
 fPy;fspy; tPq;FtJ> Fj;JtJ> NehtJ Kjypatw;iw cz;lhf;fp 
klf;fTk;> ePl;lTk;. mirf;fTk; xl;lhkw; nra;J gLf;ifapy; ,Uj;jp 
IaKk; $l;b Ru Kjypa Jiz Neha;fisAk; cz;lhf;Fk; ,ay;GilaJ. 
 
NtWngah;fs; 
 re;Jtyp. %l;Ltyp> Nkf#iy> Klf;FthA. Mkthjk;. 
 
ngah;f; fhuzk; 
 fPy;thA  - fPy;fspy; tspf;Fw;wk; $b Nehia   
     cz;lhf;Ftjhy.; 
 %l;Ltyp  - %l;Lfspy; NehiaAz;lhf;Ftjhy;. 
 Nkf#iy  - Nkfj;jpd; njhlh;G Nehahf tUtjhy;. 
 Klf;FthA  - %l;Lfis Klf;fp itg;gjhy;. 
 Mkthjk;  - tapw;wpy; ke;jk; cz;lhfp Iaj;ijg;   
     ngUf;fp Neha; cz;lhtjhy;. 
fPy;thAtpd; tiffs; 
 rpj;j kUj;Jt E}ypy; Kf;Fw;w mbg;gilapy; gj;J tifahf 
tifg;gLj;jg;gl;Ls;sJ. 
¾ tsp fPy;thA 
¾ moy; fPy;thA 
¾ Ia fPy;thA 
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¾ tsp moy; fPy;thA 
¾ tsp Ia fPy;thA 
¾ moy; tsp fPy;thA 
¾ moy; Ia fPy;thA 
¾ Ia tsp fPy;thA 
¾ Ia moy; fPy;thA 
¾ Kf;Fw;w fPy;thA 
 
 “Mj;k ul;rhkph;j itj;jpa rhu rq;fuk;” vd;Dk; E}ypy; gjpndl;L 
tif fPy;thAf;fs; fhzg;gLfpd;wd. 
 
 jpU%yh; fUf;fil itj;jpa fhtpak; 600y; MW tifahf 
tifg;gLj;jg;gl;Ls;sJ. mfj;jpah; Fzthflj;jpy; MW tifahf 
tifg;gLj;jg;gl;Ls;sJ. [Ptul;rhkph;jj;jpy; VO tifahf tifg;gLj; 
jg;gl;Ls;sJ. 
 
Neha; tUk; top 
¾ tspf;Fw;wj;ij J}z;Lk; czTfs; (thiof;fha;> cUisfpoq;F). 
¾ Fsph;r;rp jUk; nghUs;fs; cz;zy;. 
¾ Fsph; fhw;wpyPLgly;. 
¾ kioapy; eidjy;. 
¾ gdpthilapy; gLj;jpUj;jy;. 
¾ cah;e;j kiyapy; jq;Fjy;. 
“tspjU fha;fp oq;F tiutpyh japyy;Nfhio 
  Kspjaph; Nghd;kp Ff;F Kiwapyh Tz;b Nfhly; 
 Fsph;jU tspapw; Nwfq; Fdpg;Gw Tyty; ngz;bh; 
 fspj;jU kaf;fk; ngw;Nwhh; fb nray; fUtpahkhy;” 
      - rghgjp ifNaL 
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“ePuJ td;wpr; NrhiftuhNj neLNkfr; 
rhh;tJ td;wpr; #iytuhNj jtwhNj” 
- jd;te;jhp itj;jpak; 
 
 NkfNuhfk; ,y;yhky; #iyNuhfk; Vw;glhJ(gpuNkfk;> ePhpopT 
Kjyhd Nuhfq;fspypUe;J #iy Neha; (fPy;thA) Vw;gLfpd;wJ vd;W 
Gyg;gLfpd;wJ. 
  
Kw;Fwpfs; 
 %f;filg;G> %f;fpy; ePh;gha;jy;. njhz;ilf;fl;ly;> rpWRuk;. 
iffhy; Nehjy;> Fj;jy;> Filjy;. vd;Dk; Kw;Fwpfisf; fhl;b gpd;Neha; 
njhlq;Fk;. 
 
tsp moy; fPy;thA 
FwpFzq;fs; 
   “thjgpj;j fPy;thAtpd; tUq;Fwp rhw;wf; Nfsha;  
    Vjkhh; ke;jNkg;gk; ,iur;rYk; tapw;wpw; fhZk; 
    xjUq; Fj;jy; tPf;fk; Xa;jy; vhpr;rYz;lhk; 
    fhjW Kwf;f kpd;ik fha;r;rYq; fhZq; fz;lha;” 
         (rghgjp ifNaL) 
ke;jk;> Vg;gk;> ,iur;ry; - Indigestion  
Fj;jy;   - pain in affected joint. Initially motion is limited by pain. 
tPf;fk;   - Synovial inflammation causes swelling, tenderness, 
limitation of motion.  Joint swelling results from accumulation of 
synovial fluid, hypertrophy of synovium and thickening of joint 
capsule. 
Xa;jy; vhpr;rYz;lhk; - Generalised stiffness is frequent and is 
greater after periods of inactivity. Morning stiffness is due 
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toincreased fluid in and around the joint and dilated synovial 
vessels causes the joint to feel warm. 
cwf;fkpd;ik  - Sleeplessnes due to pain 
fha;r;ry;    -  Fever 
 
  cjputhj RNuhzpjk; 
„itfpjkha;f; fizf;fhY Koq;fhy; jhD 
kw;flQ; re;JGw tbAk; tPq;fpr; 
nra;fpjkhQ; rpWtpuy;fs; kpfTk; nehe;J 
rpe;ijf;F khwpNa rypg;Gz; lhFk; 
igfpjkhk; gapj;jpaj;jpy; thj kpQ;rpg;  
ghukh Aw;gtpj; joYz; lhFk; 
ca;fpjkh krdkJ jhDk; Ntz;lh 
cjputhjr; RNhzpjj;jp Dzh;r;rp ahNk” 
- a+fp itj;jpa rpe;jhkzp 
 
 vd;gjdhy; ,e;Neha; fZf;fhy;> Koq;fhy;> re;J Gwtb 
g+l;L ,tw;wpy; tPq;fpr; rpW tpuy;fspy; Nehiag; gpwg;gpf;Fk;. rpe;ij fyf;fk;> 
rypg;G> gpj;jj;jpy; thjk; kpQ;rp ghukha; moy; cz;lhFk;> czT 
Ntz;lhik vd;Dk; FwpFzq;fis cz;lhf;Fk;. ,/J moy; tspf; 
Fw;wq;fspd; fyg;ghy; cz;lhtjhFk;. 
 
thjgpj;j #iy 
 “Mfhj thjKk; gpj;jKk; #iyahk; 
 thfhd if fhy; tskha;f; fuNlWk; 
 jhfhd Nkdpjdpy; ntbg;Gz;zhFk; 
 Nghfhkdpd;W Gzh;r;rpahy; nfhy;YNk” 
    - mfj;jpah; Fzthflj; jpul;L 
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thjgpj;j #iyapy; if> fhy; fuL fl;Lk;> Nkdp Gz;zha; 
typf;Fk;. ,e;Neha; cliytpl;L NghfhJ guk;giu Nehahf tUk;. 
 
 „if fhy;fs; nghUj;Jfspy; fuL fl;Lk;> Nkdp nay;yhk; 
 jbj;J Gz;zhk; thj gpj;j #iy vdg;gLk;” 
     - itj;jpa rhu rq;fpufk; 
 
if> fhy;fs; nghUj;jfspy; fuL fl;Lk;> Gz;zha; typf;Fk; 
  
 
nkhop thjk; 
 ‘tpz;l nkhop thjk; nkhopfNlhWq; fuizfl;Lk; krpe;J NehFk;” 
- Njiuah; thflk; 
 
 nkhop thjj;jpy; re;Jfs; NjhWk; JhW cz;lhfpf; fuL fl;Lk; 
ehsiltpy; ,aq;Fk; %l;Lfs; ,aq;fhjha;tpLk;. %l;Lfspy; ,rpTld; 
$ba typAz;lhFk;. 
 
jPUk; jPuh epiy 
 tsp moy; fPy;thA NehahdJ vspjpy; kUj;Jtj;jpw;F 
mlq;fhkYk;> kUj;Jtj;jpw;F mlq;fpDk; kPz;Lk; tUtJkha; ,Ue;J> 
mf;fPy;fs; fuL fl;bdJ Nghy ePl;lTk; klf;fTk; Kbahj tz;zk; 
epiyj;Jtplr; nra;tJKz;L. 
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gpzpawpKiwik 
 “gpzpawpKiwik” vd;gJ cliy gpzpj;jyha Nehiaj; njhpe;J 
nfhs;Sfpw xOf;fk; vdg;gLk;. 
 
tpjpAk; xOf;fKk; 
 nghwpahw;Nwh;jy; 
 Gydhywpjy; 
 tpdhjy; 
 vd;Dk; tpjpfisAk; mtw;iwj; Jizahfg; gw;wp xOFk; 
xOf;fq;fisAk; Fwpf;Fk;. 
nghwpfs; 
1. nka; 
2. tha; 
3. fz; 
4. %f;F 
5. nrtp 
Gyd;fs; 
1. CW 
2. Rit 
3. xsp 
4. ehw;wk; 
5. xir 
 
 Nehahspapd; nghwp kw;Wk; Gyd;fis kUj;Jth;; Nrhjpj;J 
mwpjyhFk;. 
 
tpdhjy; 
 tpdhjy; vd;gJ Nfl;lwpjy;. kUj;Jtd; jd;id Nehf;fp te;j 
gpzpAw;wtidg; gw;wp mwpa Ntz;batw;iw mwpe;Jk;> jd;nghwp> 
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Gyd;fshy; gpzpahsDila nghwp> Gyd; topaha; czh;tijf; Nfl;L 
gpzpiaf; fzpj;jy;. 
 
vz;tifj; Njh;T 
 vz;tifj; Njh;T vd;gJ gpzpia mwpAk; top 
  “ehb ];ghprk; eh epwk; nkhop top 
   kyk; %j;jpukpit kUj;JtuhAjk;” 
        - Njud; 
  “njhLf;fYw;w ml;ltpjg;g ghPl;ir jd;id 
   Jyf;fKWk; gz;bjNu njsp tjhfg; 
   gFj;jhpa ehbia eP gpbj;Jg; ghU 
   gfh;fpd;w thh;j;ij ghh; ehitg; ghU 
   tskhd rhPuj;jpd; epwj;ijg; ghU 
   rfpf;fhpa kyj;ijg; ghh; ryj;ijg; ghU 
   rhh;e;j tpopjidg; ghh;j;J njsptha; fhNz” 
      - mfj;jpah; itj;jpa ty;yhjp 600 
 
vz;tifj Njh;Tfs; 
¾ ehb 
¾ ];ghprk; 
¾ eh 
¾ epwk; 
¾ nkhop 
¾ tpop 
¾ kyk; 
¾ %j;jpuk; 
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1. ehb 
 thjhjp Kj;Njhlq;fspd; Fzh Fzq;fis ekJ tpuy;fshy; 
Miu uj;jf; Fohapd; Nky; itj;J mOj;jpAk; jsh;j;jpAk; ghh;f;Fk; NghJ 
Vw;gLk; Jbg;G. 
 
 ehbia Fjpre;J> fhkpak;> ce;jp> khh;G> fhJ. %f;F> fz;lk;> fuk;> 
GUtk;> cr;rp Mfpa ,lq;fspy; ghh;f;fyhk;. 
 
thjgpj;jnjhe;j ehbf; FwpFzq;fs; 
’nghUshd thjj;jpy; gpj;jQ; Nrh;e;J 
nghUe;J Fzq;fsh K\;zthA rj;jp 
nrhpahik Gspj;Njg;gk; nghUky; ePhpw; 
rptg;Gkyk; gpbj;jYUe; jhJ ehl;lk; 
fUthd Njfkjp Yisr;ry; Nrhk;gy; 
if fhy; jwpg;Gehf; frf;F kd;dk;  
ghpthd Cz;Fiwjy; UrpNf lhjy; 
gyNehAk; tUj;jpitf;Fk; ghq;FjhNd” 
- rjfehb 
 
 thj gpj;j njhe;j ehbapy; c\;zthA> nrhpahik> Gspj;Njg;gk;> 
nghUky;> kyf;fl;L> Njf cisr;ry;> Nrhk;gy;> if> fhy; jwpg;G> ,d;Dk; 
gy NehAk; cz;lhFk;. 
 
 %tpuy;fshy; ehb eilia MuhAk; NghJ Ms;fhl;b 
tpuYzh;j;JtJ thjk; vdTk;> eL tpuypYzh;j;JtJ gpj;jnkdTk;> Mop 
tpuypYzh;j;JtJ IankdTk; mwpf. thjk;> gpj;jk;> fgk; ,tw;wpd; 
khj;jpiuasT KiwNa 1 : ½ : ¼. ,e;j khj;jpiuastpy; ,it khWgLk; 
NghJ Neha;epiy mwpag;gLfpwJ. 
 
 thjgpj;j njhe;jpj;j NghJ ehbahdJ ,uz;L ehfq;fs; 
$Lk;NghJ gpize;J nfhz;Ls;sJ Nghy elf;Fk;. 
 thjfyg;G ehb czug;gLfpwJ. 
 23
thjk; ,uz;Lk; gpj;jk; xd;WkhAs;s ehbfspd; y$\zk; 
“tho;tpop khNd‚ uz;L thjKk; gpj;jnkhd;Wk; 
NfhSw elf;Fk; td;ik nfhLQ;Rik rpuNkw;nfhz;L 
ehSw elg;Nghdhf eLtpdpw; rypahNjhL 
%Swg; gpj;jk; uz;LQ; rpNyj;knkhd; Wiuf;ff; NfNs” 
      jd;te;jhp itj;jpak; 
 
jiyapy; Rikiaj; J}f;fpf; nfhz;L ele;J nry;Yk; kdpjidg; 
Nghy ehbapd; eil njd;gLk;. 
2. ];ghprk;  : ghjpf;fg;gl;l gFjp #lhfTk tPf;fk; kw;Wk; typAld; fhzg;gLfpwJ. 
3. eh   : ehthdJ khg;gbe;J ntSj;Jf; fhzg;gLfpwJ. 
4. epwk;   : epwk; ,ay;ghf cs;sJ. 
5. nkhop : Nehahspapd; Ngr;Rj; jho;e;j xypahf Nfl;fg;gLfpwJ. 
6. tpop  : tpop ,ay;ghff; fhzg;gLfpwJ. 
7. kyk;  : kyf;fl;L fhzg;gLfpwJ. 
8. %j;jpuk; : ,g;ghpNrhjidapy; ePh;f;Fwp kw;Wk; nea;f;Fwp  
    Mfpait mlq;Fk;. 
ePh;f;Fwp 
¾ epwk; 
¾ vil 
¾ kzk; 
¾ Eiu 
¾ vQ;ry; 
nea;f;Fwp 
ghhf;Fk; Kiw 
 “mUe;Jkh wpujKk; mtpNuh jkjha; 
  m‡fy; myh;jy; mfhyTz; jtpe;jow; 
  Fw;wstUe;jp cwq;fp itfiw 
  Mbf; fyrj; jhtp NafhJ nga; 
  njhlUK$h;j; jf;fiyf; Fl;g LePhpd; 
  epwf;Fwp nea;f;Fwp ep&kpj;jy; flNd” - Njiuah; 
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thj ePh; : “muntd ePz;bd‡Nj thjk;” (muT-ghk;G) 
gpj;j ePh; : “MopNghy; gutpd; m‡Nj gpj;jk;” (Mop-Nkhjpuk;) 
fgePh;  : “Kj;njhj;J epw;fpd; nkhoptjd; fgNk” 
njhe;j ePh; 
 “mutpyhopAk; Mopapy; muTk; 
  mutpd; Kj;Jk; Mopapy; Kj;Jk; 
  Njhw;wpy; njhe;j Njhlq; fshNk” 
gpw ghpNrhjid Kiwfs; 
  QhNde;jphpaq;fs; 
  fd;Nke;jphpaq;fs; 
  caph;j;jhJf;fs; 
  VO clw;fl;Lfs; 
  gUtfhyq;fs; 
  jpiz 
  cly; td;ik 
I. QhNde;jphpaq;fs; 
 QhNde;jphpaq;fs; ,ay;ghf fhzg;gLfpd;wd. 
II.  fz;Nke;jphpaq;fs; (Ie;J njhopy; cWg;Gfs;) 
 if> fhy; ghjpg;gile;Js;sJ. 
III. caph;jhJf;fs; 
 
thjk; 
thOkplk; 
 mghdd;> kyk;> ,lfiy. ce;jpapd; fPo;%yk;> 
fhkf;nfhb> ,Lg;GvYk;G> Njhy;> euk;Gf;$l;lk;> fPy;fs;> kaph;f;fhy;> Cz;. 
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thjj;jpd; gphpTfs; 
1. mghdd; (fPo;Nehf;Fq;fhy;) 
 fPo;Nehf;fp kyryj;ijj; js;Sk;> Mrd thiar; RUf;Fk;> md;d 
rhuj;ijr; Nru Ntz;ba ,lq;fspy; Nrh;g;gpf;Fk;. 
2. tpahdd; (guTfhy;) 
 clypYs;s mirAk;> mirahg;nghUs; vd;Dk; ,uz;bYkpUe;J 
cWg;Gfis ePl;lTk;> klf;fTk; nra;Ak;. 
3. rkhdd; (eLf;fhy;) 
 kw;w thAf;fis kpQ;r nthl;lhky; klf;fp rhpg;gLj;jpr; 
Nrug;gz;Zk;. 
4. Njtjj;jd; 
Nrhk;giyAk; cly;Khpj;jiyAk; cz;lhf;Fk;> kpf;f Nfhgk; cz;lhf;Fk;. 
 thjj;jpy; mghdd> tpahdd;> rkhdd;> Njtjj;jd; Mfpait 
ghjpg;gile;Js;sJ. (kpFFzk;) 
 mghdd;  - kyf;fl;L. 
 tpahdd;  - ghjpf;fg;gl;l %l;Lfspy; typ> ePl;bklf;f rpukk.; 
 rkhdd;  - grpapd;ik> nrhpahik. 
 Njtjj;jd;  - mah;r;rp> J}f;fkpd;ik. 
 
tpahdthA gpuNfhgpj;j y\;zk; 
“gifajha; tpahdd; kPwpg; gapj;jar; Ruq;fs; tPf;f 
kpFjpah aq;fq;Fj;Jq; FilTkha; tpahjpahNk” 
- jd;te;jhp itj;jpak; 
 
 tpahdthA gpuNfhgkile;J Ruk;> tPf;fk;> clk;Gtyp 
Kjyhditfis cz;lhf;Fk;. 
 
rkhdthA gpuNfhgpj;j y\;zk;: 
“gf;FthraNk khuh khrak; gjpe;j Nuhfk; 
kpf;fjha;f Fdkk; #iy kpFe;jpLq; fpuhzpAz;lhk;” 
- jd;te;jhp itj;jpak; 
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 gf;Fthra Nuhfq;fSk;> Mkhra Nuhfq;fSk; Vw;gLk;.  Fd;kk;> 
#iy rk;gtpf;Fk;. 
 
gpj;jj;jpd; tiffs; 
1. mdw;gpj;jk; - cz;l czTg;nghUl;fisr; nrhpf;Fk;gb nra;Ak;. 
2. ,uQ;rfg;gpj;jk; 
 - cztpypUe;J gphpe;Jz;lhd rhw;Wf;Fr; nre;epwj;ijj; jUk;. 
3. rhjfg; gpj;jk; - tpUg;gkhd njhopiyr; nra;J Kbf;Fk;. 
 
 gpj;jj;jpy; mdw;gpj;jk;> ,uQ;rfg;gpj;jk;> rhjfg;gpj;jk;> 
ghjp;g;gile;Js;sJ.(FiwFzk;) 
 mdw;gpj;jk;  - grpapd;ik. 
 rhjfg;gpj;jk;  - md;whlg; gzpfis nra;a ,ayhik. 
 ,uQ;rfg;gpj;jk; - cly; ntSj;Jf; fhzy;. 
thj gpj;jf; Fwpfs; (thjk; 2 > gpj;jk; 1) 
 
“me;j thjq;fs; ,uz;L kLj;jpLk; gpj;jnkhd;We; 
njhe;jpj;J elf;Fkhfpw; Nwhd;wpLq; Fzj;ijf; Nfsha; 
te;Jnehe; jJjhd;tpk;kp typj;jpLk; jhfNkhfQ; 
rpe;jid kpfTz;lhFk; Grpg;giAQ; nrhpahjhf;Fk; 
ige;njhb thjgpj;j nkd;Wjhd; gfuyhNk” 
      jd;te;jhp itj;jpak; 
 clk;gpy; typ> jhfk;> kaf;fk;> jPuhj kdf;ftiy> czT 
nrhpahik ,itfNsw;gLk;. 
 
tpahd gpj;jhtuz thj Fwpfs;: 
“ntFtpa gpj;je;jd;dpy; tpahdth; thdthjk; 
tU Fzq;iffhy; ePl;l klf;f tuhJ Nehthk; 
vhpTWQ; rhPunky;yhk; nahpj;jpLk; tpahit Az;lhq; 
jUkdj; jhgKz;lh nkd;dNt rhw;wpNdhNk” 
      jd;te;jhp itj;jpak; 
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 if fhy;fis ePl;b klf;f KbahJ.  jhq;f Kbahj typAz;lhFk;.  
rhPuk; KOtjpYk; jhq;f Kbahj vhpr;rYz;lhFk;.  tpah;it 
mjpfkhf ,UfFk;.  kdjpYk; Ntjidiaj; jUk;. 
 
rkhd gpj;jhtuz thjk;:: 
“tUgpj;je; jd;dpy; Nrh;e;j rkhd thtuz thjk; 
ntUTw;Nw Tlnyhpe;J tpah;itah Aly;Fsph;e;J 
epWkpj;j gjhh;j;jnky;yh kUrpaha;j; jpfoe; jhfe; 
jUkpf;f NrhfKz;lh kpf;Fze; rhw;wNdhNk” 
      jd;te;jhp itj;jpak; 
 
 clypy; vhpr;rYk;> tpah;itAk; cz;lhFk;.  rpw;rpy rkaq;fspy; 
FspUk; fhZk;.  vij rhg;gpl;lhYk; Urp ,uhJ.  kpfTk; Ntjidiaj; 
jUk;. 
 
fgj;jpd; tiffs; 
1. mtyk;gfk; 
 ehd;F Iaq;fl;Fk; gw;Wf; NfhlhapUf;Fk.; 
2. fpNyjfk; 
 cz;zg;gl;l czTg;nghUs;> ePh; Kjypaitfis <ug;gLj;jp 
nkj;njdr;nra;Ak;. 
3. re;jpfk; 
 %l;Lfspy; epd;W ,aw;ifaha; vy;yh fPy;fisAk; xd;Nwhnlhd;W 
nghUj;jp jsur; nra;Ak;. 
 fgj;jpy; mtyk;gfk;> fpNyjfk;> re;jpfk; ghjpg;gile;Js;sJ. 
 fpNyjfk; - grpapd;ik 
 re;jpfk; - %l;Lfspy; typ 
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IV. VO clw;fl;Lfs; (clw; jhJf;fs;) 
clYf;F epue;ju tYthdJk; mbNtuhfTk; cs;sit jhJf;fs; vdg;gLk;. 
t. 
vz; clw;fl;Lfs;  FiwFzk; kpFFzk; 
1. rhuk; 
Njhy;> RuRug;giljy;> 
nka;tUj;jk;> ,isg;G> 
thl;lk;. 
Ia tsh;r;rpahYk; 
clypw;fhZk; nfl;l gz;Gfs;. 
grpj;jP Fiwj;jy;. 
2 nre;ePh; euk;Gjsh;r;rp> twl;r>p clypy; epwk; Fiwjy;. 
grpapd;ik> kpfr; 
rpte;jfz;fs;> ,uj;jgpj;jk;> 
fhkhiy> fl;bfs;. 
3 Cz; Ik;nghwp fl;Fr; Nrhh;T> fPy;fspy; NehAz;lhjy;. 
fz;lkhiy. fpue;jp cz;lhjy;> 
fd;dk;> tapW> 
njhil>Mz;Fwp ,t;tplq;fspy; 
fOj;jpy; Cz; mjpfhpj;jy;. 
4 nfhOg;G ,;;lg;ghl;Buy; tsh;r;rpAk;> clypisj;jy;. 
Cz; kpFjpahy; Vw;gLk; 
gpzpfs;> fisg;G> mw;g 
ciog;gpYk; ngU%r;R. 
5 vd;G 
vd;G> re;Jfspy; NehT> gw;fs; 
foyy;> efk;> kaph;ntbj;jy;> 
cjph;jy.; 
vd;GfSk; gw;fSk; kpFjpg;gLk;.
6 %is 
vd;Gfspy; njhis 
tpOjy;>jpifj;jy>; 
fz;fspy; ,Us; fk;ky.; 
cly; ghhpj;jy;> fz; fdj;jy;> 
rpWePh; Fiwe;J Nghjy;. mhpjpy; 
jPUk; Gz;. 
7 ntz;zPh; tpijapy; Fj;jYld; typ. 
ngz;fsplj;jpy; fhjy; kpFjy;. 
fy;yilg;G. 
 
  
rhuk;> nre;ePh;> Cz;> nfhOg;G> vd;G> %is Mfpa clw;fl;Lfspd; 
FiwFzk; fhzg;gLfpwJ. 
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V. gUt fhyq;fs; 
  thj> gpj;j> fgq;fs; ve;j fhyq;fspYk; $Ljy;. Fiwjy;> 
rkdk; vd;w %d;W epiyfis milfpd;wdNth> me;jf; fhyq;fs; 
#hpad;> Nk\k; Kjypa gd;dpnuz;L uhrpfspy; NrUtjhy; MW gUt 
fhyq;fshf tFf;fg;gl;Ls;sd. 
 
Kf;Fw;wq;fs; njhlf;fk; mjpfhpj;jy; rkk; 
thjk; ,sNtdpy; fhyk;(rpj;jpiu>itfhrp)
KJNtdpy; fhyk;
(Mdp> Mb) 
$jph; fhyk;
(Ig;grp> 
fhh;j;jpif) 
gpj;jk; fhh;fhyk; (Mtzp> Gul;lhrp)
$jph; fhyk;
(Ig;grp> 
fhh;j;jpif) 
gpd;gdp fhyk; 
(khrp> gq;Fdp) 
fgk; Kd;gdp fhyk; (khh;fop> ij) 
gpd;gdp fhyk; 
(khrp> gq;Fdp) 
KJNtdpy; 
fhyk; 
(Mdp> Mb) 
 tsp moy;fPy; thAthdJ $jph; (Ig;grp> fhh;j;jpif) fhyj;jpy; 
mjpfsT fhzg;gLfpwJ. 
 
VI. jpiz 
 Ky;iy epyj;jpy; trpg;gth;fSf;F thj Neha; tUk.; 
 czT kw;Wk; tho;f;if Kiw khWghl;lhy; kUj epyj;jpy; 
mjpfstpy; fhzg;gLfpwJ. 
 
nea;jy;   thjk;> gpj;jk; mjpfhpf;Fk;. 
FwpQ;rp thjk;; mjpfhpf;Fk;. 
Ky;iy thjk;> fgk; mjpfhpf;Fk;. 
kUjk; fgk; mjpfhpf;Fk;.      
- jd;te;jhp itj;jpak; 
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VII. cly;td;ik 
1. ,aw;if td;ik 
,J rj;Jt> uN[h> jNkh Fzq;fspypdpd;Wk; ,aw;ifahfNt 
cz;lhtjhk;. 
2. fhy td;ik 
,J tajhYk;> ,sNtdpy; Kjypa ngUk; nghOjhYk; 
cz;lhtjhk;. 
3. nraw;if td;ik 
cliy mjd; Fzj; jd;ikf;F chpa czthjp> nray;fshYk;> 
clw;fl;Lfspd; td;ik Nflhtz;zk; epiyepWj;jf;$ba 
kUe;JfshYk; fhj;Jf; nfhs;Stjhy; cz;lhtjhFk;. 
tsp moy;fPy; thAtpy; ,aw;if td;ikAk;> nraw;if td;ikAk;> 
ghjpg;gile;Js;sJ. 
 
kUj;Jt Kiw : (Line of Treatment) 
  
According to siddha system, the line of treatment is divided into 
three types. They are. 
1. fhg;G (Prevention) 
2. ePf;fk;  (Treatment) 
3. epiwT ( Restoration) 
 
fhg;G (Prevention) 
It may be divided into two types 
1. Primary prevention 
2. Secondary prevention 
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Primary prevention 
 Action taken prior to the onset of disease, which removes  the 
possibility so that a disease will ever occurs. 
 
 Naal ozhukkam, Kaala Ozhukkam and noi anuka vithi have 
been described in siddha text as primary prevention. 
 
Secondary prevention : 
 It can be defined as action which halls the progress of a 
disease at its incipient stage and prevents complications 
 
ePf;fk;  (Treatment) 
The aim of Noi neekam is based on 
 
1. To bring the mukkutram to equilibrium 
jd;dpiy jphpe;j thj Fw;wj;ijj; jd;dpiygLj;j fopr;ry; 
kUe;Jfisj; ju Ntz;Lk;. 
“Ngjpahy; thje;jhOk;” 
 
15kpyp nts;is vz;nza;> fhiy kl;Lk;> ntWk; tapw;wpy; 
gpzpahspfl;F nfhLf;fg;gl;lJ. 
 
2. Treatment of the disease by internal medicines and external 
applications. 
a. Nkf#iy tPf;fj;Jf;F #uzk; 1 fpuhk; Njdpy; fye;J %d;W 
Ntis rhg;gplNtz;Lk;. 
 
b. mh;f;fhjp ijyk; ntspg;gpuNahkhfj; jltNtz;Lk;. 
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gj;jpak; 
,r;rhgj;jpaj;jpy; ePf;Fk; nghUl;fs; 
“fLf ew;wpiyj;njz;nza; $o;g; ghz;lq;fs; fliy 
 tLtjhfpa njq;Fkh tUf;if ew;fhak; 
 kbtpyhj nts;Ss;sp nfhs; Gifapiy kJngz; 
 ,‡J ghfNyhlfj;jp ePf;fp tpr;rh gj;jpaNk” 
- rpj;j kUj;Jthq;fr; RUf;fk; 
 
NkYk; Riu> g+rzp> nts;shp> Gliy> gPh;f;F Kjypa ePh; $ba fha;fwp 
tiffisAk; nkhr;ir> fhuhkzp> nfhs;S> Njq;fha;> fpoq;F tiffs;> 
ke;jKs;s gjhh;j;j tiffs; Kjypaitfs; ePf;f Ntz;Lk;. 
“GspJth; tpQ;Rq;fwp ahw;g+hpf; Fk;thjk;” 
Gspg;G> Jth;g;Gg; nghUl;fis ePf;f Ntz;Lk;. 
 
,r;rh gj;jpaj;jpy; MFk; nghUl;fs; 
“gUtuhy; fUq;Fwit Njd;kPdp idg;gUfy; 
  chpaTs;sy; fhl;Lg;Gwh fgpQ;ryq; fiykhd; 
 nghpants;is apd;wir gRk;ghnda; NkhhPjyhk; 
 mhpark;gPug; goj;jpd; rhwUe;J jyhNk” 
 
 gUj;jtuhy;> fuq;Fwit> Njsp Mfpa kPd;fSk;> cs;shd;> 
fhl;LGwh> fhil> fiykhd>; nts;shL ,itfspd; ,iwr;rpfSk;> 
gRk;ghy;> nea;> Nkhh;>vYkpr;rg;gok;Mfpa ,itfSk; ,r;rhgj;jpaj;jpy; 
MFk; nghUl;fshk;. 
 
 Proper diet regimen enhances the bioavailability of the drug 
and reduces harmful effect of the drug 
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rpwg;G kUj;Jtk; 
 
¾ xw;wlk;  
¾ njhf;fzk; 
¾ Nahfhrdk; 
¾ Kj;jpiu 
¾ gpuhzhahkk; 
¾ jpahdk; 
xw;wlk; 
ijyq;fis NehAs;s ,lq;fspy; g+rp nehr;rp> vUf;F> jOjhio> 
Mkzf;F> thj ehuhazd; ,iy Nghd;w ,iyfis Mkzf;F nea; 
tp;l;L tjf;fp xw;wlkplyhk;. 
 
MASSAGE 
1. Massage is strongly encouraged by the American Arthritis 
Foundation for the sub-acute phases of RA, though 
discouraged in the acute phase, as massage increases 
circulation and may increase the chance that the disease in 
this phase may spread.  
2. Massage is  beneficial in reducing the effects of RA on joints' 
range of motion and be beneficial in keeping the joints supple 
and mobile. 
3. Massage promote the mobility and health of the soft tissues 
around the joints. Massage involves the manipulation of soft 
tissues with the hands through rubbing, stroking, pressure, 
and so on. 
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4. Myofascial release - This approach uses long, stretching 
strokes to release tension in the fascia, the connective tissue 
around the muscles.  
5. Kneading -Grasp the muscle between your palm (or thumb) 
and fingers. Work into the muscle itself with a slow, regular 
squeeze-and-release motion. Be careful not to overdo it. 
Fifteen to 20 seconds on the same spot is enough.  
6. Stroking -Cup your hand over the muscle you want to 
massage. Then firmly glide your hand over the length of the 
muscle in a slow, repeated movement. 
 
Massage for Pain Control 
1. Massage confuses the body's pain signals.  
2. It stimulates the release of endorphins the body’s natural 
pain killers.  
3. It relieves muscle tension, spasm, and stiffness. Massage 
improves blood circulation, bringing with it oxygen and other 
forms of nourishment. The muscle then relaxes, and pain 
decreases. 
4. Massage relieves mental stress and anxiety. Touch  lasting for 
less than 1 second has the ability to make people feel better. 
Contra indicated in inflammation.  
 
YOGASANAM 
    People with rheumatoid arthritis who practiced yoga therapy 
over a three month period experienced greater handgrip strength 
compared to those who did not practice yogasanam.  
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 "Asana", means simple postures and a path to unity of spirit. 
The practice of asanas promotes: 
¾ Muscle flexibility. 
¾ Tendon strength. 
¾ Brings various internal and glandular functions into balance. 
 All the patients were advised to practice  
 
Padmasanamm, Savasanam, Pathivarthana thirigonasanam,  
Thiri gonasanam, Ukadasanam, Artha chandrasanam. 
 
Mudras In Yoga Heailing, Finger Postures  
Mudra means ‘GESTURE’ ‘SYMBOL’ or ‘SEAL’. It's 
characterised by muscular contraction and relaxation or 
manipulation of internal pressure devised for shutting off or 
stimulating temporarily some specific parts of the body. Their 
regular practice will help to control the involuntary organs and 
muscles which are connected with nerve or channels which 
conduct the life force throughout the body. Benefits could be 
derived more quickly from mudras than from asanas.  
 Revitalize the internal organ. A beneficial effect on the 
visceral, vascular, nervous and glandular system. Many functional 
disorders could be prevented or cured. They increase the immunity 
of the body against disease. 
Duration 
 Each of the mudras should be done for at last 45 minutes at 
one time, or for two 30 minute periods. 
 
Note  : A mudra is most effective if you can do it with both  
   hands at the same time. 
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Vayu Mudra 
 For joint pain like Rheumatism & Arthritis even Paralysis : 
Procedure 
 The index finger lightly touches and presses the base of the 
thumb. The thumb curls over and lightly presses the knuckle of the 
index finger. 
 
PRANAYAMAM 
Patanjali defines pranayama as "the regulation of the 
incoming and outgoing flow of breath with retention."  
The word pranayama consists of two parts: prana and 
ayama. Ayama means stretch and control and describes the action 
of pranayama. Prana is energy. When this self-energizing force 
embraces the body with extension, expansion and control, it is 
pranayama.  
When we practice pranayama the mind becomes ready for 
deep meditations. Thus, pranayama is first and foremost 
awareness of the breath.  
 
MEDITATION 
Meditation is an attempt to concentrate mind on a single form 
or an idea or an aspect of divinity at the exclusion of all other 
forms, thoughts, and ideas. Thirty-two per cent increase in blood 
flow to the forearm occurs. 
During anxiety and tension states there is a rise in the level of 
lactate in the blood. Lactate production in the body is mainly in 
skeletal muscle tissue; during meditation the faster circulation 
 37
brings a faster delivery of oxygen to the muscles and less lactate is 
produced.  Anxiety decreases the threshold for pain and pain 
causes anxiety. Meditation breaks this cycle.  
 
 
KANMA NIVERTHY 
Niraivu : (Restoration) 
 After the treatment, efforts should be taken to clear the 
residual affects of the disease to bring back the body condition of 
the patient to normal. 
 
Neha; fzpg;G tpthjk;  
kiyj;j fk;gthjk; 
 “Fk;ghq; ifapdkzpf; fl;L jd;dpw; 
  Ftpe;jiuapy; nkhj;ijNgh Yuj;Jf; fhZe; 
 Jk;gkh kq;fq;fs; Jbg;g jhFe; 
  Jz;LNk fhy;ifA eLf;f khFk; 
 mk;gkh kiuf;Fq;fPo; jpkpUz;lhFk; 
  mjuNk kpff;fWj;J ntbg;Gz;lhFk; 
 tk;gkhk; thAjhd; Ghpa ehw;wk; 
  tUkiyj;j fk;gj;jpd; khf;f khNk” 
 
 
 ifapd; kzpf;fl;Lg; G+l;Lfspy; tPq;fpf; jbj;Jf; fhZk;> 
clw;Wbf;Fk;> if fhy; eLq;Fk;> miuf;Ff; fPo;j;jpkpUz;lhFk;. cjL 
kpff; fUj;J ntbg;Gz;lhFk;. kpf;f ehw;wj;Jld; fhw;Wk; ghpAk; vd;Dq; 
FwpFzq;fis ,e;Neha; ngWk;. 
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re;J thjk; 
 “nra;ifjhd; re;JfS kpfj;jp kph;e;J 
  rlnkq;F nehe;JNk kpft ow;wp 
 ieifaha; eYj;JNk kaph;f;$r; rpl;L 
  ehzpNa Kd;Nghy eilnfh lhJ 
 ikifjhd; kaf;fnkhL tha;eP UWk; 
  twz;bLNk ehTjh dbf;f bf;Ff; 
 iffhy;jhd; juzpjdpw; whpf;nfh zhJ 
  rQ;rypf;FQ; re;Jthk; thjq;NfNs” 
 
 ,jpy; fPy;fs; NjhWk; jpkph;j;J> clnyq;Fk; nehe;J> kpFe;j mow;rp 
Az;lhFk;. kaph;f;$r;nrwpAk;> elf;f Kbahik> kaf;fk;> tha; ePUwy;> 
ehtwl;rp Kjypa FwpFzq;fOq;$b mbf;fb iffhy;fs; epyj;jpy; 
gbahjthW Jd;GWj;Jk;. 
 
gapj;jpa thj RNuhzpjk; 
 “czHr;rp aha;r; RNuhzpje;jhd; kpfnt Jk;gp 
  Cf;fkha;j; Njfnkq;F kpfNt nehe;J 
 Kzh;r;rpaha; Koq;fhy;fs; Koq;if nahf;f  
  Kidahd rpWtpuy; fd;dk; new;wp 
 jzh;r;rpaha;r; re;JrU thq;f nkq;Fe; 
  jhl;bfkha;f; File;J RuK Kz;lhFk; 
 gzh;r;rpaha;g; ghz;lJ nghd; Nkdp ahFk; 
  gapj;jpathj RNuhzpjj;jpd; gz;G jhNd”. 
 ,e;Nehapy; clypy; cs;s FUjp> gpj;j thjf Fw;wg; ngUf;fhy; kpff; 
nfhjpj;J> cly; KoikAk; gha;e;J Nehfr; nra;J> Koq;fhy;> Koq;if> 
rpWtpuy;fs;> fd;dk;> new;wp Kjypaitfs; Nrh;e;J vy;yh cWg;GfSk; 
nehw;W> Ruj;ijAk>; ghz;L> Nrhig NehiaAk;> gapj;jpaj;ijAk; 
gpwg;gpf;Fk;. 
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moy;fPy; thA 
  “gpj;jf;fPy; tha;T jd;dhw; gpwq;FfPy; Kl;L tPq;fpr; 
   rpj;jh;nra; kUe;J tj;JQ; rPh;glhj; jd;ikj; jhfpj; 
   jj;jW fha;r;ry; fz;L rhyNt jidjhd; je;Nj 
   nkj;jW rpfpr;ir jd;dhy; nkd;nky ePq;F kg;gh” 
        - rghgjp ifNaL 
 
 %l;Lfspy; cz;lhFk; tPf;fk; ehSf;Fehs; ngUj;Jf; nfhz;Nl 
te;J> kpFe;j jP Fw;wj;jhy; fPy;fspdpilNaAs;s gir tuz;L> giraw;Wf; 
fPy; mirAk; Nghnjy;yhk; “fYf;” “fYf;” nfd;w xh; xyp 
cz;lhtJkha; ,Uf;Fk;. fPYf;Ff; fPy; $b xl;bf;nfhz;L> xU fopNghy 
klf;f KbahkNy epd;WtpLtJk; cz;L. 
 
Kf;Fw;w NtWghLfs;; 
 “tspkpF tghd tpahd thAf;f sjpf hpf;Fk; 
  ,skpf kyePh;f; fl;Lk; ,ak;gpa tghdd; nra;Ak; 
  tpspepyh tpahdd; fPypd; tpsq;FW Giof NlhWk; 
  xspAW Fw;w nky;yh nkhd;wpnyd; Wytr; nra;Ak;” 
       - rghgjp ifNaL 
 
 jd;nray;> Gwr;nray;> epyj;jpy; vOk; jl;gntl;gq;fs; Mfpatw;why; 
tspf;Fw;wk; kpFe;J> Iaj;ij jdf;F Jiz nfhz;L tspapd; njhopy; 
nra;Ak; fhy;fshfpa Ie;jpy; (mghd Kjyp Ie;J thAf;fspy;) guTfhy; 
(tpahd thA)> fPo; Nehf;Ff;fhiy (mghd thAit)j; J}z;lr; nra;J 
Kjypy; kpFe;j Fw;wq;fshfpa tspAk; IaKk; $b> fPy;fspy; typ 
Kjypadtw;iw cz;lhf;fp tPq;fp> ePh; Nfhh;j;jiyAk;. mira 
xl;lhikiaAk; nra;jy; guTfhypd; njhopyhk;. xhplj;jpYs;s tPf;fj;ij 
kw;nwhhplj;jpw;F khw;WjYk; fPo; Nehf;Ff;fhypd; nrayhk;. kyKk;> rpW 
ePUk; fl;Lk;. 
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 Nflile;j Fw;wj;jpd; mstha; clw;fl;Lfspy; (rg;j jhJf;fspy;) 
Kjypy; ,urKk;> FUjpAk; NflilAk;> Mjyhy; grpapd;ik> cly; 
ntSj;jy;> cly; Cjy; vd;Dk Neha;fisAk; njhlur; nra;Ak;. Neha; 
ePz;l ehs; epiyf;Fkhapd; kw;iwa clw;fl;Lfis KiwNa Nflilar; 
nra;J cly; td;ikaf; nfLf;Fk;. 
 
tsp moy; fPy; thAtpw;fhd nghJ kUj;Jtk; : 
 
cs; kUe;Jfs; 
1. tq;f Rz;zk;> gts gw;gk; xh; cSe;jsT $l;b> gRk;ghypy; 
nfhLf;fTk; my;yJ 
 
2. tq;f Rz;zk;> Kj;J gw;gk;> jq;f gw;gk; ,tw;iw xh; mhprp vilf; 
$l;bg; ghypy; nfhLf;fTk;. 
 
ntsp kUe;Jfs; 
 Ff;fpy; ntz;nza;> mow;rp vz;nza;> cSe;J ijyk;> 
Kjypaitfisg; g+rp> gl;b fl;lTk;. 
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MODERN ASPECTS 
Rheumatoid Arthritis 
 The word Rheumatoid is derived from Greek language 
(Rheuma : Flux, eidos - resemblance) indicating a condition 
resembling rheumatism. 
 'Le rheumatisme' the French term refers to musculo skeletal 
pains and the term gave us rheumatoid arthritis is a systemic 
illness with joint involvement. 
 Sir Alfred Barring Garrod first proposed the term Rheumatoid 
Arth ritis in 1858. 
 The potential of the synovial inflammation to cause 
cartilage destruction and bone erosion and subsequent changes 
in joint integrity is the hall mark of the disease. 
 
Definition  
 Rheumatoid arthritis is a progressive inflammatory arthritis 
of unknown origin involving multiple joint characterized  by a 
tendency  to spontaneous  remissions and subsequent relapses. 
Arthritis is the most prominent manifestation being a generalized 
immune  system connective tissue disorder it may involve para 
articular structures  such as bursae , tendon sheaths,  tendons 
and extra articular  tissues such as the subcutis,  Cardio Vascular 
System, lungs, spleen, lymph nodes, skeletal muscle, central and 
peripheral nervous systems and eyes. 
 
Epidemiology 
• The prevelance of Rheumatiod Arthritis is approximately 0.8% 
of the population. 
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• Women are affected approximately three times more 
often than men. 
• The prevalence increases with age and sex differences 
diminishes in the older age group. 
• Rheumatoid Arthritis is seen throughout the world and 
affects all races. The prevalence is highest in pima Indians. 
 
Aetiology 
 No single factor had been identified to data. 
1. Host genetic factor 
2. Immuno regulatory abnormalities and auto immunity 
3. A triggering (or) persisting microbial infection 
 
Genetic Factor 
• Severe Rheumatoid Arthritis is found at approximately 4 
times   the   expected  rate  in   first   degree   relatives  of 
individuals with disease associated with the presence of the 
auto antibody, Rheumatoid factor.  
• HLA-DR4 is the major susceptibility halotype in most ethnic 
groups, DR1 is more important in Indian and Israelis.  
 
Environmental Factors  
Infectious Agent 
• The organisms that have been implicated are Epstein - Barr 
virus, cytomegalo virus, parvo virus, rubella virus and 
mycoplasma. 
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• The microorganism or response to microorganisms might 
induce an immune response to components of the joints by 
altering it's integrity and revealing antigenic peptides. 
• Another possibility is that the infecting micro organism might 
prime the host to cross - reactive determinants expressed 
with in the joint as a result of "molecular mimicry". 
 
Trauma 
 Many patients have mentioned traumatic incidents as a 
precipitating cause. 
 
Psychological Stress 
 The study of identical twins in one of whom rheumatoid 
arthritis developed tends to support this concept. 
Vascular Changes 
 Alteration of the normal, peripheral vascular bed perhaps by 
autonomic influence has been suggested as the primary 
abnormality. 
 
Neurogenic 
 Neuropeptides can cause inflammation. Reflex sympathetic 
areas through the spinal cord could account for the contralateral 
distribution. Rheumatoid Arthritis affects the non - paralysed side 
much more severely in a hemiplegic patient. 
 
Auto immunity  
 Normally the body has the tolerance against the self antigen. 
However, in some occasions, the tolerance fails or becomes 
incomplete against the self antigen. This state is called auto 
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immunity. Here antibody is directed against the common Fc region 
of human IgG. Antibodies to cyclic citrullinated peptide bind to 
peptides in which the amino acid arginine has been converted to 
citrulline by peptidyl arginine deiminase an enzyme abundant in 
the inflamed synovium. 
 
Life style factors 
¾ Smoking is known to be a major environmental risk factor.  
¾ Coffee drinkers seems to be at increased risk  
¾ Long term breast feeding protects mother from risk. 
¾ Alcohol cuts the risk by upto 50%. 
¾ Alcohol cuts the risk most in smokers with genetic risk factors.  
 
PATHOPHYSIOLOGY 
The Initial Events 
 The Macrophages or dendritic cells that serve as the antigen 
presenting cells are the first to be involved in the human immune 
response. The relevant receptors on the antigen presenting cells are 
the class II major histocompatibility complex (MHC) molecule. 
 The macrophages ingest process and presence of the foreign 
antigen to T-lymphocytes initiate a cellular immune response and 
stimulate the B-lympocytes into plasma cells that secrete 
antibodies. Early stage doesnot produce any symptoms. 
 
Organisation of Inflammation 
 The immune response becomes organised in the perivascular 
areas in the synovial membrane, as the increase in the number of 
T-cells leads to the proliferations and differentation of B-cells. 
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 Macrophage from the synovial tissue secrete cytokines which 
activate the endothelial cells to proliferate and organize them selves 
into blood carrying tubes. Also within the synovial fluid of an 
inflamed   rheumatoid  joint,   there   is   virtual   absence   of  the 
suppressor - inducer T cells and marked increase of the helper T-
lymphocytes and presence of of the relevant antigen activate the B 
lymphocytes in synovial membrane to differentiate into antibody 
secreting cells. These steps are mediated by interleukin - 2. 
 The antibodies are immunoglobulins directed against the Fc 
region of the IgG and have been named as rheumatoid factors. 
Neutrophils are attracted into the joint cavity by complement 5a, 
leukotriene B4 and platelet activation factor. The neutrophils release 
enormous quantities of proteinases and additional chemo-
attractant molecules. 
 Presence of larger amounts of the proteinases and their 
respective natural inhibitors, allowing unrestricted enzymatic 
degradation of articular cartilage, meinsci and ligaments. 
 Rheumatoid Arthritis becomes symptomatic at this 
stage.Hands wrist and knee are the first to be affectd. General 
fatigue and malaise are caused by cytokines such as interleukin 
and tumour necrosis factor. Morning stiffness is probably due to 
increased fluid in and around the joint, proliferated and dialated 
synovial vessels causes the joint to feel warm. 
 
The Destruction Phase 
 The production of proteolytic enzymes and prostaglandins by 
synovial cells is induced by cytokines [interleukin 1]. Dendritic cell 
has a high level of collagenase and interleukin 1 production. 
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Besides collagenease, the rheumatoid synovium cells also release 
stromelysin and both proteinases are capable of destroying almost 
all matrix protein present in articular cartlage and bone. 
 
PATHOGENIC SPECTRUM 
 
 
 
 
 
 
 
 
 
 
 
Rheumatoid arthritis = Synovitis + Vasculitis + Granuloma 
 
HISTOPATHOLOGY : The characteristic feature is diffuse proliferative 
synovitis with formation of pannus . The microscopic changes are : 
1. Numerous folds of large villi of synovium 
2. Marked thickening of the synovial membrane due to oedema, 
congestion and  multi layering of synovio cytes. 
3. Intense inflammatory cell infilt rate in the synovial membrane with 
predominance of lymphocytes  plasma cells and some macrophages 
at places forming lymphoid follicles. 
4. Foci of fibrinoid necrosis and fibrin deposition.  
Synovitis 
Vasculitis Granuloma 
Formation  
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IMMUNO PATHOGENESIS  
 
 
 
  
  
 
 
 
  
 
  
Genetic susceptibility 
(MHC Class II) 
CD4 + T-Cells  
Cytokines 
TNF- α , INF – γ, IL -1 
Antigenic stimulation  (Infection agent)
Activate Activate Activate 
B Cells Cytokine cells Endothelial cells 
Anti IGG antibody 
( Rh factor) 
Macrophages Release of adhesion  
moleculae  
Formation of immune complex, inflammatory cells, pannus  
inflammatory damage to synovium, small vessels, collagen 
Destruction of cartilages, bone, fibrosis, ankylosis 
Joint deformities  
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FLOW CHART OF THE STAGES OF PATHOGENESIS PROCESS 
Principal target site 
SYNOVIUM 
VASCULITIS 
(Increased Vascularity, edema, congestion, villows hypertrophy) 
 
Fibrinoid degeneration / Necrosis (Rice bodies) 
 
Inflammatory cell infiltration 
(Lymphocytes, monocytes, macrophages, plasma cells) 
 
Fibroblastic proliferation. (Palisaded histiocytes) 
 
Rheumatioid granulation 
(Pannus invading connective tissue by creeping substitution) 
 
 
 Capsule & Ligaments 
Tendon & 
aponeuroses 
Joint larticular 
cartilage 
Subordinate 
tissues 
Bursae 
Edema 
Fibrosis 
Sublurations Contractures 
Severe 
deformities Dislocations 
Laxity 
Pannulus infiltration 
from synovial 
reflection into 
subchondral bone
Secondary 
deformity 
Attenuation or 
rupture 
Avascularity 
and attrition 
Pannus invasion of 
adjacent tendons 
Tendon synovial 
sheath infiltration 
Total 
destruction of 
cartilage 
Nodules 
(Aschoff’s 
nodule) 
Cellulardeath 
Fragmentation of 
articube cartilage or 
erosion of plaques of 
devitalized cartilage
Deprivation of 
nutrition 
Bursitis 
Ankylosis Disorganization of 
joint 
Secondary dislocation 
or juxtra articular 
pathological fractures 
Other sites 
 
Eye – Cornea 
Lungs – Pleura 
Heart - Pericardium 
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PATHOGENESIS 
 Intracavitary fibrin clots may initiate pannus formation and  
the immunopathology of rheumatoid arthritis. 
 Two critical steps, probably host dependent, may determine 
the development of rheumatoid arthritis an altered regulation of 
extravascular haemostasis or an aberrant reactivity of synovial 
fibroblasts to the adhered fibrin clots. 
 
Pathogenesis of rheumatoid arthritis as a fibrin induced disease 
1. Exudation of fibrinogen and clotting factors to the joint 
space follows joint swelling 
2. Haemostasis activation within the cavity leads to fibrin 
formation 
3. Fibrin clots are partially removed by the plasminogen 
system, but most of them get stuck to the synovial intima. 
4. Cells at the fibrin-synovium interface migrate into and 
around the deposits. 
5. Clot components induce multiple activating pathways in 
synoviocytes by the coupling of specific receptors. These 
include proliferation, secretion of proteinases and 
synthesis of proinflammatory mediators. 
6. A fibro proliferative tissue appears underneath the front of 
migrating cells, as a result of remodelling the invaded clots 
by activated cells. In this area, macrophages and blood 
vessels are increased owing to the release of growth factors 
and chemokines. 
7. Remodelling induces modifications in the structure of 
fibrin chains, which become immunogenic. 
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 Epitopes from these transformed autologous peptides are 
presented to T lymphocytes, which in turn initiate a specific 
immune reactivity against them. Continuous deposition of fibrin 
clots and the advance of the front of migration account for tissue 
hypertrophic growth at the areas of attachment. 
 
CLINICAL FEATURES AND MANIFESTATION 
 The small joints of the hands and feet are first affected in 70% 
of the patients. In older patients the shoulder joint commonly 
involved first. The onset is acute with fever and serious 
constitutional symptoms in about 20% of cases.  
Rheumatoid Arthritis [Peri as well as Polyarticular in site] 
Pathological 
Process 
 
Tissue 
Involved 
 
Results In 
 
Deformitis 
 
Vasculitis 
Necrosis 
Fibrosis 
 
Joint 
Structures 
 
1. Synovitis - 
effusion  
2.  Articular 
cartilage 
destruction 
3. Peri capsulitis 
4. Ligamentatio
n 
instability 
5. Arthritis 
 
1. Swelling 
 
2. Stiffness 
Instability 
subluxation 
 
3. dislocation 
 
4. intrinsic 
plus 
defromity 
Plasma cell 
Proliferation 
 
Tendon 1. Tenosynovitis 
 
 
 
 
2. Rupture 
1. Ulnar 
   deviation of    
    fingers  
 
 
2 Concertina 
collapse of 
fingers 
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Granulation 
tissue and 
Pannus 
formation 
Muslce        1. Wasting 
2. Atrophy  
 
3. Fibrosis 
1.Contracture 
 
2. Ankylosis 
Synovial 
hypertrophy 
in joint 
In tendon 
1. Bone 
 
 
1. osteoporosis -
thinning of 
cortex and 
loss of 
trabecular 
structure  
 
2. cyst formation 
–Subchondral 
erosions 
(adjacent to 
metaphysic)  
 
3. Destruction 
 
2.Subcutaneous Nodules  
 
DISTINCT PATTERNS OF ONSET  
Palindromic Onset 
 In about one-fifth of the patients with rheumatoid arthritis 
typically the inflammation develops over few hours and is 
accompanied by erythema and swelling of the affected joints but 
resolves completely with in 48 to 72 hours leaving no residual 
features. 
 
Explosive Onset 
 In about 10% of cases the onset of the disease is very rapid, 
even over night, with severe symmetrical polyarticular involvement.  
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Systemic onset 
 This is particularly common in middle aged men in whom 
non-articular features may dominate the clinical picture although 
rheumatoid factor is usually present in high titres. 
Insidious Onset 
 Rheumatoid  Arthritis   develop   insidiously   over  weeks   or 
months, it is seen in upto 70% of the cases, associated with a 
relatively poor prognosis.  
Polymyalgic Onset 
 Limb / Girdle muscle symptoms may precede the onset of an 
overt arthropathy, particularly in the elderly.  
Mono and Pauci articular onset 
 In young women there may initially be very limited joint 
involvement, particularly involving the knees.  
Acute (or) Subacute Onset 
 One third of patients have an acute or sub acute onset.  
 
SIGNS AND SYMPTOMS 
 Pain in the affected joints, aggravated by movement, is the 
most common manifestation of established RA. 
 Generalised stiffness is frequent and is usually greatest after 
periods of inactivity. Morning stiffness of greater than one hour 
duration is an almost invariable feature of Inflammatory 
arthritis and may serve to distinguish it from various non-
inflammatory joint disorders. 
 
 Constitutional symptoms such as weakness, easy 
fatiguability, anorexia and weight loss are experienced by majority 
of the patients. 
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 Although fever to 40°C occurs on occasion. Clinically synovial 
inflammation causes swelling, tenderness and limitation of motion. 
 Joint swelling results from accumulation of synovial fluid, 
hypertrophy of synovium and thickening of the joint capsule. 
 Initially motion is limited by pain. Later fibrous or bony 
ankylosis or soft tissue contractures lead to fixed deformities. 
 Warmth is usually evident on examination, especially of large 
joints such as knee but erythema is infrequent. 
 
INVOLVEMENT OF INDIVIDUAL JOINTS  
Hands and wrist 
 Proximal interphalengeal joints and the metacarpo phalangeal 
joints are commonly involved.  
 Early in the disease there may be soft tissue swelling around 
the affected joints. 
 The typical patients show fusiform inflammatory swellings, 
often with a dusky cyanosis over the inflammatory joints, which 
produce characteristic spindle shaped fingers. 
 Later marked synovial hypertrophy on the dorsum of the 
wrist with involvement of extensor tendon sheath results in 
dropped finger affecting the little finger. 
 Tenosynovitis of the long flexor tendons in the palm of the 
hand may exacerbate stiffness of the fingers and cause trigger 
finger. 
 Synovitis at the wrist with in the flexor retinaculum may 
cause compression of the median nerve with the typical features of 
the carpal tunnel syndrome. 
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 Volar subluxation of the fingers at the metacarpophalangeal 
joints occurs as a result of destruction of the articular cartilage and 
subsequent instability of these joints. 
Piano key sign 
 Weakening of the distal radio - ulnar ligament by synovitis 
allow the distal ulnar to migrate dorsally so that it overrides the 
radius (caput ulnae syndrome). The ulna can be depressed by 
pressure like a piano key. 
Carpal collapse and fusion 
 It may occur late in the disease, when instability of the wrist 
may lead to collapse of the carpal bones causing foreshortening of 
the carpus and ultimately spontaneos fusion of the wrist. 
 The eventual functional loss characterized by inability to 
make a fist, pinch thin objects and weakend grip strength. 
 Persisting synovitis with destruction of the articular surface, 
weakening of the joint capsule, muscle wasting with or without 
tendon rupture leads to characteristic rheumatoid hand deformity 
which includes, 
¾ Ulnar deviation of the fingers and subluxation of the fingers 
as a result of instability of these joints. 
¾ Swan neck deformity with hyper extension of the proximal 
interphalangeal joints with fixed flexion of the distal 
interphalangeal joints. 
¾ Button hole deformity (Boutonneir's deformity) which 
includes fixed flexion of the proximal interphalangeal joints 
and extension of the distal inter phalangeal joints. 
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¾ "Z" deformity of the thumb - radial deviation of the wrist, 
ulnar deviation of the digits after with palmar subluxation of 
the proximal interphalangeal joints. 
¾ Bull horn deformity - due to rupture of the extensor 
communis tendon from synovitis near the ulnar styloid. 
Elbow and Shoulder Joints 
¾ Involvement of the elbow is less common than of the wrist, 
but severe destructive changes leads to "fixed flexion 
deformity". 
¾ Periarticular structures (Olecranon bursa, Ulnar nerve) also 
be affected by synovitis and subcutaneous nodules are 
commonly found on the extensor surface of the fore arm close 
to the elbow. 
¾ There may be inflammation of the subacromial bursae or 
supraspinatus tendon in addition to glenohumeral joint 
synovitis, producing a typical painful arc syndrome. 
 
Feet and Ankle Joints 
¾ Active synovitis in the metatarso phalangeal joint can produce 
pain and tenderness, best elicited by the lateral squeezing of 
the joints. 
¾ The synovial swelling of the active disease together with 
constriction of the ligament between the metatarsal heads 
may broaden the forefoot and separate the foot to produce the 
Day light Sign. 
¾ Typical deformities may also developed in the feet including 
 Eversion at the hind foot (Subtalar joint) 
 Plantar subluxation of the metatarsal heads 
 Widening of the fore foot 
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 Hallux valgus and lateral deviation and dorsal subluxation at 
the toes. Patient complaints of pain arising in the ball of the foot 
(Metatarsalgia) which can vary in intensity from a feeling of 
"walking on Pebbles to like walking on broken glass".  
 Chronic Arthritis in the subtaloid and midtarsal region can 
lead to "Pes piano - valgus deformity". 
 
Knee Joints 
¾ In the knee joint synovial hypertrophy and effusion are often 
marked. 
¾ Pain and swelling in the back of the knee joint may be 
caused by extension of inflammed synovium into the 
popliteal space (Baker's cyst). 
¾ Wasting of quadriceps is present, flexion contraction may 
develop. 
 
Axial skeletal 
¾ Spinal arthritis is common, upto 80% of patients 
demonstrating radiological evidence of the disease in the 
cervical spine. 
 
Hip Joints 
¾ The Hip is less commonly involved. 
¾ Pain is usually experienced in the groin and the buttock, but 
may radiate to the knee sometimes mimicking knee arthritis. 
¾ The hall mark of the disease is progressive bone destruction 
on both sides of the joints without any reactive osteophyte 
formation. This is often referred to as "aseptic necrosis". 
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EXTRA ARTICULAR MANIFESTATION 
Systemic 
1. Fever 2. fatigue 
3. Weight loss 4. susceptibility to infection 
Musculo skeletal 
1. Muscle-wasting 2. bursitis 
3. Tenosynovitis 4. osteoporosis 
Haematological 
1. Anaemia 2. eosinophilia 
3. Thrombocytosis  
Lymphatic 
1. Splenomegaly 2. felty's syndrome 
Nodules 
1. Sinuses 2. Fistulae 
Ocular 
1. Scleritis 2. episcleritis 
3. Scleromalacia 4. keratoconjuctivitis sicca 
Vasculitis 
1. Digital arteritis 2. mono neuritis multiplex 
3. Ulcers 4. visceral arteritis 
5. Pyoderma gangrenosum  
Cardiac 
1. Pericarditis 2. Myocarditis 
3. Endocarditis 4. conduction defects 
5. Coronary vasculitis 6. granulomatous aortitis 
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Pulmonary 
1. Nodules 2. Bronchiolitis 
3. Pleural effusions 4. caplan's syndrome 
5. Fibrosing alveolitis  
Neurological 
1. Cervical cord compression 2. Peripheral Neuropathy 
3. Compression neuropathies 4. mono neuritis multiplex 
 
 Low grade fever, weight loss, anorexia and malaise are some 
of the extra atricular manifestation. 
 Besides these it includes, 
 
Subcutaneous Rheumatoid Nodules 
 Subcutaneous and intracutaneous nodules are the hall 
mark of the disease. 
 It develops in 20 to 30% of patients with  Rheumatoid 
Arthritis. 
 They are usually found on peri articular structures, extensor 
or other areas subjected to Mechanical pressure. 
 Common locations include a olecranon bursa, the proximal 
ulnar, the achilles tendon, the occiput etc., they are also found in 
the flexor tendon, the sclera, with in the aortic valve, myocardium, 
larynx and vocal cord. 
 Histologically, the nodules consist of a central zone of necrotic 
material, including collagen fibrils, non-collagenous filaments and 
cellular debris, mid zone of palisading macrophages that express 
HLA - DR antigens and an outer zone of granuloma tissue. 
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Renal Involvement 
 Renal papillary necrosis and interstitial nephritis 
occassionally occur IgA nephropathy associated with elevated 
serum levels of IgM and IgA is described in Rheumatoid Arthritis. 
 
Liver Involvement 
 There may be mild hepatospleenomegaly and asymptomatic 
elevation of the serum alkaline phosphatase. 
 Kupffer cell hyperplasia and lymphocytic infilteration of the 
portal tracts may be seen. 
 
Pulmonary Manifestations 
¾ Pleuro pulmonary nodule may occur as singly or in clusters 
when they appear in individuals with the pneumoconiosis and 
diffuse nodular fibrotic nodules 0 . 5 - 5  cm in diameter are 
seen mainly in the periphery of the lung fields. This 
association is known as Caplan's syndrome. These nodules 
may produce pneumothorax or broncho pleural fistula. 
 
Hematological Manifestations 
¾ Felty's syndrome 
 This syndrome describes the association between rheumatoid 
arthritis, spleenomegaly and leucopenia with normochromic 
normocytic anaemia, thrombocytopenia, lymphadenopathy, 
cutaneous pigmentation, persistent skin ulceration and weight 
loss. 
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Diagnosis 
 The diagnosis will be based on the pattern of symptoms, the 
distribution of the inflamed joints, and the blood and X-ray 
findings. 
¾ In rheumatoid arthritis, the small joints of the hands, wrists, 
feet and knees are typically inflammed in a symmetrical 
distribution (affecting both sides of the body).  
¾ Rheumatoid factor can be found in 80% of patients. 
¾ A test for citrulline antibodies is most helpful  
¾ The antinuclear antibody (ANA) is also frequently found  
¾ The ESR is used as a crude measure of the inflammation of 
the joints. The sedimentation rate is usually faster during 
disease flares, and slower during remissions. 
¾ The degree of inflammation is measured by C-reactive protein. 
¾ Joint x-rays may be normal or only show swelling of soft 
tissues early in the disease. 
¾ As the disease progresses x-rays can show bony erosions 
typical of rheumatoid arthritis in the joints. Joint x-rays can 
also be helpful in monitoring the progression of disease and 
joint damage over time. Bone scanning, a radioactive test 
procedure, can demonstrate the inflamed joints. 
¾ Analysis of the joint fluid, in the laboratory, can help to 
exclude other causes of arthritis, such as infection and gout. 
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The revised criteria of 1987 (American college of Rheumatology) 
 Criteria Comments 
1. Morning stiffness Duration > 1 hr lasting > 6 weeks 
2. Arthritis of 
atleast 3 areas 
Soft tissue swelling or exudation lasting > 6 weeks 
3. Arthritis of hand 
joints 
wrists, meta carpophalangeal joints or proximal 
interphalangeal joints lasting > 6 weeks 
4. Symmetric 
Arthritis 
At least one area, lasting > 6 week 
5. Rheumatoid 
nodules 
As observed by the physician 
6. Serum 
rheumatoid 
As assessed by a method positive in less than 5 
percent of control subjects 
7. Radiographic 
changes 
As seen on anteroposterior films of wrists and 
hands 
Rheumatoid Arthritis is diagnosed if 4 of the 7 criteria are met. 
Investigation 
 No test are specific for diagnosing Rheumatoid Arthritis.  
A .Haematological 
¾ Normochromic normocytic anemia is frequently present in 
active Rheumatoid Arthritis. 
¾ The WBC count is usually normal, but a mild leucocytosis 
may be present. 
¾ Eosinophilia when present usually reflects severe systemic 
disease. 
¾ The Erythrocyte Sedimentation Rate is increased in nearly all 
patients with active Rheumatoid Arthritis. 
¾ The levels of acute phase reactants including ceruloplasmin 
and C-reactive protein are also elevated. 
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IMMUNOLOGICAL 
Rheumatoid Factor 
    The amount of Rheumatoid factor in blood can be measured by 
1. Agglutination Test : Blood is xixed with tiny rubber 
(latex) beads that are covered with human antibodies. If 
rheumatoid factor is present, the latex beads clump 
together (agglutinate). 
Normal Titre is 1:20 – 1:40 or less 
In rheumatoid arthritis, titre is greater than 1:20 – 1:40 
Auto antibodies other than Rheumatoid Factor in Rheumatoid 
Arthritis. 
¾ Antiperinuclear factor 
¾ Antikeratin antibodies 
¾ Antibodies to cyclic citrullinated peptide (CCP)  
¾ Antibodies to Sa, p68 and calpastatin. 
 Of these anti-CCP antibodies stand out as the most useful 
clinically, especially in defining Rheumatoid Arthritis in early. 
 
Synovial Fluid Analysis 
 Confirms the presence of inflammatory arthritis, although 
none of the finding is specific. 
 
Synovial Fluid findings in Rheumatoid Arthritis 
Synovial Characteristics Rheumatoid Arthritis 
Colour Yellow 
Clarity Cloudy 
Viscosity Poor 
Mucin clot Poor 
White blood cell count / mm3 3000- 50,000 
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% Polymorpho nuclear leukocytes >70 
Glucose Levels 10-25 % less than serum 
Total protein >30 grams / dl 
Complement Low 
Microscopic features RA cells 
Culture Negative 
 
Synovial Biopsy 
 Villus   formation   with   thickening   of  synovial   layer   and 
infiltration with abnormal cells, 
 
Radiographic evaluation 
¾ Soft tissue changes around a joint due to an effusion 
¾ Periosteal reaction with new bone formation along the shaft 
adjacent to where the capsule is attached 
¾ Peri-articular osteoporosis 
¾ Narrowing of joint spaces 
¾ Subchondral erosions 
¾ Subluxation and ankylosis 
¾ Subchondral cyst formation 
 
Arthroscopy 
 In acute rheumatoid arthritis, synovium is oedematous, 
diffusely erythematous and friable. In more chronic conditions it 
becomes thickened. 
 
Renal Biopsy 
 Indicated in cases of reduced tubular or glomerular function. 
 
Pulmonary Biopsy 
 Used to distinguish Rheumatoid nodules from carcinoma or 
to establish diagnosis of fibrosing alveolitis. 
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Scintigraphy  
Urine analysis  
Biochemical Analysis 
CT Scan  
MRI 
 
Prognosis 
 Prognosis is variable. Majority of patients are likely to do well 
if appropriate treatment is given from early stages of disease before 
articular cartilage is damaged. Patients treated by simple methods 
show that after 10 years 50% will have improved and 50% 
deteriorated. 
 Remissions of disease activity are most likely to occur during 
the first year. The median life expectancy of persons with 
Rheumatoid Arthritis shortened by 3 to 7 years. 
 
Treatment 
Treatment aims at. 
1. Relief of pain 
2. Reduction of inflammation 
3. Minimizing undesirable side effects 
4. Preservation of muscle strength and joint function 
5. The return as rapidly as possible to a normal life style 
6. Prevention or correction of joint deformity 
7. Disease modification 
 A variety of physical therapy modalities may be useful in 
decreasing the symptoms of Rheumatoid Arthritis. 
 Rest ameliorates symptoms and can be as important 
component of the total therapeutic program. 
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 In addition splinting to reduce unwanted motion on 
inflammed joint may be useful. 
 Exercise directed at maintaining muscle strength and joint 
mobility without exacerbating joint inflammation. 
 
Spot light on Research  
¾ Treatments that block the action of the special inflammation 
factors, such as tumour necrosis factor (TNF alpha) and 
interleukin -1 (IL-1) are in trial. 
¾ Predicting Rheumatoid arthritis genetic markers will allow the 
identification of patients at risk.  
¾ TNF α affects osteoblasts through an enzyme called smurf, 
which in turn, turns off two proteins that drive bone building. 
¾ Twin study reveals that three gene namely CYR 61, Laeverint 
and 11β –HSD 2 are involved. 
¾ Two molecular pathways, the notch and toll like receptor 
pathways are linked and that manipulating a protein called 
RBP-J involved in both pathways, could serve as treatment. 
 
Juvenile Rheumatoid Arthritis 
The disease begins with 
¾ Sudden onset of fever of over 39 °C   
¾ Severe malaise   
¾ A morbilliform rash   
¾ Often generalized lymphadenopathy   
¾ Hepatomegaly   
¾ Spleenomegaly   
¾ Some times a pericardial effusion, pleural effusion, 
myocarditis or pneumonitis   
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 These symptoms persist for weeks or months before 
polyarthritis become evident. 
 This acute form of Juvenile Rheumatoid Arthritis is called 
'Still's disease' after the English physician Sir George Still who 
described it in 1897. 
 In 30% of children the disease is confined to a few joints most 
often a knee or ankle. 
In Juvenile Rheumatoid arthritis  
         Oligo arthritis is more common 
¾ Systemic onset is more frequent 
¾ Larger joints are affected more than smaller joints 
¾ Rheumatoid nodules and rheumatoid factor are usually 
absent and 
¾ Antinuclear antibody seropositivity is common. 
 Genetic susceptibility, abnormal immuno regulation, cytokine 
production and viral infection may all play a role in the 
pathogenesis. 
 
DIFFERENTIAL DIAGNOSIS 
Ankylosing spondylitis 
 Ankylosing spondylitis is a chronic, progressive and crippling 
disease affecting the spine.  The majority of ankylosing spondylitis 
patient is found to belong HLA - B27 groups. The disease occurs in 
the 3rd and 4th decades of life and is more common in males The 
patients present with complaints of diffuse pain in the back and 
vague pain in other joints. 
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Reiter's disease 
 Reiter's disease characterized by triad of polyarthritis, 
urethritis, conjunctivitis. The joint condition is an acute 
polyarthritis resembling rheumatoid arthritis, it does not cause 
destructive changes in the joint structures. 
 
Psoriatic arthritis 
¾ The most common type is the one involving the distal 
interphalangeal joints of the hands and feet with 
psoriatic nail. Metacarpophalangeal joints are never 
involved in psoriatic arthritis. 
¾ Arthritis multilens is a severe form where there is marked 
destruction of joints. 
¾ Symmetrical poly arthritic type. 
¾ Oligo arthritic type. 
¾ Spondyloarthritic type 
 
Enteropathic Arthritis 
 Chronic inflammatory bowel diseases like regional enteritis 
(chron's disease) and ulcerative colitis are associated with Arthritic 
lesion in about 10% of the cases. The joint condition shows 
remission and exacerbation along with activity of the underlying 
bowel disease. 
Sjogren's syndrome 
 Sjogren's syndrome is an immunologic disorder characterized 
by progressive destruction of the exocrine glands leading to 
mucosal and conjunctival dryness (Sicca Syndrome) 
accompanied by a variety of auto immune phenomena. 
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COMPLICATIONS 
Septic Arthritis 
 It may complicate Rheumatoid Arthritis, particularly in 
patients with longstanding nodular sero-positive disease. In 
debilitated patients, fever and leucocytosis may be absent and the 
signs of infection limited to malaise and slight exacerbation of 
inflammation in one or more joints. Staphylococcus aureus is 
commonly implicated secondary to invasion from an ulcerated 
nodule or infected skin lesion. 
 
Amyloidosis 
 It is a complication of prolonged active disease and is formed 
in 25% to 35% of patients at autopsy, making Rheumatoid Arthritis 
a leading cause of secondary amyloidosis. 
 
Fixed Deformities 
 Early assessment and planning should prevent postural 
deformities that will result in joint contractures. 
 
Joint Rupture 
 Occasionally the joint lining ruptures and synovial contents 
spill in to the soft tissue. 
 
Systemic Vasculitis 
 This is a rare but potentially serious complication. 
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SURGERY 
   
Synovectomy – When one or two joints are affected more severely 
than others, this procedure is used to reduce the amount of 
inflammatory tissue by removing the diseased synovium or lining of 
the joint. It may result in less swelling and pain and the slowing or 
prevention of further joint damage. 
 
Arthroscopic Surgery – In this procedure, a very thin tube with a 
light at the end is inserted into the joint through a small incision. It 
is connected to a closed-circuit television and the extent of the 
damage in the joint is seen.It is most commonly performed on the 
knee and shoulder. 
 
Joint Replacement Surgery or Arthroplasty - Joint replacement 
surgery involves the removal of the joint, resurfacing and relining of 
the ends of bones and replacing the joint with a man-made 
component. This procedure is usually recommended for people over 
50 or who have severe disease progression. Typically a new joint 
will last between 20 and 30 years. 
  
Arthrodesis or fusion – This procedure fuses two bones 
together. While it limits movement, it does decrease pain and 
increase stability of the joints in the ankles, wrists, fingers, toes 
and spine. 
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Supportive therapies  
¾ Physical therapy  
¾ Occupational therapy  
¾ Exercises - passive range-of-motion; isometric; hydrotherapy  
¾ Thermotherapy - application of superficial moist heat or ice 
packs  
¾ Splints/Orthoses - wrist supports; finger splints; special 
shoes and shoe insoles  
¾ Therapeutic ulrasound - the use of sound waves applied to an 
area of the body to reduce inflammation, pain, and 
tenderness  
¾ Transcutaneous electrical nerve stimulation (TENS) - the use 
of electrical stimulation to block the sensation of pain from 
reaching the brain 
 
ADJUNCTIVE TREATMENTS 
Rehabilitation 
 Rehabilitative measures that include physical therapy, and 
special splints and appliances to help them and manage their own 
self care activities like dressing and diet. 
Physical Therapy (Physiotherapy) 
 Physiotherapy includes 
1. Active exercise 
2. Passive joint movements 
3. Local heat 
4. Massage 
5. Electrical stimulation of muscles 
6. Ultra sound therapy 
7. Light therapy, ultraviolet rays and infrared rays  
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Exercise therapy 
 Once inflammation is satisfactorily controlled, appropriate 
and regular exercises is essential to strengthen muscles weakened 
by disease. 
 
Upper Extremities  
Fore arm 
¾ Elbows bent, turn palm of the hand and then back of the 
hand towards face. 
 
Wrist 
¾ Keeping forearm steady, move the wrist up and down as in 
waving. 
¾ Again hold forearm steady, move the wrist up and down as in 
hand shaking. 
¾ Make circle with hands. 
 
Hand and fingers 
Make tight fist. 
¾ Open fingers as wide as possible 
¾ With the hand open spread fingers away from each other and 
then together. 
¾ Touch tip of the thumb to the tip of each finger. 
¾ Bend the thumb in toward palm of the hand.  
 
 
Lower Extremities 
Knee 
 Sit with your feet off the floor. Lift the leg and then allow it to 
return to the bent position slowly. 
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Ankle 
¾ Pull foot up and in, and then push back down. 
¾ Make circle with foot. 
¾ Pull foot in toward other foot. 
¾ Pull foot to outside. 
Toes 
¾ Pull up on toes then curl toes under. 
 
Exercise benefits for individuals with Arthritis 
¾ Helps to preserve muscle strength and normal mobility of 
joints. 
¾ Relieves pain and stiffness. 
¾ Prevents further deformities. 
¾ Improves over-all physical fitness. 
¾ Improves coordination. 
 
Diet Therapy 
  We can manage RA by eating a healthy diet rich in whole 
foods, vegetables and fiber and low in sugar, meat, refined 
carbohydrate and saturated fat. 
 
Food allergy  
  Wheat, corn, milk and other dairy products, beef and 
nightshade family foods (tomato, potato, eggplants, peppers and 
tobacco) aggravates  rheumatoid arthritis.  
 
Dietary fats  
Fatty acids are important in inflammation mechanism 
through their ability to form prostaglandins, thromboxanes and 
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leukotrienes. Dietary oil intake can significantly increase or 
decrease inflammation, depending on the type of oil being used. 
 
Avoid foods that contribute arachidonic acid. Arachidonic 
acid is a fatty acid that is derived almost entirely from animal 
sources (meat, dairy products, etc.) It is converted to to 
inflammatory prostaglandins and leukotrienes that contribute 
significantly to the inflammation. 
 
Consume coldwater fish such as mackerel, herring, sardines 
and salmon. These fish  and cod liver oil are rich sources of 
eicosapentaenoic acid (EPA) which competes with arachidonic acid 
for prostaglandin and leukotriene production.  
 
Nutritional Therapy 
Copper. 
On  wearing the copper bracelets copper is absorbed through 
the skin and chelated to another compound which is able to exert 
anti-inflammatory action.  
 
Proteolytic enzymes the protein digesting enzyme of the pineapple 
(bromelain) have been demonstrated to be an effective anti-
inflammatory agent. They reduce swelling and help the body 
eliminate the immune complexes that would otherwise be deposited 
within the joints. 
 
Vitamin C Vitamin C is an important antioxidant. Vitamin C 
increases SOD activity, decreases histamine levels and provides 
anti-inflammatory action.  
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MATERIALS AND METHODS 
 
 The disease Vali azhal keel vayu has been dealt in the book 
Siddha Maruthuvam according to Sabapathy Manuscript; patients 
were selected according to the symptoms as mentioned in Vali 
azhal keel Vayu. 
 
Selection of Patients 
 For these clinical study 20 patients of both sexes and of 
varying age groups suffering from Vali azhal keel vayu were 
selected and admitted in the In-patient ward of post Graduate 
Department of Sirappu Maruthuvam, Government Siddha Medical 
College, Palayamkottai. 
 
Evaluation of Clinical Parameters 
 In this study the detailed clinical history was taken from the 
patients. Special attention was laid on the pain, swelling and 
stiffness, regarding their nature, site of occurrence, mode of onset 
and severity. The seasonal variation and precipitating factors like 
emotional stress, trauma, and change of climate were enquired. 
Constitutional symptoms like easy fatiguability, anorexia, loss of 
weight, pyrexia were noted; extra articular features like 
conjunctivitis, iritis, episcleritis, vasculitis etc were noted carefully. 
  
Socio economic status, family history and other significant 
disease already treated were noted. 
 
Study of Siddha aspect of diagnosis 
 A case sheet was prepared on the basis of siddha 
methodology (ie) Envagaithervugal, Uyirthathukkal, Udalkattugal, 
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Poriyal arithal, Pulanal arithal, Vinathal etc. Besides an individual 
case sheet maintained for each case in the In-Patients ward. 
 
The clinical Investigation 
 The diagnostic tests such as Blood test for TC, DC, ESR, Hb, 
Sugar, Urea, Serum Cholesterol, Rheumatoid factor, Urine analysis 
for sugar, albumin deposits and stools examination for ova, cyst to 
rule out any systemic illness were done. 
 Pharmacological evaluation of the trial medicines were 
conducted at the pharmacology department in Government Siddha 
Medical College, Palayamkottai. 
 Bio chemical analysis of the test medicine was conducted at 
the department of Bio chemistry in Government Siddha Medical 
College, Palayamkottai. 
 
Management 
 The treatment is aimed to neutralize the vitiated vatham, 
Pitham, kabam. 
‘Viresanathal Vatham Thazhum' 
 This quotation emphasizes that vitiated vatham can be 
brought down by means of laxatives (or) purgatives. Since Vali 
azhal keel Vaya is under vatha disese. Vellai ennai which is one 
among the purgative in siddha system was selected. All patients 
were advised to take. 
 
This drug was not repeated for the next day onwards. 
The trial medicines used for this study were, 
1) Mega Soolai veekathuku Chooranam 1 gm thrice a day with 
honey (Internal) 
2) Arkaathi thylam (External application) 
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RESULTS AND OBSERVATIONS 
 For the clinical study 20 in-patients and 20 out-patients 
cases were selected and treated in Post Graduate Department of 
Sirappu Maruthuvam, Government Siddha Medical College 
Hospital, Palayamkottai. Results were observed with respect to the 
following criteria. 
1) Sex distribution 
2) Age distribution 
3) Kaalam 
4) Constitution of the Body 
5) Gunam 
6) Paruvakalam 
7) Thinai 
8) Socio-economic status 
9) Aetiological factors 
10) Mode of onset 
11) Clinical manifestations 
12) Duration of illness 
13) Systemic examination 
14) Gradation of pain, joint swelling and restricted 
Movements 
15) Duration of morning stiffness 
16) Deformities of joints 
17) Deep tendon reflexes  
18) Locomotor system  
19) Individual joint involvement  
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20) Disturbances in mukkutram 
i. Derangement of vatham 
ii. Derangement of Pitham 
iii. Derangement of kabam 
21) Diagnostic Parameters 
22) Involvement of Ezhu udal Thathukkal 
23) Radiological Examination 
24) Grading of Rheumatoid arthritis  
25) Grading of result. 
 
1. Sex Distribution 
 Table 1: Illustrates sex distribution and its relative percentage 
SL. No Sex No of cases Percentage 
1 Male 7 35% 
2 Female 13 65% 
 
 For this study 20 in patients were selected among them, 35% 
were males and 65% were females. 
 From the above table it is clear that, females were mostly 
affected than males 
SEX DISTIBUTION
35%
65%
MALE
FEMALE
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2. Age distribution 
Table 2: Illustrates Age distribution and its relative percentage 
SL. No Age No of cases Percentage 
1. 10 - 30 years - - 
2. 31-40 Years 4 20% 
3. 41-50 Years 3 15% 
4. 51-60 Years 7 35% 
5. 61 & above 6 30% 
 
 Among 20 In patients  20 % cases were observed in the age 
group 31 to 40, 15% of cases were observed in the age group of 41 
to 50, 35 % of cases were observed in the age group of 51 to 60 and 
30 % of cases were observed in the age group of above 60 years. 
 
Majority of Cases were observed in age group of 51 - 60 years 
 
AGE DISTRIBUTION
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3. Kaalam 
Table 3: Illustrates the incidence of disease with respect to life 
distribution 
SL. No Kaalam No of cases Percentage 
1 
Vatha kaalam  
( upto 33 years) 
- - 
2 Pitha kaalam (33-66 years) 18 90% 
3 
Kabha kaalam  
(above 66 years) 
2 10% 
 
Out of 20 In-patients 90% of case were in the pitha kaalam, 10% of 
cases were in the kabha kaalam. 
 
Most of the cases were in the pitha kaalam. 
KALAM
18
2
0
2
4
6
8
10
12
14
16
18
20
Vatha kaalam ( upto 33
years)
Pitha kaalam(33-66 years) Kabha kaalam (above 66
years)
 
 80
4. Constitution of the Body 
Table 4: Illustrates the constitution of the body and its relative 
percentage 
SL. No Constitution of the body No of cases Percentage 
1 Vatha thegi - - 
2 Pitha thegi - - 
3 Kabha thegi - - 
4 Thontha thegi 20 100% 
Out of 20 in patients all the patients were Thontha thegi. 
 
5. Gunam 
Table 5: Illustrates the gunam 
SL. No Gunam No of cases Percentage 
1 Sathuvagunam - - 
2 Rajothagunam 18 90% 
3 Thamogunam 2 10% 
 
6. Thinai 
Table 7: Illustrates the Thinai 
SL. No Thinai No of cases Percentage 
1 Kurinji - - 
2 Mullai - - 
3 Marutham 18 90% 
4 Neithal 2 10% 
5 Palai - - 
 
Out of 20 in patients 90% of cases were from Maruthanilam and 
10% of cases from Neithal nilam. 
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7. Paruvakalam 
Table 6:  Illustrates the seasonal incidence of the diseases. 
SL. 
No Paruvakalam Months 
No of 
cases Percentage 
 1 Kaar kaalam Avani-Puratasi  (Aug 15 to Oct 14) 4 20% 
2 Koothir Kalam Iyppasi-Karthigai  (Oct 15 to Dec 14) - - 
3 Munpani kaalam Margazhi - Thai  (Dec 15 to Feb 14) - - 
4 Pinpani kaalam Masi – Panguni  (Feb 15 to Apr 13) - - 
5 Elavenil kaalam Chithirai -Vaigasi  (Apr 14 to Jun 14) 7  35% 
6 Muthuvenil kaalam Aani - Aadi  (Jun 15 to Aug 14) 9 45% 
 Maximum number of cases were found to be admitted during 
Muthuvenil kaalam (Aani –Aadi) 
 
8. Socio economic Status 
Table 8: Illustrates the Socio economic status. 
SL. No 
Socio Economic 
Status 
No of cases Percentage 
1 Rich - - 
2 Middle class 5 25% 
5 Poor 15 75% 
 Out of 20 inpatients 75% of cases belong to poor socio 
economic status and 25% of cases belong to middle class. Poor 
people were mostly affected. 
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9. Aetiological factor 
Table 9 : Illustrates the Aetiological factors. 
SL. No Precipitating factors No of cases Percentage 
1 Positive family history 2 10%    
2 Positive previous history 6 30% 
3 Miscellaneous 12 60% 
 Out of 20 inpatients 10 % of cases had positive family history, 
30% of cases had positive previous history and 60% of cases had 
Miscellaneous cause. 
 
10.Mode of onset 
Table 10: Illustrates the Mode of onset. 
SL. No Mode of onset No of cases Percentage 
1 Acute 4 20% 
2 Gradual 16 80% 
 Out of 20 cases acute onset was observed in 20% of cases 
and gradual onset was observed in 80% of cases. 
 
11.Clinical Manifestations 
Table 11: Illustrates the symptoms. 
S.No Symptoms 
No. of .cases 
out of 20 
Percentage   
1 Joint Pain 20 100% 
2 Swelling 20 100% 
3 Morning stiffness 20 100% 
4 Restriction to walk 6 30% 
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5 Difficulty to walk 12 60% 
6 Neck pain 12 60% 
7 Difficulty in chewing - - 
8 Fever 6 30% 
9 Sleeplessness 16 80% 
10 Loss of appetite 12 60% 
11 Constipation 19 95% 
12 Easy fatiguability 20 100% 
 
 Almost all cases were affected with symptoms of joint pain, 
Swelling, Morning stiffness and easy fatigability, 60% of the cases 
were affected with symptoms of difficulty to walk, loss of appetite 
and neck pain. 30% of cases were affected with the symptoms of 
restriction to walk and fever. 80% of cases were affected with the 
symptoms of sleeplessness. 95% of cases were affected with 
constipation. 
0
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12.Duration of illness 
Table 12 illustrates the duration of illness 
S.No Duration of illness No. of cases Percentage 
1 Below 1 month - - 
2 1-3 months 5 25% 
3  3-6 months 3 15% 
4 6-9 months 2 10% 
5 9-12months 5 25% 
6 1-2 years 2 10% 
7 Above 2 years 3 15% 
Out of 20 In Patients, In 25 % of cases the duration of illness was 
from 1-3 months. In 15 % of cases the duration of illness was from 
3- 6 months.In 10% of cases the duration of illness was from 6- 
9months. In 25% of cases the duration of illness was from 9 -12 
months. n 10 % of cases the duration of illness was from 1 - 2  
years In 15 % of cases the duration of illness was above 2 years. 
 
13. Systemic Examination 
Table 13 illustrates systemic examination. 
S.No Signs No. of cases Percentage 
1 Subcutaneous nodules 3 15% 
2 Muscle wasting 3 15% 
3 Ophthalmic manifestation - - 
4 Hepatomegaly - - 
5 Spleenomegaly - - 
6 Respiratory system - - 
7 Cardiovascular system - - 
8 Central Nervous system - - 
 
Out of 20 In Patients  15% of cases had subcutaneous nodules and 
15% of cases had muscle wasting. 
 85
14. Gradation of Pain, joint swelling and Restricted Movements 
Table 14 illustrates grades of signs and symptoms. 
S.n
o 
Sign and 
Symptoms 
Mild Moderate Severe 
No.of 
cases Percentage 
No.of 
cases Percentage 
No.of 
cases Percentage 
1 Pain 5 25 10 50 5 25 
2 Joint Swelling 10 50 6 30 4 20 
3 Restricted Movement 2 10 3 15 1 5 
4 Muscle wasting 3 15 - - - - 
 Among 20 In patients, pain was mild in 25 % of cases, 
moderate in 50 % of cases and severe in 25 % of cases. Joint 
swelling was mild in 50% of cases, moderate in 30% of cases and 
severe in 20% cases. Restricted movement was mild in 10% of 
cases moderate in 15% of cases and severe in 5% of case. No severe 
muscle wasting are noted. 
 
15.Duration of morning Stiffness 
Table 15 illustrates the duration of morning stiffness. 
S.No IP . NO 
Duration of morning Stiffness 
Before Treatment  
in mts 
After Treatment  
in mts 
1 1045 30 -70 20-40 
2 1073 60 -90 30-60 
3 1078 60 - 120 20-60 
4 1150 70 - 100 60-90 
5 1291 1 5 - 3 0  10-20 
6 1416 80 - 100 60-100 
7 1420 60 - 120 30-90 
8 1588 30-80 10-30 
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9 1732 120 -  160 60-140 
10 1733 160 -  180 30-60 
11 1731 60 - 90 30-60 
12 1782 100 -  120 90-100 
13 1760 30-60 20-30 
14 1849 30 - 60 20-40 
15 2031 60 - 120 
 
30-60 
16 2032 90 - 120 60-100 
17 2189 30 - 60 20-40 
18 2239 100- 120 60-100 
19 2288 60-80 30-60 
20 2302 60-180 20-60 
 
 Among 20 In patients all the cases had morning stiffness 
ranging from  1 hour - 3 hours 
 
16. Deformities of joints 
Table 16 illustrates deformities of joints 
S.No Deformities of Joints No. of cases Percentage 
1 Interphalangeal joints 20 100% 
2 Metacarpo phalangeal joints 12 60% 
3 Wrist joint 8 40% 
4 Elbow joints 10 50% 
5 Shoulder joint 8 40% 
6 Hip joint 3 15% 
7 Knee joint 12 60% 
8 Ankle joint 5 25% 
9 Metatorso phalangeal joint 20 100% 
10 cervical Spine 12 60% 
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 Among 20 Inpatients, cent percentage of cases had 
deformities in the interphalangeal and metatarsophalangeal joints, 
60% of cases had deformities in the metacarpophalangeal, Knee 
joint and cervical spine. 40% of cases had the deformities in the 
wrist joint and shoulder joint . 50% of cases had the deformities in 
the Elbow joint. 25% of cases had the deformities in the ankle joint 
and 15% of the cases had the deformities in the hip joint. 
 
17 . Deep tendon Reflex 
Table 17 illustrates results of deep tendon reflexes. 
S.no Deep tendon reflexes 
Exaggerated Diminished/ absent 
No. of 
cases Percentage 
No. of 
cases Percentage 
1 Jaw - - - - 
2 Biceps 5 25 - - 
3 Triceps 5 25 - - 
4 Supinator - - - - 
5 Knee 1 5 - - 
6 Ankle 1 5 - - 
 
 Out of 20 In patients 25% of cases had exaggerated Biceps 
and Triceps, 5% of cases had exaggerated knee jerk and ankle jerk. 
 
18. Locomotor System 
 Table 18 Illustrates involvement of Extremities. 
S.no Involvement of extremities No. of cases Percentage 
1 Upper extremity 14 70% 
2 Lower extremity 4 20% 
3 upper and lower extremity 2 10% 
 
Most of the cases had the history of upper extremity involvement. 
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19. Incidence of joint involvement 
Table 19 illustrates incidence of joint involvement. 
S.No Joints involvement No. of cases Percentage 
1 Proximal inter phalangeal Joint 20 100% 
2 Metacarpo phalangeal joint 7 35% 
3 Wrist joint 7 35% 
4 Elbow joint 8 40% 
5 Shoulder joint 7 35% 
6 Temporo mandibular joint - - 
7 Sterno clavicular joint - - 
8 Cervical Joint 12 60% 
9 Hip joint 3 15% 
10 Knee joint 12 60% 
11 Metatarso phalangeal joint 20 100% 
12 Ankle joint 5 25% 
 
 It was observed proximal inter phalangeal joints and 
Metatarso phalangeal joints were involved in cent percentage of 
cases. Knee joint, Cervical joint were involved in 60% of cases. 
Elbow joint was affected in 40% of cases. Metacarpo phalangeal 
joint, wrist joints and shoulder joint were affected in 35% of cases. 
Hip joint was affected in 15 % of cases. Ankle joint was affected 
25% of cases. 
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20. Disturbance in Mukkutram 
 Table 20 illustrates the disturbances in Mukkutram 
A. Disturbance in Vatham 
S.No Vatham No. of cases Percentage 
1 Pranan - - 
2 Abanan 19 95 
3 Viyanan 20 100 
4 Uthanan - - 
5 Sam an an 20 100 
6 Nagan - - 
7 Koorman - - 
8 Kirukaran - - 
9 Devathathan 15 75 
10 Thananjeyan - - 
 
Out of 20 cases observed Viyanan and Samanan were affected 
in all cases. Abanan was affected in 95% of cases and Devathathan 
was affected in 75% of cases. 
 
B. Disturbances in Pitham 
S.no Pitham No. of cases Percentage 
1 Anarpitham 10 50 
2 Ranjagam 16 80 
3 Prasakam - - 
4 Alosakam - - 
5 Saathagam 20 100 
 
Out of 20 cases Ranjagam was affected in 80% of cases. 
Anarpitham was affected in 50% of cases. Saathagam was affected 
in almost all cases. 
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C. Disturbances in Kabham 
S.no Kabham No. of cases Percentage 
1 Avalambagam - - 
2 Kilethagam 12 60% 
3 Pothagam - - 
4 Tharpagam - - 
5 Santhigam 20 100% 
 
Santhigam was found to be affected in almost all cases and 
kilethagam in 60 % of the cases. 
 
21. Diagnostic Parameters 
Table   21   illustrates   the   conditions   of   the   
 diagnostic parameter. 
S.no Envagai thervugal NO. of cases Percentage 
1 Naa 18 90% 
2 Niram -  - 
3 Mozhi - - 
4 Vizhi - - 
5 Naadi 20 100% 
6 Sparism 20 100% 
7 Malam 18 90% 
8 Moothiram - - 
 
 In almost all the cases it was observed that Naadi and 
Sparism were affected. Naa and Malam were affected in 90% of 
cases. 
 In all case Neerkkuri and Neikuri were studied. Neikkuri was 
observed like Aravilaazhi in 60% of the in patients, it was observed 
as Aazhiyir aravu in 40% of in patient cases. 
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22. Involvement of Udal Thathukkal 
 Table 22 illustrates the conditions of the udal Thathukkal. 
S.no Udal Thathukkal  No. of cases  Percentage  
1 Saaram 20 100% 
2 Senner 20 100% 
3 Oon 20 100% 
4 Kozhuppu 20 100% 
5 Enbu 20 100% 
6 Moolai 12 60% 
7 Sukkilam/ Suronitham - - 
 In almost all cases Saaram, Senneer, Oon , Kozhuppu and 
Enbu were affected. Moolai thathu was affected in 60% of cases. 
 
23. Radiological examination 
S.NO IP. NO Radiological Examination Findings 
1. 1045 Both wrist joints AP view Osteoporosis 
2. 1073 Both Knee joints AP view Subchondral sclerosis seen  in both tibia 
3. 1078 Both hands AP view Rheumatoid Arthritis 
4. 1150 Both Knee joints AP view Osteoporosis 
5. 1291 Both wrist joints AP view Rheumatoid Arthritis 
6.  1416 Both hands AP view Normal study 
7. 1420 Both wrist joints AP view Rheumatoid Arthritis 
8. 1588 Both hands AP view Both Knee joints AP view Rheumatoid Arthritis 
9. 1732 Both Knee joints AP view Rheumatoid Arthritis 
10. 1733 Both wrist joints AP view Normal Study 
11 1731 Both wrist joints AP view Rheumatoid Arthritis 
12. 1782 Both hands AP view Osteoporosis 
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13. 1760 Both wrist joints AP view Rheumatoid Arthritis 
14. 1849 Both hands AP view 
Both knee joints AP view 
osteophytes seen in phalanges 
(Left) thumb 
Bilateral osteo arth ritis 
15. 2031 Both knee joints AP view 
Shoulder joint (left) AP view  
Cervical spine Oblique view 
Bilateral osteo arth ritis 
Peri arth ritis  
Cervical spondylosis 
16. 2032 Both hands AP view Shoulder 
Joint (left) 
Osteoporosis Periarth ritis 
17. 2189 
 
Cervical spine Oblique view 
Both ankle joint lateral 
view 
Cervical spondylosis 
Bilateral calcaneal spur, 
degenerative changes seen in 
calcanium. 
18. 2239 Lumbo sacral spine AP view 
Both hands AP view 
Lumbar spondylosis 
Rheumatoid arthritis 
19. 2288 Both hands AP view 
Both knee joints AP view 
Peri arthritis 
Peri arthritis 
20. 2302 Both hands Ball catcher's view 
Both ankle with feet AP view 
Rheumatoid arthritis 
 
24. Grading of Rheumatoid Arthritis  : Grading of rheumatoid 
arthiritis was useful to assess the severity of the disease. 
Table 24 illustrates grading of Rheumatoid Arthritis. 
S.no Grade No. of cases Percentage 
1 I 5 25% 
2 II 5 25% 
3 III 10 50% 
4 IV - - 
 
Grade I  :  No restriction of ability to perform normal  
  activities 
Grade II    : moderate restriction but with an ability to perform  
  most activities of daily life.  
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Grade III   :  Marked restriction with an inability to perform  
  most activities of daily living and occupations 
Grade IV  : In capacitation with confinement to bed. 
   25 % of cases belonged to Grade I 
25 % of cases belonged to Grade II  
  50 % of cases belonged to Grade III  
   
Grading of Rheumatoid Arthritis 
25 25
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Assessment of the effect of Therapy 
The patients were treated with the trial medicines, at the end of the 
treatment the results were categorized as follows 
 
Remarkable :  Complete subsidence of pain and disappearance of  
    swelling, no remissions and relapses. 
Moderate  :  Relief of pain, reduction in swelling and increased range  
    of movement  
Poor    :  No improvement. 
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25. Gradation of Results: 
Table 25 illustrates Gradation of Results. 
S.no Grade No. of cases Percentage 
1 Remarkable - - 
2 Moderate 15 75% 
3 Poor 5 25% 
 
Out of 20 In patients 
¾ 75 % of cases showed moderate response. 
¾ 25 % of cases showed Poor response. 
 
 
Gradation of result
Remarkable, 0
Moderate, 15
Poor, 5
 CASE SUMMARY OF OUT PATIENTS 
Sl. No Op No Name Age/ Sex Duration of illness 
No of days 
treated 
Treatment 
with 
medicine 
done 
Result  
1 34083 Rajathi 52/F 3 Years 52 
Mega soolai 
Veekathuku 
Choornam 
1gm 
Thrice a day 
with honey 
(Internally 
Arkaathi 
thylam 
(Externally) 
CR 
2 30782 Seviin 49/M 3 Month 52 CR
3 32385 Sasidaran 55/F 3 Years 52 CR
4 32631 Christy 40/F 6 Month 55 PR
5 1557 Visalatchi  47/F 1 Year 55 CR
6 12521 Parvathi 56/F 3 Years 45 CR
7 28143 Subbulakshmi 69/F 10 Days 45 CR
8 10392 Arunachalam 65/F 2 Years 45 PR
9 7537 Nallathai 45/F  4 Months 45 CR
10 27284 Muhamed Usain 50/F  2 Months 45 PR
11 71711 Selvam 24/F  1 Month 45 CR
12 10535 Shagul hameed 38/F 1 Month 45 CR
13 31801 Thangamari 30/F 1 Years 52 CR
14 40532 Ponnu Essakki 35/F 6 Month 52 PR
15 40641 Lakshmi 30/F 2 Years 55 CR
16 33586 Sankara gomathi 45/F 3 Years 55 CR
17 34079 Valliyammal 65/F 10 Days 55 PR
18 17672 Chellammal 49/F 4 Month 55 CR
19 69994 Anthonyammal 49/F 15 Days 55 CR
20 1949 Sudalai mani 32/F 6 Years 55 PR
CR – Clinically Relived  
PR – Partially Relived  
 CASE SUMMARY OF IN – PATIENTS 
Sl  
No 
IP 
No 
Name of the 
patent Age Sex
Duration 
of illness 
Date of 
Admission 
Date of 
Discharge 
No of 
Days Drug Dose Results 
1 1045 Saraswathi  40 F 6 months 24.4.08 17.5/08 24 
Mega soolai 
veekathuku choornam 
1 gm thrice a day with 
Honey (Internally) 
Arkaathi thylam 
(Externally) 
CR 
2 1073 Saraswathi 50 F 2 year 28.4.08 23.5.08 26 CR 
3 1078 Sommuammal 60 F 1 year  28.4.08 21.5.08 24 CR 
4 1150 Christy 40 F 1 year 6.5.08 21.5.08 16 PR 
5 1291 Savier george 46 M 3 months 21.5.08 23.6.08 34 CR 
6 1416 Valliyammal 60 F  3 ½  year 4.6.08 25.6.08 22 PR 
7 1420 Samuvel 61 M  2 year 5.6.08 3.7.08 29 PR 
8 1588 Shagul hammed 38 M 
3 month  19.6.08 30.6.08 12 CR 
9 1732 Aaudiyammal 60  F 3 month 4.7.08 28.7.08 25 CR 
10 1733 Shiam 68 M 6 month 4.7.08 16.8.08 44 CR 
11 1731 Arunachallam 57 F 6 month  4.7.08 24.7.08 21 PR 
12 1782 Iyyasamy 82 M 7 year 9.7.08 18.8.08 41 CR 
13 1760 Marimuthu 66 M 3 month  7.7.08 10.8.08 38 CR 
14 1849 Rathnam 63 F 1 year 17.7.08 26.8.08 41 CR 
15 2031 Chellathai  58 F 2 month 5.8.08 23.8.08 19 PR 
16 2032 Lakshmi 47 F 6 month  5.8.08 10.9.08 37 CR 
17 2189 Rajeena 65 F 2 month  21.8.08 26.9.08 37 CR 
18 2239 Subaiya 55 M 3 month 25.8.08 6.9.08 13 PR 
19 2288 Muppidathi 43 F 2 month  29.8.08 24.9.08 27 CR 
20 2302 Bakiyam 40 f 3 month 30.8.08 26.9.08 28 CR 
 
CR – Clinically Relived   
PR – Partially Relived 
 INVESTIGATION AT OUT PATIENT 
 
 Sl. 
No 
Op. 
No 
WBC total 
count cumm 
WBC differential 
count cumm 
ESR mm/hr 
 
 
HB% 
 
BT 
 
AT 
 
RA FACTOR
URINE ANALYSIS MOTION ANALYSIS 
BT IN% AT IN% BT AT 
BT AT
BT AT BT AT 
BT BT P L E P L E 
½ 
HR 
1HR 
½ 
HR 
1 
HR 
BS BU SC BS BU SC BT AT Alb Sug Dep Alb Sug Dep Ova Cyst Ova cyst
1 34083 9000 9200 50 48 2 52 44 4 20 50 20 40 69 72 82 18 145 90 20 145 + + Nil Nil NAD  NIL  NIL  NAD NIL NIL NIL NIL 
2 30782 9200 9300 60 36 4 63 30 7 20 40 12 24 60 70 100 26 160 96 26 170 - - Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
3 32385 8900 9000 60 38 2 65 33 2 22 45 11 22 72 75 88 17 157 90 18 157 + + Nil Nil OPC NIL NIL NAD NIL NIL NIL NIL 
4 32631 10200 10300 75 23 2 70 29 1 20 40 15 20 69 76 93 22 189 90 26 180 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
5 1557 7800 8000 58 38 4 60 34 2 26 48 20 25 66 70 90 38 150 100 36 160 + + Nil Nil FEC NIL NIL NAD NIL NIL NIL NIL 
6 12521 9300 9500 70 27 3 60 37 3 25 55 18 30 68 75 98 18 174 98 20 170 - - Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
7 28143 9200 9300 50 48 2 54 40 6 15 35 10 15 72 76 98 18 154 90 26 160 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
8 10392 9800 9800 68 30 02 63 35 02 24 49 15 30 74 79 80 21 171 80 28 170 + + Nil Nil FPC NIL NIL NAD NIL NIL NIL NIL 
9 7537 9400 9600 72 27 1 60 37 3 48 65 20 25 61 69 85 26 149 85 30 150 - - Nil Nil 1-2PC NIL NIL NAD NIL NIL NIL NIL 
10 27284 9200 9300 62 34 4 60 34 6 26 32 20 22 72 75 97 32 209 95 32 180 - - Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
11 71711 8000 8200 60 37 3 58 36 6 19 40 15 30 74 78 90 27 160 86 38 170 - - Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
12 10535 9600 9800 68 30 2 64 34 2 20 40 15 30 68 74 89 36 155 80 26 160 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
13 31801 9000 9500 62 34 4 60 32 8 26 32 20 30 62 75 80 19 150 86 25 150 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
14 40532 10700 10800 54 43 3 59 38 3 40 80 15 35 65 72 93 25 186 100 30 180 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
15 40641 9100 9300 52 46 2 60 38 2 35 80 20 30 61 80 82 30 195 88 30 190 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
16 33586 9200 9500 48 48 4 56 40 4 27 34 15 20 70 82 80 28 191 90 25 190 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
17 34079 9800 10000 70 26 4 60 34 6 24 49 20 25 68 72 90 26 151 86 30 160 - - Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
18 17672 9000 9200 55 40 5 60 34 6 20 50 15 25 72 74 90 29 160 92 26 190 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
19 69994 8800 9000 42 52 6 60 34 6 20 30 15 20 70 75 79 18 215 80 30 200 - - Nil Nil FUPC NIL NIL NAD NIL NIL NIL NIL 
20 1949 9000 9200 69 28 3 60 37 3 27 35 15 25 68 70 80 27 175 86 30 180 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
 
BS – Blood sugar  SC – Serum Cholestrol  FU. PC. – Full of Puscells  FEC – Few epithelial cells 
BU – Blood Urea  BT – Before Treatement  FPC – Few Puscells   OPC – Occasional Puscells 
AT  - After Treatment NAD – No abnormal  defect   
 INVESTIGATION AT IN PATIENT 
 
Sl. 
No 
Ip. 
No 
WBC total 
count cumm 
WBC differential 
countcumm 
ESR mm/hr 
 
 
HB% 
 
BT 
 
AT 
 
RA FACTOR
URINE ANALYSIS MOTION ANALYSIS 
BT IN% AT IN% BT AT 
BT AT
BT AT BT AT 
BT BT P L E P L E
½ 
HR 
1HR 
½ 
HR 
1 
HR 
BS BU SC BS BU SC BT AT Alb Sug Dep Alb Sug Dep Ova Cyst Ova cyst
1 1045 9400 9600 60 36 4 61 35 4 50 90 30 60 68 75 79 20 152 82 24 160 + + Nil OPC NAD  NIL  NIL  NAD NIL NIL NIL NIL 
2 1073 9000 9200 68 28 4 71 25 4 30 62 20 40 74 78 74 39 188 85 36 180 + + Nil Nil 1-2PC NIL NIL NAD NIL NIL NIL NIL 
3 1078 8700 8900 60 36 4 62 34 4 11 25 10 25 64 80 85 30 180 88 34 180 - - Nil Nil 1-2EC NIL NIL NAD NIL NIL NIL NIL 
4 1150 10200 10300 72 24 4 66 30 4 20 40 10 20 68 74 73 22 165 79 30 160 + + Nil Nil OPC NIL NIL NAD NIL NIL NIL NIL 
5 1291 9600 9800 65 30 5 68 26 6 20 35 12 15 65 72 121 16 200 120 18 180 + + Nil Nil FEC NIL NIL NAD NIL NIL NIL NIL 
6 1416 7200 8000 58 38 4 63 32 5 30 65 10 26 66 75 111 26 186 108 30 170 + + Nil Nil 1-3PC NIL NIL NAD NIL NIL NIL NIL 
7 1420 9600 9800 50 43 7 60 37 3 20 40 15 25 61 70 82 26 163 90 30 160 + + Nil Nil FEC  NIL NIL NAD NIL NIL NIL NIL 
8 1588 8900 9100 64 30 6 64 35 1 52 85 20 46 70 70 74 18 186 85 18 176 + + Nil Nil FPC NIL NIL NAD NIL NIL NIL NIL 
9 1731 8200 8500 60 34 6 64 30 6 25 52 20 26 71 75 120 26 174 110 24 170 + + Nil Nil FBC  NIL NIL NAD NIL NIL NIL NIL 
10 1732 9800 10000 58 40 2 60 36 4 25 50 15 30 62 68 100 24 160 115 20 160 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
11 1733 8600 9000 59 40 1 66 31 3 14 20 14 20 51 60 118 35 150 120 30 160 - - Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
12 1782 8000 8500 56 40 4 60 38 2 30 55 20 40 60 65 130 20 180 100 26 160 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
13 1760 7800 8000 58 40 2 60 36 4 9 18 10 20 75 78 96 34 180 110 30 160 - - Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
14 1849 9600 9800 64 27 9 66 25 9 30 58 10 26 71 75 110 36 159 120 28 170 - - Nil Nil FEC NIL NIL NAD NIL NIL NIL NIL 
15 2031 9500 10000 55 40 5 65 30 5 7 15 3 7 68 70 135 28 157 125 24 150 - - Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
16 2032 8000 8300 60 32 8 64 28 8 15 20 10 15 65 80 100 29 149 120 20 150 - - Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
17 2189 7000 7500 62 34 4 66 30 4 15 30 12 15 67 67 120 26 150 130 20 160 + + Nil Nil 1-2PC NIL NIL NAD NIL NIL NIL NIL 
18 2239 9000 9200 58 34 8 62 30 8 22 52 15 30 62 65 140 20 153 140 20 160 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
19 2288 8200 8400 68 26 6 67 27 6 40 80 15 30 70 72 108 19 149 130 26 150 + + Nil Nil 1-2PC NIL NIL NAD NIL NIL NIL NIL 
20 2302 9400 9800 60 32 8 60 34 6 35 68 15 35 68 70 90 28 156 110 28 146 + + Nil Nil NAD NIL NIL NAD NIL NIL NIL NIL 
 
BS – Blood sugar  SC – Serum Cholestrol  FU. PC. – Full of Puscells  FEC – Few epithelial cells 
BU – Blood Urea  BT – Before Treatement  FPC – Few Puscells   OPC – Occasional Puscells 
AT  - After Treatment NAD – No abnormal  defect 
 Right Side Measurement (in inches) before and After Treatment 
 
S.No IP NO Knee Joint Ankle Wrist Joint Index Finger Middle Finger Ring finge Little finger 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 1045 12 11 8 7.5 6.5 6 2.5 2.1 2.3 2 2.5 2.1 1.9 1.7 
2 1073 12.5 12 9 8.5 7.1 6.8 2.3 2 2.2 2.1 2.3 2.1 1.8 1.6 
3 1078 13 11 7.8 7.5 6.5 6 2.2 2.1 2.5 2.3 1.8 1.5 1.6 1.4 
4 1150 12 11.5 8.5 8 7.5 7 2.5 2.3 2.1 2 2.2 2 1.8 1.6 
5 1291 12.5 12 9 8.5 6.8 6.5 2.1 2 2.6 2.3 2.1 1.8 1.6 1.4 
6 1416 13 12.5 9.5 9 6.5 6.3 2.3 2.1 2.4 2.2 2.3 2.1 .2 1.8 
7 1420 13.5 12.5 10 9 7.6 7.2 2.5 2.3 2.3 2.1 2.5 2.3 1.6 1.2 
8 1588 13 12.5 9.5 8 7.2 7.1 2.3 2.1 2.2 2 2.1 1.8 1.6 1.4 
9 1732 14 13 11 10.5 6.5 6.2 2.4 2.2 2.6 2.2 2.5 2.3 2 1.8 
10 1733 13.5 12.5 10.5 10 7.4 7.1 2.5 2.1 2.4 2.1 1.6 1.4 1.8 1.6 
11 1731 11.5 10.5 10 9.5 7.5 7.2 2.6 2.2 2.1 1.8 1.8 1.4 1.6 1.1 
12 1782 13.5 12.5 12.5 11.5 7.6 7.1 2.2 2 2.5 2.1 1.4 1.1 1.8 1.6 
13 1760 14 13.5 9.5 9.1 7.2 7 2.5 2.3 2.6 2.4 1.6 1.4 1.8 1.5 
14 1849 12.5 12 10.5 10.3 7.1 6.5 2.6 2.4 2.5 2.3 1.5 1.3 1.4 1.2 
15 2031 13 12.5 8 7.5 6.8 6.5 2.2 2 2.6 2.2 2.1 2 1.5 1.3 
16 2032 14 13 11.5 10.5 7.4 7.1 2.4 2.1 2.3 2.1 2.3 2.1 1.8 1.6 
17 2189 13.5 12.5 10.5 10 7.2 7 2.5 2.3 2.1 1.8 2.1 1.6 1.2 1 
18 2239 13 12.5 9.5 9 7 6.5 2.2 2 2.6 2.2 1.8 1.5 1.8 1.6 
19 2288 14 13.5 10 9.5 7.4 7 2.4 2.2 2.1 1.8 1.4 1.1 1.5 1.1 
20 2302 13 12 9 9 7.4 7.3 2.3 2.1 2.4 2.2 1.6 1.4 1.6 1.3 
BT - Before Treatment  
AT - After Treatment 
 Left Side Measurement (in inches) before and After Treatment 
S.No IP NO Knee Joint Ankle Joint Wrist Joint Index Finger Middle Finger Ring Finger Little Finge
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 1045 11.5 11 8 7.6 6.6 5.8 2.5 2.3 2.6 2.2 2.5 2.3 1.8 1.6 
2 1073 13 12.5 10.5 10 6.8 6.5 2.3 2.1 2.3 2.1 1.8 1.6 1.6 1.4 
j 1078 12.5 11.5 9.5 9.1 7.2 6.8 2.4 2.2 2.2 2 2.2 1.8 2.3 2.1 
4 1150 11.5 11 9 8.5 7.6 7.2 2.5 2.3 2.4 2.2 2.1 1.6 2.2 2 
5 1291 10,5 10 10.5 10 7.2 6.8 2.6 2.4 2.6 2.2 2.2 2 1.6 1.4 
6 1416 12.5 12 11. 10.5 6.5 6.2 2.1 1.8 2.5 2.1 2.5 2.2 2.3 2.1 
7 1420 12 11.5 9.5 9 5.7 5.5 2.3 2 2.2 1.8 2.3 2.2 1.8 1.5 
8 1588 13.5 13 10.5 10 7.8 7.5 2.5 2.1 2.6 2.2 2.1 1.5 2.1 1.8 
9 1732 13 12.5 10 9.5 7 6.5 2.3 1.8 2.4 2.1 2.4 1.8 2.5 1.9 
10 1733 12.5 12 8 7.5 6.6 6.2 2.5 2.2 2.2 1.6 2.6 2.1 1.6 1.4 
11 1731 13.5 13 9.5 9 7.2 7 2.4 2 2.4 1.8 2.3 1.6 1.8 1.5 
12 1782 14. 13.5 10.5 10 7.6 7.2 2.3 2.1 2.3 1.5 2.6 2.2 1.8 1.6 
13 1760 12.5 12 11 10.5 7.2 7 2.1 1.8 2.5 2 2.4 2 2.2 2 
14 1849 13 12.5 9.5 9.3 6.4 6.2 2 1.8 2.3 2.1 2.2 1.8 2.4 2.1 
15 2031 13.5 13 10.5 10.1 7.5 7.2 2.5 2.3 2.6 2.3 2.5 2.3 1.6 1.2 
16 2032 11.5 11 11.5 11.2 6.8 6.5 2.3 1.8 2.3 2.1 2.1 1.8 2.3 2.1 
17 2189 13.5 12.5 8.5 8.2 7 6.5 2.2 1.6 2.4 2.1 2.3 1.6 2.1 1.8 
18 2239 12.5 12 10.5 10.2 7.2 6.5 2.5 1.8 2.2 1.6 2.1 1.8 2.5 2.3 
19 2288 14 13.5 9.5 9.3 6.4 6.2 2.3 1.6 2.6 2.2 2.2 2 2.3 2.1 
20 2302 13.5 13 11.5 11.2 6.6 6.2 2.1 1.5 2.1 1.8 2.5 2.1 1.6 1.8 
 
BT - Before Treatment 
AT - After Treatment 
 Measurement of Pain 
Sl. 
No 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
BT II IV III II IV II IV III III II III II IV IV IV II III III II III
AT I II II I II I II II II I II I II II II I II II I I 
 
Verbal rating scale 
 I -No Pain        II - Mild pain     III - Moderate Pain       IV-Severe pain  
    Mild Pain is completely recovered. 
   Severe pain, reduced to mild pain and Moderate pain 
 
Assessment of Joint Tenderness  
 
Sl. 
No 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
BT II IV III II IV II IV III III II III II IV IV IV II III III II IV
AT 0 I 0 0 I 0 I 0 0 0 0 0 I I I 0 0 0 0 I 
 
Grade 0 - No tenderness 
Grade 1 - The patient says the joint is tender 
Grade 2 -  The patient winces  
Grade 3 - The patient winces and withdraws the affected part. 
Grade 4 - The patient will not allow the joint to bee touched. 
 
Radiological  Progression  
   
Sl. 
No 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
BT I III II I III N III II II N II I III III III I II II I II 
AT I III II I III N III II II N II I III III III I II II I II 
 
 I - Periarticular osteoporosis 
II - Loss of articular cartilage (Joint Space) 
III - Erosions 
IV - Subluxation or ankylosis  
     No progression of Radiological Changes occurred. 
 
 
 Duration of morning Stiffness 
Table  illustrates the duration of morning stiffness. 
S.No IP . NO 
Duration of morning Stiffness 
Before Treatment  
in mts 
After Treatment  
in mts 
1 1045 30 -70 20-40 
2 1073 60 -90 30-60 
3 1078 60 - 120 20-60 
4 1150 70 - 100 60-90 
5 1291 1 5 - 3 0  10-20 
6 1416 80 - 100 60-100 
7 1420 60 - 120 30-90 
8 1588 30-80 10-30 
9 1732 120 -  160 60-140 
10 1733 160 -  180 30-60 
11 1731 60 - 90 30-60 
12 1782 100 -  120 90-100 
13 1760 30-60 20-30 
14 1849 30 - 60 20-40 
15 2031 60 - 120 
 
30-60 
16 2032 90 - 120 60-100 
17 2189 30 - 60 20-40 
18 2239 100- 120 60-100 
19 2288 60-80 30-60 
20 2302 60-180 20-60 
 
 Among 20 In patients all the cases had morning stiffness 
ranging from  1 hour - 3 hours 
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DISCUSSION 
 For this Dissertation study out of 25 patients the author had 
selected 20 Inpatients and they were admitted in the In-patient 
ward Government Siddha Medical College Hospital, Palayamkottai. 
A case sheet was prepared and maintained individually for all the 
20 Inpatients. 
 
Sex distribution 
 Among the 20 patients 7 were male and 13 were female. From 
this study the sex incidence was higher in females (65%) than in 
male (35%). 
 Indicating Valiazhal keelvayu is predominate in females 
 
Age distribution 
 Among 20 cases. 20% of cases were in the age group of 31 - 
40 years. 15% of cases were in the age group of 41 - 50 years. 35% 
of cases were in the age group 51-60years and 30% of cases were in 
the age group of 61 and above. 
 No age group is exempted for Rheumatoid arthritis but the 
usual incidence is during 4th and 5th decade. 
 
Kaalam 
 According to siddha literature life span has divided into three 
kalam. They are 
Vatha kaalam  - First 33 years and 4 months  
Pitha kaalam  - Second 33 years and 4 months  
Kabha kaalam  - Third 33 years and 4 months 
 From this study the occurrence of this disease is as follows  
Pitha kaalam 90%  
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Kabha kaalam 10%     
  The maximum number of cases were observed in pitha 
kaalam which correlates with that of modern concept age incidence 
4th and 5th decades. 
 
Paruvakaalam   
20% of cases were admitted in Kaar Kalam 
35% of cases were admitted in Elavenil kaalam  
45% of cases were admitted in Muthuvenil kaalam 
 
  So this disease occurs derangement of vatham and pitham 
due to seasonal variations that leads to thannilai valarchi and 
vetrunilai valarchi of vatham and pitham in the body.  
 
Thinai 
Maximum, number of cases from maruthanilam. 
 
Aetiology 
10% of patients had a positive family history. 
30% of patients had a previous history. 
60% of patients are affected by miscellaneous reason. 
 Literary evidence indicates that the disease Vali azhal keel 
vayu is common in winter and genetic predisposition as a cause for 
Vali azhal keel vayu.  
 
Mode of onset 
 The onset of Vali azhal keel vayu was acute in 20% and 
gradual in 80%. The incidence was more in gradual onset. 
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Clinical manifestations 
 Vali azhal keel vayu present with articular and extra articular 
manifestations. In this study both this manifestation were noticed 
and recorded. Cent percent of patients had joint pain, swelling, 
Easy fatigue and morning stiffness, 30% of cases had restriction to 
walk and fever, 60% of cases had difficult to walk, neck pain and 
loss of appetite, 80% of cases had sleeplessness, and 95% had 
habitually constipated. 
 Joint pain was assessed by the words of the patients and was 
classified into mild moderate and severe. Mild pain was noticed in 
25% of cases moderate pain was noticed in 50% of cases and severe 
pain was noticed in 25% of cases.  
 Swelling of the affected joints were noticed in all the cases. 
Swelling of the joints were measured by means of a non elastic 
measurable tape. Areas of maximum level of swelling around the 
joints were measured both before and after treatment. The joints 
subjected to measurements were knee joint, ankle joint, wrist joint, 
proximal interphalangeal joint of index finger, middle finger and 
Little finger. 
 The degree of joint swelling was observed. Thus mild swelling 
in 50% of cases, moderate swelling in 30% of cases and severe 
swelling in 20% of cases. Measurements were taken after treatment 
reveals that 40% of cases under regular treatment had marked 
reduction in swelling 30% of cases showed mild reduction and 30% 
showed no signs of improvement. 
 Almost all the patients experienced early morning stiffness 
ranging from 1 to 3 hours. After treatment it gradually came down 
to 60 minutes. 
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 Restricted movements or decreased range of movements were 
seen in 30% of cases. Asking the patients to move the joint in a 
particular direction assessed restricted movements of patients. 
When the active movements of other joint was impossible 
movements were considered as restricted or decreased range of 
motion. 
 
 After treatment with Megasoolai Veekathukku chooranam 
(internally) and Arkaathi thylam (Externally) along with 
Thokkanam in most of the cases increased range of movement was 
noticed. 
 
Involvement of extremities 
 The incident of initial involvement of joints of upperlimb was 
noted in 70% of cases and in 20% of cases in the lower limb was 
involved first. 10% of cases involved both extremities. 
 
Incidents of individual joint involvement 
 Proximal interphalangeal and metatarsophalangeal joints 
were involved in cent percentage of cases. Metacarpophalangeal, 
wrist, shoulder joints were affected in 35% of cases. Elbow joint 
was affected in 40% of cases. Cervical spine, knee joints were 
affected in 60% of cases. Hip joint was affected in 15% of cases. 
Ankle joint was affected in 25% of cases. 
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Deformities of joints 
 Cent percentage of cases had deformity in the interphalangeal 
joints. 60% of cases had flexion deformity of the knee joint and 60% 
of cases had deformity of the spine. 
 
Elicitation of extra articular manifestations 
 Along with the symptoms told by the patient certain signs 
were also noted. These include Hepatomegaly, spleenomegaly, 
presence of subcutaneous nodules, Respiratory symptoms, 
cardiovascular symptoms, muscle wasting, reflexes and ophthalmic 
manifestation etc., 15% of cases had mild muscle wasting in the 
thenar and hypothenar muscles and subcutaneous nodules. 
 
 Hepatomegaly and spleenomegaly were not present in any 
case. Likewise ophthalmic manifestations and cardiovascular 
manifestations were not present. 
 
Uyir thathukkal 
 Uyirthathukkal constitute vatham, pitham and kabam. 
Disturbances in Uyir thathukkal lead to disease entities. 
 
Disturbances in vatham  
 Abanan was affected in 95% of cases. Viyanan and samanan 
were affected in cent percent of cases, Devathathan was affected in 
75% of cases. Affected Abanan produce constipation. Affected 
viyanan produce pain and restriction of movement in joints. 
Affected    samanan   produce   loss   of   appetitie.   Affected 
Devathathan produce sleeplessness. 
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Disturbances in pitham 
 Among 20 Inpatients sathaga pitham was affected in cent 
percentage of patients causing difficulty to carry out regular works. 
Anarpitham was affected in 50% of Inpatient and cause loss of 
appetite. Ranjaga pitham was affected in 80% of the In patients 
producing anaemia. 
 
Disturbances in Kabham 
 Among 20 In patients santhigam was affected in cent 
percentage of cases. Affected santhigam cause pain and swelling in 
the joints, Kilethagam was deranged in 60% of Inpatients  cause 
loss of appetite.   
 
Involvement of Ezhu Udal Thathukkal 
 Among 20 In-patients Saaram, Senneer, Oon, Kozhuppu, 
Enbu were affected in cent percent of the cases , Moolai thathu was 
affected in 60% of the case.  
Affected saram produced easy fatiguability (100%)  
Affected senneer produced anaemia (100%)  
Affected Oon produced muscle wasting (100%)  
Affected kozhuppu produced pain in the joints (100%)  
Affected Enbu produced joint pain (100%) 
Affected Moolai produced swelling of the interphalangeal 
joints.[60%] 
 
Envagai thervugal 
 In 60% of In-patient the naadi was vathapitham and 40% 
belonged to pithavatham.  
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 Sparisam was affected in cent percent of Inpatient producing 
warmth in the painful joints Naa was affected in 90% of the 
Inpatient producing either coated tongue due to constipation or 
paleness of the tongue due to anaemia.  
 Malam was affected in 90% of inpatient cases producing 
constipation.  
 Neikkuri was observed like aravilaazhi in 60% of the 
inpatient. It was observed as Aazhiyir aravu in 40% of inpatient 
cases. 
 
Grading of Rheumatiod Arthritis. 
Among 20 Inpatients 
25% of the cases belonged to Grade I 
 25% of the cases belonged to Grade II  
 50% of the cases belonged to Grade III  
  
Investigation 
 Routine Examinations of blood, urine and stools were done 
during the time of admission and discharge. 
 Among 20 In - patients 75% of cases showed decreased Hb% 
and cent percent of cases showed increased ESR. 
 The investigations include Blood sugar, Blood urea, serum 
cholesterol, RA factor. Some of the patients were advised to do the 
test outside lab with their consent not in compulsion. 
 The patients were also subjected to radiological examinations 
Serological test for syphilis was done in some patients. 
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X- ray both hands with wrist joints 
 Anteroposterior view was taken in 11 Inpatients. It showed 
osteoporosis, reduction in interphalangeal joint spaces, synovial 
thickening, periarticular erosions, soft tissue swelling, deformities 
etc., 
X - ray of both the knee joints 
 Anteroposterior and lateral view was taken in 12 in patients 
the reports revealed osteoporosis with reduction of joint space. 
 
X-ray Both feet with ankle joints 
 Anteroposterior view was taken in 2 In patients. Synovial 
thickening, sclerosis and narrowing of the joint space were noted.  
 
X-ray cervical spine 
 Oblique view was taken in 2 In - patients.  
The clinical observations are, 
 
¾ Mild pain is completely recovered.severe pain and moderate 
pain are reduced to mild pain. 
 
¾ Joint tenderness of grade 2,3,4 are brought to grade 0 and 1. 
 
¾ Swelling had been reduced in both sides of the joints. 
 
¾ Morning stiffness had been moderately reduced. 
 
¾ Range of movement had been increased. 
 
¾ Deformities are maintained and no progression occurs. 
 
 Investigations  
 
¾ Haemoglobin level increased. 
 
¾ Erythrocyte sedimentation rate reduced. 
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X-ray Findings 
 
      No progression of radiological changes occured. 
 
Viraeshanam with vellai ennai 15ml at early morning in 
empty stomach with warm water was given before the 
administration of trial drug. 
 
The internal medicine Mega soolai veekathukku chooranam 
has the following therapeutic action. 
 
WITHANIA SOMNIFERA 
 
Anti stress, anti oxidant. 
Cyclo oxygenase inhibition and hence reduces synthesis of 
prostaglandins – mediators of inflammation – Anti inflammatory. 
Increases the activities of anti oxidant enzymes superoxide 
dismutase. 
Increase Red Blood Cell count, white blood cell count and 
platelet count in blood.  
Enhances the immune cells. 
 
PIPER LONGUM 
Analgesic, Anti inflammatory 
 
TRACHYSPERMUM AMNI 
 
Inhibits  arachidonic acid and collagen induced platelet 
aggregation  
Antispasmodic 
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PIPER LONGUM ROOT 
Anti inflammatory, analgesic. 
 
TERMINALIA CHEBULA 
Anti inflammatory. 
Chebulagic acid, chebulinic acid, Tannin.  
Chebulin possesss anstispasmadic activity similar to that of  
papaverine. 
Hyaluronidase and collagenase inhibitor prevented degradation 
of cartilage. 
Anti lipoxygenase, anti superoxide radical formation, free 
radical scavenging activities.restore anti oxidant enzyme 
superoxide dismutase from the radiation induced damage. 
 
PHYLLANTHUS EMBLICA 
Anti inflammatory. 
 Detoxifier. 
Enhances immune function. 
Anti oxidant –gallic acid. 
Increases superoxidase dismutase activity. 
 
SMILAX CHINA 
 Anti inflammatory. 
 Immune enhancer. 
Enhance the  circulating level of corticosteroids by slowing their 
metabolism, this will not only increase the natural cortico steroids 
but also any steroids administered as drugs.  
Facilitate absorbtion of drugs and phytochemicals by the body. 
rhuk; nfl;bUf;Fk; NghJk;> Njhy; gpzpf;fg;gl;bUf;Fk; NghJk;> 
guq;fpg;gl;il Nrh;e;j kUe;Jfis toq;fyhk;. 
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HYDNOCARPUS LAURIFOLIA 
no cyano genetic glycosides. 
 
nre;ePh; nfl;bUf;ifapy; ePubKj;J rk;ge;jkhd kUe;Jfis nfhLf;f 
Ntz;Lk 
 
TERMINALIA BELLERICA 
Anti inflammatory. 
 
 
MYRISTICA FRAGRANS 
Nut meg - Anti inflammatory, Anti microbial, Anti thrombotic. 
Mace  is used  in collagen induced pulmonary thrombo embolism 
 
SYZYGIUM AROMATICUM 
 
Anti spasmodic, Aromatic. Anti viral.  
Inhibitor of platelet aggregation. 
Anti thrombotic.  
 
HONEY 
Demulcent, Laxative, Anti septic, Stomachic. 
 
Polyvalent action of herbs leads to improved products with 
increased efficacy, reduced toxicity and in case of antibiotic 
action, less likely to lead to microbial resistance.  
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EXTERNAL MEDICINE 
Anti inflammatory action 
Ricinus communis 
Crataeva magna 
Calotropis gigantea 
Vitex negundo 
Euphorbia antiquoraum 
Euphorbia nerifolia 
Pergularia daemia 
Clerodendrum phlomoidis 
Withania somnifera 
Adhatoda vasica  
Phyla nodiflora 
 
Analgesic action 
Sesamum indicum 
Calotropis gigantea 
Vitex negundo 
 
Biochemical analysis of the trial drug shows the presence of sulphate, 
ferrous, reducing sugar, Tannic acid, unsaturated compound.  
 
The pharmacological analysis of Mega Soolai Veekathuku chooranam 
¾ Significant acute anti inflammatory action 
¾ Moderate chronic anti inflammatory action 
¾ Significant anti pyretic action 
¾ Significant analgesic action 
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Arkaathi Thylam 
Significant acute anti inflammatory action 
  
¾ Massage is strongly encouraged by the American 
Arthritis Foundation for the sub-acute phases of RA, 
though discouraged in the acute phase, as massage 
increases circulation and may increase the chance that 
the disease in this phase may spread.  
It stimulates the release of endorphins the body’s natural pain 
killers.  
 
¾ People with rheumatoid arthritis who practiced yoga therapy 
over a three month period experienced greater handgrip 
strength compared to those who did not practice yogasanam. 
¾ Vayu Mudra was effective in relieving pain. 
¾ Pranayama  prepares the mind ready for deep meditations. 
¾ During meditation thirty-two per cent increase in blood flow 
to the forearm occurs.Lactate produced by anxiety and stress 
is reduced. 
¾ Proper diet regimen enchances the bio availability of the drug 
and reduces harmful effect of the drug. 
¾ Tomato , potato, wheat , corn, meat, milk and other dairy 
products aggravates rheumatoid arthritis. 
¾ Salmon fish, cod liver oil are rich soures of eicosapentaenoic 
acid, which competes with arachidonic acid for prostaglandin 
and leukotriene production. 
¾ Bromelian of pineapple reduces swelling and helps the body 
to eliminate the immune complexes. 
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¾ Smokers, coffe drinkers are at risk. 
¾ Long term breast feeding protects mother from risk. 
¾ Alcohol cuts the risk factors. 
 
Recent studies like manipulating RB-J protein in notch and 
toll like receptor pathways could serve as treatment and the 
treatment that block the action of TNF-ALPHA  and IL-1 are in trial. 
 
This is my contribution to give hand in relieving the 
symptoms without side effects in vali azhal keel vayu by giving the 
trial medicine mega soolai veekathukku chooranam and arkaathi 
thylum which had been trialed already by siddhars before centuries. 
 
I had chosen this medicine to know whether this combination 
works out in vali azhal keel vayu patients of this centuries at this 
environmental conditions. 
 
I hereby conclude that the trial medicine  mega soolai 
veekathukku chooranam and arkaathi thylum had given moderate 
improvement (75%)  in patients suffering from vali azhal keel vayu. 
 
It will be very effective in the point of efficacy, safety and low 
cost in the treatment of vali azhal keel vayu. 
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SUMMARY 
 The disease Vali azhal keel vayu correlates with the 
Rheumatoid Arthiritis in modern medicine. 
 
 The aetiology, pathology, pathogenesis, clinical features, 
course and prognosis of the disease were collected from numerous 
literatures both in siddha system as well as modern medicine. 
 
 About 50 cases were treated as In-patient and Out-patient 
cases in post graduate department of sirappu maruthuvam, 
Government siddha medical college, palayamkottai. 
 
 The diagnosis of Rheumatoid Arthritis was based on the 
criteria mentioned in American Rheumatoid Association and 
Graded according to the CECIL Textbook of medicine. After through 
evaluation of history, clinical findings and laboratory results, 
Envagai thervugal were used for the diagnostic purpose. 
 
 The diagnosing criteria mainly the morning stiffness, joint 
pain,swelling and restriction to walk are noted for the clinical 
accessment of the prognosis. 
 
 The present study was chosen with an eager to treat Vali 
azhal keel vayu with the Mega Soolai Veekathukku chooranam 
internally and Arkaathi thylam externally. 
 
 The efficacies of the medicines Mega soolai veekathakku 
chooranam and Arkaathi thylam were studied during the course 
of this research. 
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 Clinically marked reduction of pain and swelling in the joints 
along with an improvement to do their day to day activities, were 
observed while treated with the trial medicine. 
 
 No signs of complications were reported. Laboratory 
investigations were encouraging after the treatment. Clinically the 
drugs were free from adverse effects. 
 
The pharmacological analysis of Mega Soolai Veekathuku chooranam 
¾ Significant acute anti inflammatory action 
¾ Moderate chronic anti inflammatory action 
¾ Significant anti pyretic action 
¾ Significant analgesic action 
 
Arkaathi Thylam 
Significant acute anti inflammatory action 
 Biochemical analysis of the trial drug shows the presence of 
sulphate, ferrous, reducing sugar, Tannic acid, unsaturated 
compound. 
 
 With the above studies the management of the disease 
brought by viraeshanam with vellai ennai 15ml at early morning in 
empty stomach with warm water before the administration of trial 
drug. Thokkanam was done to all patients after the application of 
external oil and then advised to take hot water fomentation. 
 
 All patients were advised to take complete bed rest before the 
subsidement of the inflammation. Yoga and regular simple exercise 
were advised to follow up. 
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CONCLUSION 
 
 In this research the treatment of Vali azha keel vayu with 
Mega soolai veekathakku chooranam and Arkaathi thylam  
showed  moderate improvement clinically. 
 
 Hereby the author concluded that the treatment with Mega 
soolai veekathakku chooranam and Arkaathi thylam showed 
remarkable improvement. 
 
 It will be very effective in the point of efficacy, safety and low 
cost in the treatment of Vali azhal keel vayu. 
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ANNEXURE I 
Nkf#iy tPf;fj;Jf;F #uzk; 
NrUk; ruf;Ffs; 
mKf;fuh  - 4gyk; 
gwq;fpg;gl;il 
epubKj;J 
fLf;fha; 
ney;ypf;fha; 
jhd;wpf;fha; - 1gyk; 
xkk; 
jpg;gpyp 
jpg;gpyp %yk; 
rhjpf;fha; 
rhjpgj;jphp  - 1 tuhfd;  
fpuhk;G 
 
nra;Kiw   :  Nkw;$hpa ruf;Ffis jdpj;jdpNa #uzpj;J 
fye;J nfhs;sTk; 
msT   :  1gm 
mDghdk;   :  Njd; 
jPUk; Neha;fs;  :  Nkf #iy> tPf;fk;.  
MAl;fhyk;  : %d;W khjk; 
Mjhuk;   :  Mj;k ul;rhkph;jk; vd;Dk; itj;jpa  
      - rhu rq;fpufk; (gf;fk; 374) 
 
Polyvalent action leads to improved products with increased 
efficacy, reduced toxicity and in case of antibiotic action, less likely 
to lead to microbial resistance.  
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rPik mKf;fuh 
English Name    - Winter cherry 
Botanical Name   - Withania somnifera 
Family   -  solanaceae 
Parts used   -  Roots, leaves 
Suvai -  Kaippu, Thanmai -  Veppam, Pirivu – kaarpu 
Therapeutic action – Anti stress, anti oxidant, anti stress adaptogen.  
Cyclo oxygenase inhibition and hence reduces synthesis of 
prostaglandins – mediators of inflamation – Anti inflammatory. 
Increases the activities of anti oxidant enzymes superoxide 
dismutase. 
Chemical constituents –  somniferin, anaferinge, Withanolide. 
nghJFzk; 
 nfhQ;re; Jth;g;ghq; nfhbafgk; #iyahp 
 kpQ;Rfug; ghd;ghz;L ntg;gjg;G - tpQ;rp 
 KfTW NjhlKk;Ngh Nkhfk; md Yz;lhk; 
 mRfe; jpfnfd; wwp 
  -mfj;jpah; Fzthflk; 
 nfhba fgk;> #iy> fug;ghd;> ghz;L> Ruk;> tPf;fk;> Njhlk; ePq;Fk; 
 Therapeutic uses – In Rheumatism decoction of the root is used 
internally.  Increase Red Blood Cell count, white blood cell count and 
platelet count in blood. Enhances the immune cells. 
 
jpg;gpyp 
English Name   –  long pepper 
Botanical Name   –  Piper longum 
Family    –  piperaceae 
Parts used    –  Fruits 
Suvai – kaarpu, Thanmai – Veppam, Pirivu – Inippu 
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Therapeutic action  – Analgesic, Anti inflmmatory 
Chemical consitutents - piperome, piopernonaline. 
nghJFzk; 
jpg;gpypapd; wz;LtQ; rpNyj;kj;ijg; Nghf;fptpLk; 
cg;gprj;ij Nkfj;ij xl;Lq;fhz; - jg;ghky; 
thj Rue;jzpf;Fk; khfgNuh fe;njhiyf;Fk; 
jhJit tsh;gpf;FQ; rhw;W. 
- mfj;;jpah; Fzthflk; 
cg;Grk;> Nkfk;> thjRuk; ,tw;iw Nghf;Fk; jhJit tsh;f;Fk;. 
  
Therapeutic uses 
 Used as a counter irritant and analgesic for muscular pain & 
inflammation. 
Xkk; 
 English Name  –  Bishops weed 
 Botanical Name  –  Trachyspermum amni 
 Family   –  umbelliferae 
 Parts used   –  seeds 
 Suvai   –  Kaarpu, Thanmai – veppam, Pirivu – Kaarpu 
 Therapeutic action – antispasmodic, stimulant, tonic 
 Inhibits  arachidonic acid and collagen induced platelet aggregation  
Chemical consituents – Thymol  
nghJFzk; 
    rPjRuq; fhrQ; nrhpahke; jk;nghUky; 
 Ngjpapiur; ry;fLg;G Nguhkk; - xjpUky; 
 gy;nyhLgy; %yk; gfkpitNeh nad; nrANkh? 
 nrhy;nyhLNghk; xknkdr; nrhy;. 
- mfj;jpah; Fzthflk; 
 IaRuk;> ,Uky;> nrhpahke;jk;> nghUky; NghFk;. 
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Therapeutic Uses 
 Xk Nyfpaj;jpdhy; thA jPUk;. 
 
jpg;gpyp %yk; 
English Name  –  Long pepper - Root 
Botanical Name  –  Piper longum 
Family   –  Piperaceae  
Parts used   –  Roots 
Suvai – Kaarpu, Thanmai – veppam, Pirivu – Kaarpu 
Therapeutic action –  Anti inflammatory, analgesic 
Chemical constituent – piperome, poperundecalidine 
nghJFzk; 
 jhfgpj;jQ; Nrhfe; jzpahr; RukpUky; 
 Nkfq; Fuy;fk;ky; nka;f;fLg;Gk; - VFq;fhz; 
 jpg;gpyp% yq;fz;lj; jpg;gpypa jhk;eWf;Fj; 
 jpg;gpypnad; NwnahUf;fhw; nrg;G. 
- mfj;jpah; Fzthflk; 
,jdhy; Ruk;> ,Uky;> jhfk;> Nkfk;> Fuw;fk;ky;> nka;fLg;G NghFk;. 
Therapeutic Uses  : Used as counter irritant and analgesic for muscular  
     pain and inflammation. 
 
fLf;fha; 
English Name  –  Ink Fruit 
Botanical Name  –  Terminalia chebula 
Family   –  Combretaceae  
Parts used   –  unripe fruit,  
Suvai – Thuvarpu, inippu, pulippu, kaippu, kaaripu Thanmai – veppam, 
Pirivu – Inippu 
Therapeutic action – Laxative, Stomachic, Anti inflammatory 
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Chemical constituents - Chebulagic acid, chebulinic acid, Tannin.  
Chebulin possesss anstispasmadic activity similar to that of  papaverine. 
Hyaluronidase and collagenase inhibitor prevented degradation of 
cartilage. 
Anti lipoxygenase, anti superoxide radical formation, free radical 
scavenging activities.restore anti oxidant enzyme superoxide 
dismutase from the radiation induced damage. 
 
nghJFzk; 
 jhil fOj;jf;fp jhY Fwpaptplg; 
 gPil rpypgjKw; NgjpKlk; - Milnal;lhj; 
 J}ykb Gz;thj Nrhzpfh khiy apuz; 
 lhykpb Nghk;thpf;fh ahy;. 
- Fzghlk; - %ypif tFg;G 
 fd;dk;> fOj;J> eh> Mz;Fwp> ,t;tpl Neha;fs; fhybg;Gw;WNeha;> 
thj Nrhzpjk;; Nghk;. 
 
Therapeutic uses : fLf;fha; #uzk; thj Neha;fSf;fhd kUe;Jfspy; 
Nrh;f;fg;gLfpd;wJ. 
ney;yptw;wy; 
English Name  –  Indian gooseberry 
Botainical Name  –  Phyllanthus emblica 
Family   -  Euphorbiaceae 
Parts used   –  dried fruit 
Suvai – Pullipu, Thuvarppu, Inippu  Thanmai – Thatpam   Pirivu – Inippu 
Therapeutic action – Anti inflammatory, Detoxifier, Enhances immune 
function.Anti oxidant –gallic acid,Increases superoxidase dismutase 
activity. 
Chemical constituents – gallic acid, ellageic acid, covilagin phyllembic acid 
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nghJFzk; 
 Mftd yQ;rrpm rph;f;nfd;G Uf;fpfz;Nzha; 
 Jhf Kjpugpj;je; jhJ e\;lk; - Nkfdj;jpd; 
 ,y;ypKs;sp NghyUfy; vz;fh kpatpaq;fk; 
 ney;ypKs;sp ahw;Ngh epid 
 - Njud; 
 cl;#L> vYk;GUf;fp Neha;> FUjpaoy;Neha;> Mfpad tpyFk;. 
Therapeutic uses 
 ney;ypKs;sp Nyfpaj;jhy; jpkph; thA Nghk;. 
 
gwq;fpg;gl;il 
English Name  –  China Root, Bamboo briar root 
Botainical Name –  Smilax china 
Family   –  Liliaeceae 
Parts used   –  rhizomes 
Suvai – inippu, Thanmai – thatpam, Pirivu – inippu 
Therapeutic action –  Anti inflammatory, Immune enhancer. 
Enhance the  circulating level of corticosteroids by slowing their 
metabolism, this will not only increase the natural cortico steroids but also 
any steroids administered as drugs. Facilitate absorbtion of drugs and 
phytochemicals by the body. 
Chemical constituents – Tannin, sarasapogenin, Sarsasaponin. 
 nghJFzk; : 
 jhfk; gythje; jhJ el;lk; Gz;gpsit 
 Nkfq; fbfpue;jp tPo;Kye; - NjfKld; 
 Fl;il gfe;jNkw; nfhs;tkdk; Nghk;gwq;fpg; 
 gl;ilapid Ar;rhpj;Jg; ghh;. 
  - Njud; 
 ,jdhy; gw;gy tspNeha;fs;> Klf;Fthjk;> the;jp ,it ePq;Fk;. 
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 Therapeutic uses – They are used in vitited conditions of vatham 
and used from centuries for rheumatism. 
 rhuk; nfl;bUf;Fk; NghJk;> Njhy; gpzpf;fg;gl;bUf;Fk; NghJk;> 
guq;fpg;gl;il Nrh;e;j kUe;Jfis toq;fyhk;. 
 
ePh;;ntl;bKj;J 
English Name  –  Chaulmugra  
Botanical Name  –  Hydnocarpus laurifolia 
Family   –  Flacourtiaceae 
Parts used   –  seed 
Suvai – karppu, Thanmai – veppam, Pirivu – karppu 
Therapeutic action – Alterative, stimulant, parasiticide 
Chemical constituents – ethyl hydno corpate, no cyano genetic glycosides  
nghJFzk; 
 ePub Kj;jpw;F ePq;fhf; fpue;jpFl;lk; 
 NghhpL thjKNk NghFq;fhz; - fhuLf;Fk; 
 nkd;Foyha;! gpj;jk; kpFkdyk; cz;lhFk; 
 Kd;fpsh; e ikr;ryW Kd;. 
 - mfj;jpah; Fzthflk; 
 
 ,jdhy;; thjNuhfk;> Njhiyg;gw;wp tUk; nrhwp rpuq;F ePq;Fk; 
 
Therapeutic uses 
 Seed is used in leprosy skin infections  and ophthalmia. It has 
antimicrobial action against mycobacterium leprae, mycobacteruium 
tuberculi.  
nre;ePh; nfl;bUf;ifapy; ePubKj;J rk;ge;jkhd kUe;Jfis 
nfhLf;f Ntz;Lk;. 
jhd;wpf;fha; 
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English Name  –  Belleric myrobalan 
Botanical Name  –  Terminalia bellerica 
Family   –  Combretaceae 
Parts used   –  Unripe fruit 
Suvai – Thuvarppu, Thanmai – veppam, Pirivu – inippu 
Therapeutic action –  Anti inflammatory 
Chemical constituents – β sitosterol, gallic acid, ellagic acid, galloyl 
glucose, chebulagic acid, bellericanin 
nghJFzk;:  
 Mzpg;nghd; Nkdpf; foFk; xspAkpFk; 
 Nfhzpf;nfhs; thjgpj;jf;nfhs;ifNghk; - jhdpf;fha; 
 nfhz;lth;f;F NkfkWk; $wh mdw;wzpAk; 
 fz;lth;f;F thjk;Nghk; fhz; 
 - Fzghlk; %ypif tFg;G 
 ,J clw;F moifAk;> xspiaAk; nfhLj;J tsp> jP Fw;wq;fshy; 
tUk; Neha;fis Nghf;Fk;. mdy; jzpAk;> thjNeha;fs; NghFk;. 
Therapeutic uses :  jhd;wpf;fha; #uzk; thj Neha;fspy; 
gad;glj;jg;gLfpd;wJ 
rhjpf;fha; 
 English Name  –  Nut meg 
 Botanical Name  –  Myristica fragrans 
 Family   – myristicaceae 
Parts used   –  dried fruit 
Suvai  – Thuvarppu, kaippu, Thanmai – Veppam, Pirivu – kaarppu 
Therapeutic action – Anti inflammatory, anti microbial, narcotic,  aromatic, 
Anti thrombotic. 
 Chemical constituents – myristicin, methyl eugenol, elemicin 
nghJFzk; 
 jhJ el;lk; Ngjp rUthrp aQ;rpu Neha; 
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 xJRth rq;fhrk; cl;fpuzp – NtNjh 
 byf;fha; tUk;gpzpNghk; Vw;wkay; gpj;jq; 
 Fyf;fh aUe;Jth;f;Ff; $W 
- Fzghlk; %ypif tFg;G 
 ,jdhy; thAtpdhy; cz;lhFk; Neha;> ntg;gj;jpid Kd;dpl;L 
tUk; gpzpfs; ,itfs; NghFk;. 
Therapeutic uses 
rhjpffha; ijyk; - 1.5Jsp> thjg;gpzp> fPy;thAitg; Nghf;Fk;  
rhjpf;fha; nghb- 3.6 Fd;wp thjtyp NghFk;. Used in rheumatism 
rhjpg;gj;jphp 
English Name  –  Mace (Arillus of the nut)  
Botainical Name  –  Myristica fragrans 
Family   –  Myristicaceae 
Parts used   –  mace, arills 
Suvai  – kaarpu, thuvarpu, Thanmai – veppam, Pirivu – kaarpu 
Therapeutic action – aphrodisiac, carminative, stimulant, hyphotic 
Chemical constituents – lignans, fragransol a,b, myristicin,  
nghJFzk; 
 rhjpjUk; gj;jphpf;Fj; jhgr; Rue;jzpAk; 
 XJfpd;w gpj;jk; caUq;fhz;- jhJtph;j;jp 
 Az;lhq; fpufzpNah Nlhjf; fopr;ryWk; 
 gz;lhq; FiwNa gfh;. 
- mfj;jpah; Fzthflk; 
 ,J clw;fl;Lfis tYf;fr; nra;Ak;.  
Therpeutic uses 
 Mace is used in rheumatism and in collagen induced pulmonary 
thrombo embolism. 
 
fpuhk;G 
English Name  –  cloves 
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Botanical Name  –  Syzygium aromaticum (Eugenia cayophyllus) 
Family  –  Myrtaceae 
Parts used   –  dried buds 
Suvai – kaaram, Thanmai – veppam, Pirivu – kaarppu 
Therapeutic action – Anti spasmodic, aromatic, anti viral, Inhibitor of 
platelet aggregation, anti thrombotic.  
Chemical constituents – Eugenol, Farnesol, campestrol. 
 
nghJFzk; 
 gpj;jkaf;fk; NgjpNahL the;jpAk; Nghk; 
 Rj;jtpu  jf;fLg;Ge; Njhd;WNkh - nkj;j 
 ,ytq;fq; nfhz;ltUf; Nfw;RfkhFk; 
 kykq;Nf fl;Lnkd tho;j;J 
  - mfj;jpah; Fzthflk; 
 kaf;fk;. Ngjp> the;jp> FUjpf; fopr;ry;> ehl;gl;l fopr;ry; ePq;Fk;. 
Therpeutic uses 
 gpj;jrhe;jp nghUl;Lr; nra;ag;gLfpw kUe;Jfspy; fpuhk;G NrUk;. 
 
Honey (Njd;) 
 Honey is a saccharine substance deposited by the hive bee, 
Apis mellifera in the cells of the honey comb. The best honey is  
that derived from flowers such as clover and heather. 
Chemical constituents – Invert sugar, sucrose, dextrin, formic acid. 
Therapeutic action – Demulcent, laxative, anti septic, stomachic. 
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nghJFzk; 
MASl Dl;bzk Nuhrp aff;fgK 
Nka toFk; tsh;e;jpLq;fhz; - Jha 
Kjpa nkDtjd khjuNr ehSk; 
Gjpa eWe;Njdhw; Gfy; 
- Fzghlk; [pt tFg;G 
 
Njdpdhy; epiwe;j MASk;> cly; ntg;gKk;> xspAk; cz;lhFk; 
Therapeutic uses 
 Njd; xU rpwe;j Jiz kUe;jhFk;. ,‡J mDghdg; 
nghUshtjd;wp mtpo;jg; nghUSkhfp Njfj;ij ed;dpiyapy; itj;J 
thj Kjypa Kf;Fw;wq;fisAk; Nghf;Ffpd;wJ. 
 
mh;f;fhjp ijyk; 
NrUk; ruf;Ffs; 
Kjpahh; $e;jy; ,iy 
Mkzf;F ,iy 
Kjph; khtpyq;F ,iy 
vUf;fpiy 
nehr;rpapiy 
rJuf;fs;sp 
,iyf;fs;sp ,iy 
cj;jhkzp ,iy 
jKjhioapiy 
mRtfe;jp ,iy 
MlhNjhil ,iy 
nghLjiy 
vs; nea; 
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nra;Kiw 
 Nkw;fz;l ,iyia rhp gq;fhf vLj;J ,bj;J miuj;J 
vz;nza;apy; fye;J fha;r;rp gjj;jpy; ,wf;fp vLj;Jf; nfhs;sTk; 
gpuNahfk;  :  ntspg;gpuNahfk; 
jPUk; Neha;fs; :  thj Neha;fs;> vYk;G KwpT 
MAl;fhyk;  : xU tUlk; 
MjhuE}y;: ruNge;ju itj;jpa Kiwfs; - thjNuhf rpfpr;ir (gf;fk; - 13) 
 
Kjpahh; $e;jy; ,iy 
English Name –  Hastata 
Botainical Name  –  Merremia tridentata 
Family   – Convolvulaceae 
Parts used   –  Leaf 
Suvai – kaippu, Thanmai – thatpam, Pirivu – kaarppu 
Therapeutic action – Astringent, alterative, stomachic. 
Chemical constituents – luteolin, diosmetin, luteolin. 
nghJFzk; 
 ,Lg;Gtyp thj kpTw;Nwh…….  
- mfj;jpah; Fzthflk;  
,jdhy; ,Lg;Gtyp> thjk;> Nkfk; NghFk;. 
Therapeutic uses : Used in Rheumatoid arthritis.  
 
Mkzf;F ,iy 
English Name  –  Castor 
Botanical Name  –  Ricinus communis 
Family   –  Euphorbiaceae 
Parts used   –  leaf 
Suvai – kaippu, Thanmai – veppam, Pirivu – kaarppu 
Therapeutic action – antivatha, galactogogue, Anti inflammatory 
Chemical constituents – ricininne,  β sistosterol, quercetin. 
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nghJFzk; 
‘thjj; njhlf;if tunthl;lh kw;gbf;Ff;’ 
- Njud; ntz;gh 
 thj Njhlj;ij Nghf;Fk; 
 
Therapeutic  uses 
 ,itfis rpWf eWf;fp rpw;whkzf;F tpl;L tjf;fp #l;Lld; 
typAld; $ba fPy;tha;TfSf;Fk;> tPf;fq;fSf;Fk; xw;wlkplyhk;. 
 
Kjph;khtpyq;F ,iy 
English Name  –  Three leaved caper 
Botainical Name  –  Crataeva magna 
Family   –  Capparaceae 
Parts used   –  leaf 
Suvai    –  kaippu, Thanmai – veppam, Pirivu – kaarpu 
Therapeutic action –  Anti inflammatory 
Chemical constituents – Friedelin lupeol, betulinic acid, diosgenin 
nghJFzk; 
 #uq;fbapd; Nwhle; njhiyahj thjk; 
 cuk;ngW tplq;f nyhopAk; 
- mfj;jpah; Fzthflk; 
 ,jdhy;> jPuhj tsp Neha;fSk; Nghk;. 
Therapeutic uses 
 ,iyia miuj;Jg; gw;wpl tPf;fq; fiuAk;. ,iyia miuj;J 
cs;sq;fhypy; gw;wpl typ> tPf;fk; vhpr;ry; ePq;Fk;. 
vUf;fpiy 
English Name  –  Mudar 
Botanical Name  –  Calotropis gigantea 
Family   –  ascelpiadaceae 
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Parts used   –  leaf 
Suvai – kaippu, kaarppu, Thanmai – veppam, Pirivu – kaarppu 
Therapeutic action –  Anti inflammatory, analgesic 
Chemical constituents – caoutchouc, asclepin, gigantin, mudarine 
nghJFzk; 
 typ#iy thAtpl ke;jk; - kyge;jk; 
 vy;yh kfY nkUf;fpiy iaf;fz;lhy; 
 - mfj;jpah; Fzthflk; 
vUf;fpiyahy;> Itiftyp> tPf;fk;> fPy;tPf;fk;> tsp> mf;fpdpke;jk; Nghk;. 
Therapeutic uses 
 ,iyfis xd;wd;kPJ xd;W ,Uf;Fk;gb mLf;fpr; RUl;b xU 
Gwj;ij xOq;Fgb mWj;Jj; js;sp Ntg;ngz;nziaf; fhaitj;J 
Jitj;J xw;wlkpl> Iaj;jhYk;> typahYk; gpwe;j Neha;fSk;> ,rpTfSk; 
Nghk;. 
nehr;rpapiy 
English Name  –  Five leaved chaste tree 
Botanical Name  –  Vitex negundo 
Family   –  Verbanaeceae 
Parts used   –  leaf 
Suvai – kaippu, Thuvarppu, Thanmai – veppam, Pirivu – kaarppu 
Therapeutic action  – Anti inflammatory, Analgesic 
Chemical constituents –  Eurostoside, aucubin, monoterpenes agnuside. 
 
nghJFzk; 
 te;jKjy; ez;ghfp thjj;ij NaAwthw; 
 rpe;Jth uq;fdYe; jP 
  - Njud;.ntz;gh 
 ,jdhy; thj Neha;fs; NghFk;. 
 
 126
Therapeutic uses 
 ,iyia tjf;fp xw;wlkpl tPf;fk;> fPy;thA jPUk;. 
 ,iyia Ntfitj;J ePuhtp gpbf;f tspf;Fw;wj;jhy; cz;lhd 
cly;typ Nghk;. 
rJuf;fs;sp (tr;rpuk;) 
English Name  –  Quadrangular spurage 
Botanical Name –  Euphorbia antiquoraum 
Family   –  Euphorbiaceae 
Parts used   –  Latex 
Suvai – kaarppu, Thanmai – veppam, Pirivu – kaarppu 
Therapeutic action –  Anti inflammatory, deobstruent. 
Chemical constituents – caoutchoue, antiquorin, mortenone  
nghJFzk; 
 ‘Fl;lq; fb#iy Fd;kNk fk;thA’ 
- mfj;jpah; Fzthflk; 
,J #iy> tspFd;kk;> tspNeha; ,itfis Nghf;Fk;. 
Therapeutic uses 
 %l;L tPf;fj;jpw;F ,jd; ghiyj; jltp Nth; kz;iz mjd; kPJ 
jlTtJ tof;fk;. 
Juice of the plant is used as an irritant in rheumotisin  
,iyfs;sp ,iy 
English Name  –  Common milk hedge 
Botanical Name  –  Euphorbia nerifolia 
Family   –  Euphorbiaceae 
Parts used   –  Leaf 
Suvai  – Kaippu, Thanmai – veppam, Pirivu – kaarppu 
Therapeutic action – Anti inflammatory, Deobstruent 
Chemical constituents –  Caoutachouc, euphol, taraxerol 
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nghJFzk; 
 nra;afug;ghd; nrtpNeha;th jk;Nghf;Fk; 
 igatUQ; #iyjidg; ghohf;F  
- mfj;jpah; Fzthflk; 
 ,jdhy; #iy> thjk;> fpue;jp> Gz; ,it NghFk;. 
Therapeutic uses - used in rheumatism 
 
cj;jhkzp ,iy 
English Name   –  Dog’s bane whitelow plant 
Botanical Name   –  pergularia daemia 
Family    –  Asclepiadaceae 
Parts used   –  leaf 
Suvai – Kaippu, Thanmai – veppam, Pirivu – kaarppu 
Therapeutic action –Anti inflammatory  
Chemical constituents –   
 Betaine, hentriacontane, lupeol 
nghJFzk; 
 fz;bf;Fk; thjq; fLQ;rd;dp NjhlKk; Nghk; 
- mfj;jpah; Fzthflk; 
 ,jdhy; thjk;> rd;dp Njhlk; Nghk; 
Therapeutic uses 
,jd; rhw;iwAQ; Rz;zhk;igAq; fye;J fhy; tPf;fq;fl;Fk; Nghlyhk;. 
jOjhio ,iy 
English Name  –  wind killer 
Botanical Name –  clerodendrum phlomoidis 
Family   –  Verbaneaceae 
Parts used   –  leaf 
Suvai – Thuvarppu, Thanmai – veppam, Pirivu – kaarppu 
Therapeutic action – Anti inflammatory, Astringent 
Chemical constituents –  Phlomoidin 
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nghJFzk; 
 thjg; gpbg;ngd;w tw;fhyp iag;Gyp Nghw; 
 Nghjg; gpbf;Fk; Gytw;Nwh – fhj 
- mfj;jpah; Fzthflk; 
 
 thjg;gpbg;G> gPeprk; Kjypatw;iw Nghf;Fk;. 
Therapeutic uses 
 ,iyia ePhpy; Nrh;j;J fha;r;rp typAs;s ,lq;fis fOtyhk;. 
   
rPik mRtfe;jp ,iy 
English Name  –  winter chrry 
Botanical Name –  Withania somnifera 
Family   –  solanaceae 
Parts used   –  leaf 
Suvai – Kaippu, Thanmai – veppam, Pirivu – kaarppu 
Therapeutic action –Anti inflammatory 
Chemical constituents –  Withasomine, cuscohygrine, anahygrine,  
withaferin A 
 
nghJFzk; 
 nfhQ;re; Jth;g;ghq; nfhbafak; #iyahp 
- mfj;jpah; Fzthflk; 
nfhba fak;> #iy Kjypatw;iw ePf;Fk; 
Therapeutic uses :  
 ,iyia miuj;J Nkff;fl;b NehAld; $ba tPf;fk;> 
Gz; ,itfl;Fk; G+ryhk;. 
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MlhNjhil ,iy 
English Name  –  Malabar nut 
Botanical Name –   Adhatoda vasica  
Family   –  Acanthaceae 
Parts used   – leaf 
Suvai – Kaippu, Thanmai – veppam, Pirivu – kaarppu 
Therapeutic action – Antispasmodic, Anti inflammatory 
Chemical constituents –  adha vasinoune, vasicine, adhatodine,  
 
nghJFzk; 
 #lhFk; jhgRuk; gpj;jfg thj 
  muNuhfQ; re;jpd; jQ;#iy Fl;lk; 
 - Fzghlk; %ypif tFg;G 
 tsp> Ia Fw;wq;fspd; ngUf;if mWf;Fk;. thjNjhlk;> the;jp 
tp;f;fy;> #iy mz;lthA ,tw;iw Nghf;Fk;. 
Therapeutic uses 
 xU gq;F ,iyf;F vl;L gq;F ePh; Nrh;j;J vl;by; xd;whff; FWf;fp 
tbfl;ba FbePiur; rPiyapw; Neha;j;J xw;wlkpl tPf;fk;> #iy> fPy;gpbg;G 
jzpAk;. 
 
nghLjiy 
English Name  –  purple lippia 
Botanical Name –  phyla nodiflora 
Family   –  Verbanaceae 
Parts used  –  leaf 
Suvai – Kaippu, Thanmai – veppam, Pirivu – kaarppu 
Therapeutic action – Deobstruent, Anti inflammatory 
Chemical constituents –  Nodifloridin, nodifloretin 
 130
nghJFzk; 
 NgjpnahL #iyNeha; Ngrhpa ntz;Nkfk; 
 thjKk;Ngh nka;Auf;Fk; tho;j;J. 
- Fzghlk; %ypif tFg;G 
 
,jdhy; #iyNeha;> tsp Neha; Nghk;. 
Therapeutic uses 
,iyia miuj;J tPf;fj;jpd; kPJ G+ryhk;. 
 
vs;nea; 
English Name  –  Gingilee oil 
Botanical Name  –  Sesamum indicum 
Family   –  Pedaliaceae 
Suvai – Inippu, Thanmai – veppam, Pirivu – Inippu 
Therapeutic action – Demulcent, analgesic 
Chemical constituents –  Seasamin, sesamolin, phytosterol, vitamin E 
nghJFzk; 
 gj;jpeaf; Fsph;r;rp g+hpg;G nka;GsgQ; 
rj;Jtq; fe;jp jzpapsik nkj;jTz;lhq;  
fz;Nzha; nrtpNeha; fghy toy; fhrNeha; 
Gz;Nzha; Ngh nkz;nza;ahw; Nghw;W 
 - mfj;jpah; Fzthflk; 
 
fz; Fsph;r;rp cz;lhFk;> moy; Neha; jPUk; 
 
Therapeutic uses : It is used  due to its cooling effect and used as a 
medium for absorbtion of the constituents present in the medicated oil to 
get absorbed in the body. 
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Annexure - II 
Govt. Siddha Medical College, Palayamkottai . 
Bio- Chemical Analysis of Mega soolai veekathakku chooranam 
 
Preparation of the extract 
 5 gms of Choornam was weighed accurately and placed in a 
250ml beaker. Then 50 ml distilled water is added and dissolved 
well. Then it is boiled well for about 10 minutes. It was cooled and 
filtered in a 100ml volumetric flask and then it is made up to 100 
ml with distilled water. This fluid is taken for analysis. 
 
Qualitative analysis: 
S.No  Experiment Observation Inference 
1. 
Test for Calcium 
2ml of the above prepared 
extract is taken in a clean test 
tube. 2 ml of 4% Ammonium 
oxlate solution is added to it 
No white 
precipitate is 
formed 
Absence of 
Calcium 
2. 
Test for Sulphate 
2ml of the extract is added to 
5% barium chloride solution 
white 
precipitate is 
formed 
Presence of 
Sulphate 
3. 
Test For Chloride 
The extract is treated with 
silver nitrate solution 
No    White 
precipitate is 
formed 
Absence of 
chloride 
4. 
Test for Carbonate 
The substance is treated with 
concentrated HCL. 
No brisk 
effervescence is 
formed 
Absence of 
Carbonate 
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5. 
Test for Starch 
The extract is added with 
weak iodine solution 
 
No blue 
colour is 
formed  
 Absence of Starch 
6. 
Test for Iron 
Ferric: the extract is treated 
with glacial acid and 
potassium Ferro cyanide 
 
No blue 
colour is  
formed 
Absence of 
Ferric iron.  
7. 
Test for Iron Ferrous 
The extract is treated with 
concentrated Nitirc acid and 
ammonium thio cyanide 
 
Blood red 
colour is 
formed 
 
Indicates the 
presence of 
Ferrous  
8. 
Test for Phosphate 
The extract is treated with 
ammonium Molybdate and 
concentrated nitric acid 
 
No yellow 
precipitate 
formed 
is Absence of Phosphate 
9. 
Test for Albumin 
The extract is treated with 
Esbach's regent 
 
No yellow 
precipitate 
formed 
is 
Absence of 
Albumin 
 
10 
Test for Tannic Acid 
The extract is treated with 
ferric chloride 
 
Blue black 
precipitate is 
formed  
Indictes the 
Presence of 
Tannic Acid 
11. 
Test for unsaturation 
Potassium permanganate 
solution is added to the 
extract 
 It gets decolorized  
Indictes the 
Presence of 
unsaturated 
compound 
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12. Test for the Reducing Colour 
change 
occurs 
 
 
Indicated the 
presence of 
reducing sugar 
 Sugar 
 5 ml of Benedict's qualitative 
 solution is taken in a test 
 tube and allowed to boil for 2 
 mts and added 8-10 drops of 
 the extract and again boil it 
 for 2 minutes  
13. Test for Amino Acid No Violet 
colour is 
formed 
 
 
Indicated the , 
 One or two drops of the absence of 
 extract is placed on a filter Amino Acid 
 paper and dried it well after  
 drying 1% Ninhydrin is  
 sprayed over the same and  
 dried it well  
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ANNEXURE III 
PHARMACOLOGICAL ANALYSIS  
ANALGESIC ACTION OF 
MEGA SOOLAI VEEKATHUKKU CHOORANAM  
 
Introduction 
 According to siddha medicine the Mega soolai veekathukku 
chooranam   is indicated in vatha diseases. From this indication 
the drug  Mega soolai veekathukku chooranam might possess 
analgesic activity. 
 
Aim 
 To study the analgesic effect of  Mega soolai veekathukku 
chooranam on albino rats by tail flick method 
 
Materials and Methods 
Preparation of the test drug l00mg of  Mega soolai veekathukku 
chooranam was suspended in 10 ml of water as suspending agent. 
This 1 ml contained lOOmg of the test drug. 
 
Equipement 
 Hot water bath 
Procedure 
 Six male albino rats (weighing 80 -lOOgms) were used in 
three groups. The animals were allowed to free access to food and 
water until they brought for the experiment. The animals which 
showed the positive response to the stimulus within a given time 
were selected for the study. 
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 After the selection of animals which were responding to 
stimulus within 2 seconds, they were divides in to 3 groups, each 
group consisting of two rats. 
 
 The hot water was maintained at 55°C. The tip of the tail was 
immersed into the water bath and the time was noted when the rat 
flicked the tail. 
 
 First group was administered with Mega Soolai Veekathukku 
chooranam at a dose of l00mg / 100 gm body weight of the animal. 
 
 Second group was administered with paracetamol at a dose of 
20mg /lOOgm of body weight. Third group was given to the 1 ml of 
water and kept as control. 
 
 After the drug administration, the reaction time of each rat 
after half an hour and one hour were noted in each group (when a 
rat fails to flick the tail, it should not be continued beyond 8 
seconds to avoid injury) and the average was calculated. 
 
 The results of control group, standard group and drug treated 
group were tabulated and compared. 
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Results 
Effect of  Mega soolai veekathukku chooranam 
Serial 
No 
Name of the 
drugs / 
Groups 
Dose / 
100 gram 
body 
weight 
Initial 
reading 
After drug Administration 
Mean 
difference 
Remarks ½  hr. 
Average 
1 hr 
Average 
1 ½  hr 
Average 
1 
Mega soolai 
veekathukku 
chooranam 
100 mg 2.5secs 2.5secs 4.0secs 5.0secs 5.0secs Significant 
2. Paracetamol 20mg 2secs 3.0secs 4.5secs 6.5secs 6.5secs  
3. Water 2ml 2secs 2.5secs 2.5secs 2.5secs 2.5secs  
 
Inference 
 From the above tabulation it is noted that Mega soolai veekathukku chooranam has 
significant analgesic action. 
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ANTI - PYRETIC STUDY ON 
MEGA SOOLAI VEEKATHUKKU CHOORANAM 
 
Aim 
 To study the anti-pyretic activity of the Mega soolai 
veekathukku chooranam 
 
Procedure 
 Three groups of healthy albino rats were taken, each weight 
about 100 - 200 gm and divided into three groups, each group 
consists of two rats . All the rats were made hyperthermic by 
subcutaneous injection of 12% suspension of yeast at a dose of 
l00gm/100ml of body weight. 
 
 10 hours later one group of rats were given the test drug 
Mega soolai veekathukku chooranam at a dose of 200mg/ 
lOOgmofbody weight. The other group received distilled water at a 
dose of 2ml / rat and kept as control. The last group was given 
paracetamol at a dose of 20mg / lOOgm of body weight and kept as 
standard. 
 
 The mean rectal temperature for 3 groups was recorded at 0 
hour, 1½ hours, 3 hours, and 4½ hours after the drug 
administration. The difference between the mean temperature of 
the control group, standard and the test drug were noted and 
compared. 
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Effect of Mega soolai veekathukku chooranam 
 
Serial 
No 
Name of the 
drugs / Groups 
Dose / 
100 gram 
body 
weight 
Initial 
temperature 
in Centigrade 
After drug Administration 
Mean 
difference 
Remarks 1½   hr. 
Average 
3.0 hr 
Average 
4½ hr 
Average 
1 
Mega soolai 
veekathukku 
chooranam 
 
100 mg  
38.0 
38.0 
37.5 
37.5 
37.0 
37.0 
36.0 
36.0 
36.0 Significant 
2. Paracetamol 
       
20mg 
37.0 
38.0 
 
37.0 
37.0 
36.5 
36.5 
35.0 
34.0 
34.5  
3. Water 1ml 
36.0 
37.0 
36.0 
37.0 
 
36.0 
38.0 
37.0 
39.0 
 
38.0 
 
 
 
Inference 
 The test drug Mega soolai veekathukku chooranam  has significant antipyretic action 
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ACUTE ANTI - INFLAMMATORY STUDIES ON  
MEGA SOOLAI VEEKATHUKKU CHOORANAM 
Aim 
 To study the acute anti - inflammatory effect on Mega soolai 
veekathukku chooranam 
 
Method: 
The acute anti - inflammatory activity of Mega soolai 
veekathukku chooranam was screened by rat Hind paw oedema 
method. 
 
Preparation of the test drug 
 200 mg of Mega soolai veekathukku chooranam was 
suspended in 10 ml of water. From the above test drug 1ml was 
administered orally and this 1ml contain lOOmg Mega Soolai 
veekathukku chooranam. 
 
Procedure 
 The anti-inflammatory activity of Mega soolai veekathukku 
chooranam was studied in healthy Albino rats weighing 100 - 150 
gms . Six rats were selected and divided into three groups, each 
containing three rats. The first group was given distilled water 1ml, 
internally and was kept as control. The second group was given the 
test drug at a dose of lOOmg/ lOOgms, body weight. The third 
group was given ibubrufen at a dose of 20mg / lOOg body weight. 
 
 Before administration of the drug, the hind paw volume of all 
rats were measured by dipping the hind paw upto the tibiodorsal 
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junction in a mercury plethysmograph. Soon after measurement, 
the drug was administration internally 
 
 An hour after adminstration of the drugs a subcutaneous 
injection of 0.1 ml . Of 1% W/V of carrageenin in water was 
injected in the plantar surface of both the hind-paw and volume 
was measured once again. The difference between the initial and 
final volumes would show the amount of inflammation. Taking the 
volume in the control group as 100% of inflammation, the 
inflammation or anti-inflammatory effect of the drug was 
calculated. Tabulations of the results were recorded. 
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Results 
Effect of Mega soolai veekathukku chooranam 
 
Serial 
no 
Name of drug 
/ groups 
Dose 
100 
gram 
body 
weight 
Initial 
reading 
average 
Final 
reading 
average 
Mean 
difference 
Percentage 
Inflammation 
Percentage 
Inhibition 
Remarks 
1. 
Mega soolai 
veekathukku 
chooranam 
100mg  0.65 0.97 0.32 37.6 62.4 significant 
2. Ibu brufen 20mg 0.55 0.85 0.3 35.2 64.8  
3. Water 1ml 0.55 1.4 0.85 100.0 -  
 
Inference 
From the above experiment it is observed that the test drug Mega soolai veekathukku chooranam 
Significant acute anti inflammatory action. 
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CHRONIC ANTI INFLAMMATORY STUDY BY COTTON - 
PELLETS GRANULOMA METHOD 
 
Aim 
 To study the chronic anti inflammatory activity of the drug in 
albino rats by cotton pellets implantation (granuloma) method. 
 
Procedure 
 Cotton pellets each weighing lOmg were prepared and 
sterlised in an autoclave for about one hour under 15 lbs 
atmosphere pressure. Six albino rats each weighing between 100 -
200gms were selected and were divided into 3 groups . Each rat 
was anaesthetized with ether and cotton pellets were implanted 
subcutaneously in the groin, two in each side. 
 
 From the day of implantation, one group of animals received 
Mega soolai veekathukku chooranam at a dose of 200mg of body 
weight. Another group of animals were received distilled water. Last 
group was given ibubrufen at dose of 20mg/ lOOgm body weight. 
 
 On the eighth day the rats were sacrificed and the pellets 
were removed weighed. Then they were put in a incubator at 60°C -
80°C and then weighed. 
 The concordant weight was noted for all groups and 
compared. 
 The effect of Mega soolai veekathukku chooranam in chronic 
anti inflammatory study. 
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Results 
Effect of Mega soolai veekathukku chooranam 
Serial 
No 
Name of drug / 
Groups 
Dose/100 
gram 
body 
weight 
Pellet 
weight 
 
Granuloma 
of drugs 
Mean 
difference 
Percentage 
Inflammation 
Percentage 
Inhibition 
Remarks 
1. 
Mega soolai 
veekathukku 
chooranam 
lOOmg / 
1ml 
lOmg 100mg - 50 50 Moderate 
2. I brufen 
20mg / 
1ml 
10 mg 55 mg - 22 78  
3. Water 1ml lOmg 250mg - 100.0 -  
 
Inference 
 The   Mega soolai veekathukku chooranam show moderate chronic anti inflammatory 
action. 
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ANTI - INFLAMMATORY STUDIES ON 
ARKAATHI THYLAM 
Procedure 
Anti-inflamnmatory activity of Arkaathi thylam was studied in 
healthy albino rats, weighing between 100 - 150 gms. For studying 
acute inflammation, rat hind paw oedema method   was used. 
 
 Six albino rats were selected and divided into three groups 
each containing two rats. To first group distilled water was given 
and kept as control. Before the application of the drug, the hind 
paw volume of all rats were measured. This was done by dipping 
the hind paw upto the tibiodorsal junction in Mercury 
plethysmograph. 
 
 Subcutaneous injection of 0.1% of carrageenin (W/V) in water 
was made into plantar surface of both the hind paw of each rat. To 
the test/ group Arkaathi thylam was topically applied frequently 
over the inflamed surface in a thin layer. To the control group, no 
drug was applied over the inflamed surface. One and half hours 
after injection the hind paw volume was measured once again. The 
difference between the initial and final volumes would show the 
amount of inflammation. 
 
 Taking the volume in the control group as 100% of 
inflammation, the inflammation or anti-inflammatory effect of the 
group is calculated. 
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Results 
Effect of Arkaathi thylam 
 
Serial 
No 
Name of 
drug / 
groups 
Dose / 100 
gram 
body weight 
 
 
Initial 
Reading 
average 
Final 
reading 
average 
Mean 
difference 
Percentage 
Inflammation 
Percentage 
Inhibition Remarks 
      
1. 
Arkaathi 
thylam 
External 0.65 0.96 0.31 36.4 63.6 Significant 
2. Ibu brufen 20mg/ 1ml 0.55 0.85 0.3 35.2 64.8  
3. Water 1ml 0.55 1.4 0.85 100.0 -  
 
Inference: 
It is observed that Arkaathi  Thylam has significant anti-inflammatory action  
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                                       Annexure - IV 
CASE SHEET PROFORMA FOR VALI AZHAL KEEL VAYU 
GOVERNMENT SIDDHA MEDICAL COLLEGE, DEPARTMENT OF 
POST GRADUATE PALAYAMKOTTAI, TIRUNELVELI.  
BRANCH III - SIRAPPU MARUTHUAM 
I.P.No  :      Occupation : 
Bed. No  :      Income  : 
Ward  :      Nationality  : 
Name  :      Date of admission: 
Age   :      Date of discharge: 
Sex   :      Diagnosis  : 
Permanent address     Result  : 
        Medical officer : 
Temporary address 
 
 
Complaints and duration 
 
 
History of Present illness 
 
 
Personal history and Habit 
 
Family History 
 
 
General condition on Examination 
Consciousness 
General appearance 
Stature  
Nourishment 
Skin changes 
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Facies  
Pallor  
Jaundice  
Cyanosis  
Clubbing 
Lymphadenopathy 
Abdominal distension 
Jugular venous pulsation 
Engorged veins 
Koilonychia 
Pedal oedema 
Generalised oedema 
Temperature 
Pulse 
Rate 
Rhythm 
Volume 
Character 
Peripheral pulses 
Pulses paradoxus 
Respiration  
Rate  
Rhythm  
Character 
Heart rate  
Blood pressure  
Miscellaneous 
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rpj;j Kiw Njh;Tfs; 
1. epyk; 
 Fwp;Q;rp  
 Ky;iy 
 KUjk; 
 nea;jy; 
 ghiy 
2. gUtfhyk; 
 fhh;fhyk; (Mtzp - Gul;lhrp) 
 $jph; fhyk; ([g;grp - fhh;j;jpif) 
 Kd;gdp (khh;fop - ij) 
 gpd;gdp ( khrp - gq;Fdp) 
 ,sNtdpy; (rpj;jpiu-itfhrp) 
 KJNtdpy; (Mdp - Mb) 
3. ahf;if (cly;) 
 thjk; 
 gpj;jk; 
 fgk; 
 fyg;G 
4. Fzk; 
 rj;Jt Fzk; 
 ,uNrh Fzk; 
 jNkh Fzk; 
5. nghwp> Gyz;fs; 
 nka; (njhL czh;T) 
 tha; (Rit)  
 fz;(ghh;it) 
 %f;F ( ehw;wk;) 
 nrtp (Nfl;ly;) 
 
 149
6. fd;Nke;jphpak;/fd;ktplak; 
 if (jhdk;) 
 fhy; (fkdk;) 
 tha; (trdk;  
 vUtha;(tprh;f;fk;) 
 fUtha; (Mde;jk;) 
7. cl;fha mjf;fhak; 
 Gak; 
 rak; 
 fhy; 
 ghjk; 
8. Kk;kyk; 
 kyk; 
 %j;jpuk; 
 tpah;it 
9. gpw cWg;Gfspd; epiy 
 ,Ujak; 
 Gg;Grk; 
 ,iug;ig 
 fy;yPuy; 
 kz;zPuy; 
 rpWFly; 
 ngUq;Fly; 
 rpWePufk; 
 rpWePh;g;ig 
 %is 
 fUg;ig 
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10. caph;j;jhJf;fs; 
a) thjk; 
 gpuhzd; 
 mghzd; 
 tpahdd; 
 cjhdd; 
 rkhdd; 
 ehfd; 
 $h;kd; 
 fpUfud; 
 Njtjj;jd; 
 jdQ;nrad; 
b) gpj;jk; 
 mdw; gpj;jk;. 
 ,uQ;rf gpj;jk; 
 rhjf gpj;jk; 
 MNyhrf gpj;jk; 
 gpuhrf gpj;jk; 
c) fgk; 
 mtyk;gfk; 
 fpNyjfk; 
 Nghjfk; 
 jw;gfk; 
 re;jpfk; 
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11. cly; jhJf;fs; 
 rhuk; 
 nre;ePh; 
 Cz;  
 nfhOg;G 
 vd;G 
 %is 
 Rf;fpyk;/RNuhzpjk; 
12. vz; tifj; Njh;Tfs; 
 ehb 
 ];ghprk; 
 eh 
 epwk; 
 nkhop 
 tpop 
kyk; 
 epwk; 
 vil 
 ,Wfy; 
 ,sfy; 
%j;jpuk; 
 
m. ePh;f;Fwp 
 epwk; 
 kzk; 
 vil 
 Eiu 
 vQ;ry; 
M. nea;f;Fwp 
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Laboratory Investigation 
Blood 
 TC      :   cells/cu.mm 
 DC     : P   %  L   %  E   % 
ESR   
 ½  hour  :      mm 
 1 hour :      mm 
Hb   : 
Blood sugar :  F/PP/R 
Serum cholesterol: 
Uric acid  : 
Urea   : 
VDRL  : 
Urine 
 Albumin : 
 Sugar : 
 Deposits : 
Motion 
 Ova  : 
 Cyst   : 
Immunological 
 RA factor  
Anti ccp antibody 
Radiographic evaluation 
 Serological test for syphilis 
Synovial fluid analysis  
Arthrography 
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Locomotor system 
Inspection 
Overlying skin  
Colour 
Scars and ulcers 
Periarticular swelling 
Bones 
Deformity 
Unusual feature 
Muscle changes 
Symmetrical distribution 
Joint movement 
Gait 
Palpation 
Skin temperature 
Soft tissues 
Bony enlargement 
Crepitation 
Subcutaneous nodules  
Rheumatoid vasculitic lesions  
Lymphadenopathy  
Pitting oedema 
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RANGE OF MOVEMENT 
 
Examination of individual Joints 
Cervical spine 
Thoracic spine 
Lumbar spine 
Sacroiliac joint 
Shoulder joint 
Elbow joint 
Wrist joint 
Interphalangeal joint 
Hip joint 
Knee joint 
Metatarso phalangeal joint 
 
Examination of individual joints (Affected joints)  
Measurement 
Knee joint  
Ankle joint  
Wrist joint 
Elbow joint  
Index finger 
Middle finger  
Ring finger  
Little finger 
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Examination of other system 
Respiratory system 
Cardiovascular system 
Gastro intestinal system 
Central nervous system 
 
Signs and Symptoms 
Management: 
 
DAILY PROGRESS 
Date   Symptoms Drug 
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
HOSPITAL  
POST GRADUATE DEPARTMENT 
BRANCH - III SIRAPPU MARUTHUVAM 
 PALAYAMKOTTAI, TIRUNELVELI - 627 002. 
 
ADMISSION - DISCHARGE SHEET FOR "VALI AZHAL KEEL VAYU" 
 
I.P.No  :      Occupation : 
Bed. No  :      Income  : 
Ward  :      Nationality  : 
Name  :      Date of admission: 
Age   :      Date of discharge: 
Sex   :      Diagnosis  : 
Permanent address     Result  : 
        Medical officer : 
Temporary address 
 
CLINICAL PICTURES 
SI. No. During Admission During Discharge 
   
PLACE:  
DATE:            Signature of the medical officer 
 157
BIBLIOGRAPHY 
1. Gunapadam - Mooligai - Dr.Murugesa Mudaliyar 
2. Kannusamiyam ennum vaithya sekaram 
3. Man murugiyam ennum tamil maruthuva nool 
4. Noi naadal Noi mudhal naadal I 8 II — Dr.M.Shunmuga Velu 
H.P.I.M 
5. Thanvanthari vaithiyam. 
6. Aruvai maruthuvam- uthamarayan 
7. Pathartha Guna vilakkam 
8. Siddha Maruthuvam - Dr. Kuppusamy Mudhaliyar 
9. Siddha maruthuvanga churukkam - Dr.K.S. Uthamarayan 
10. Thirumoolanayanar Sikicha ratna theepam 
11. Yugi Vaidhya Chinthamani 
12. Agathiyar 2000 I,II Part 
13. Theriyar Vagadam 
14. Yugi munivar perunool vaidhya kaviyam 1000 
15. Sathaganadi 
16. Agathiyar Nadi 
17. Agathiyar Gunavagada thirattu 
18. Agathiyar vaidhya vallathy 600 
19. Davidsons principles and practice of medicine - 19th edition 
20. CECIL Text book of medicine. 
21. Text book of orthopaedics and trauma - G.S.Kulkarni 
22. Mercer's orthopaedics surgery book 
23. Harrison's Text book of medicine 
24. Wealth of India 
25. Pharmacopoeial standards of herbal plants 
26. T.V.Samba sivam pillai Tamil - English Dictionary 
 158
27. Indian Medicinal Plants 
28. Essentials of medical physiology - K.Sembulingam 
29. Fundamentals of Biochemistry for medical students – Ambika 
Shanmugam 
30. Text Book of Medicinal Botany - Dr.S.Somasundaram 
31. www.wikipedia.org 
32. www. yo gaonline. Com 
33. www.photos.google.com 
 
